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I. RECOMMENDATIONS FOR A GLYCIDYL ETHERS STANDARD
NIOSH recommends that employee exposure to glycidyl ethers in the 
workplace be controlled by adherence to the following sections. The 
recommended standard is designed to protect the health and provide for the 
safety of employees for up to a 10-hour workshift, 40-hour workweek, over a 
working lifetime. Compliance with all sections of the recommended standard 
should substantially reduce any risk of mutagenic or tumorigenic effects of 
glycidyl ethers and prevent other adverse effects of exposure in the 
workplace. Employers should regard the recommended workplace environmental 
limit as the upper boundary for exposure and make every effort to keep the 
exposure as low as is technically feasible. The criteria and standard will 
be subject to review and revision as necessary.
Glycidyl ethers are characterized by the presence of a three-carbon 
chain with an epoxide group and an ether linkage. This recommended 
standard applies to monoglycidyl ethers and diglycidyl ethers that contain 
an alkyl group, an aromatic group, or a moiety of the structure -(RO)n-R'. 
It does not include any halogenated compounds or polymerized forms.
Most of the glycidyl ethers are liquids but some are solids. The 
most common use of these compounds is as reactive diluents in epoxy resins. 
Toxicologic data concerning these compounds are scarce, but those available 
show that glycidyl ethers are primary skin and eye irritants and that they 
are potential skin sensitizing agents. Some data suggest that 
di(2,3-epoxypropyl) ether should be regarded as a potential occupational
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carcinogen and that n-butyl glycidyl ether is a mammalian mutagen. Some 
glycidyl ethers have also produced cytotoxic effects in animals.
The differences in toxicity among members of the class of glycidyl 
ethers and the absence of data on some of them prevent the setting of a 
single environmental limit for all glycidyl ethers. Dermal contact is the 
major route of exposure to glycidyl ethers; in addition to producing 
irritation and sensitization, high doses of the compounds may be absorbed 
through the skin and cause systemic effects. Glycidyl ethers have 
relatively low vapor pressures, but inhalation is, nevertheless, a possible 
secondary route of exposure to these compounds. Exposures to airborne 
glycidyl ethers have caused eye irritation and, at high concentrations, 
systemic effects and death in animals.
"Occupational exposure" to glycidyl ethers is defined as work in any 
area where these substances are manufactured, stored, used, or handled.
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to glycidyl ethers shall be controlled so that 
concentrations do not exceed the following ceiling concentration limits, 
listed in milligrams per cubic meter of air (mg/cu m) and converted to 
parts per million (ppm), as determined during a 15-minute sampling period:
Allyl glycidyl ether (AGE) 45 mg/cu m (9.6 ppm) 
240 mg/cu m (50 ppm)
5 mg/cu m (1 ppm)
Isopropyl glycidyl ether (IGE)
Phenyl glycidyl ether (PGE)
n-Butyl glycidyl ether (BGE) 30 mg/cu m (4.4 ppm) 
1 mg/cu m (0.2 ppm)Di(2,3-epoxypropyl) ether (DGE)
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(b) Sampling and Analysis
Procedures for the collection and analysis of workroom air samples 
for compliance with the standard shall be as provided in Appendices I, II, 
and III or by any methods shown to be at least equivalent in precision, 
sensitivity, and accuracy to the methods specified.
Section 2 - Medical
Medical surveillance shall be made available as outlined below to all 
workers with occupational exposure to glycidyl ethers.
(a) Preplacement examinations shall include at least:
(1) Comprehensive medical and work histories with special 
emphasis directed to past exposure to glycidyl ethers or other vinyl 
derivatives and history of sensitivities, allergies and reproductive events.
(2) Physical examination giving particular attention to the
skin, eyes, and mucous membranes.
(3) If indicated in the judgment of the responsible 
physician, clinical tests, such as total and differential leukocyte counts, 
urinalysis, pulmonary function tests, and tests of manual dexterity and 
visual-motor coupling.
(4) A judgment of the worker's ability to use positive 
pressure respirators.
(b) Periodic examinations shall be made available as directed by 
the responsible physician. These examinations shall include at least:
(1) Interim medical and work histories.
(2) Physical examination as outlined in (a)(2) and (a)(3)
above.
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(c) During examinations, applicants or employees found to have
medical conditions, such as neurodermatitis, dyshydrosis, or atopy (an 
inherited predisposition to allergy), that would be directly or indirectly 
aggravated by exposure to glycidyl ethers shall be counseled on the 
increased risk of impairment of their health from working with these
substances. Workers shall also be notified that BGE was mutagenic in mice 
and bacteria and DGE caused skin papillomas in mice. Strict adherence to 
work practices and sanitation are advised.
(d) In the event of an illness known or suspected to be due to
glycidyl ethers, a physical examination as described in paragraphs (a)(2) 
and (a)(3) above shall be made available.
(e) In the event of an emergency involving gross contamination
with or inhalation or ingestion of glycidyl ethers, appropriate first-aid 
treatment shall be given, and a physician shall be contacted.
(f) Pertinent medical records shall be maintained for at least 30 
years after termination of employment. Records of environmental exposure 
applicable to an employee shall be included in that employee's medical 
records. These records shall be made available to the designated medical 
representatives of the Secretary of Health, Education, and Welfare, of the 
Secretary of Labor, of the employer, and of the employee or former 
employee.
Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in 
the predominant language of non-English-reading workers. Workers unable to
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read the labels and signs provided shall receive information regarding 
hazardous areas, the hazards of working with glycidyl ethers, practices and 
procedures for protecting themselves, and the instructions printed on 
labels and signs.
(a) Containers
Shipping and storage containers of glycidyl ethers shall have a 
readily visible label that bears the name of the ether and information on 
the effects of exposure on human health. The information may be arranged 
as in the following example:
NAME OF ETHER 
(synonym)
WARNING !
COMBUSTIBLE (or FLAMMABLE, as appropriate)
MAY CAUSE SKIN SENSITIZATION 
OR OTHER ALLERGIC RESPONSE
Keep containers closed when not in use.
Prevent all contact with skin and eyes.
Do not inhale vapors or aerosols.
Use only with adequate ventilation.
Store in a cool area - Compound may react 
violently if heated.
First Aid: In case of contact with eyes, immediately flush
eyes with plenty of water and consult a physician. In case 
of skin contact, wash with soap and water.
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Many glycidyl ethers are combustible or flammable liquids, and this 
information, when pertinent, shall be included on the label directly under 
the word "WARNING." Labels for 2,3-(epoxypropyl) ether (DGE) shall also 
include the words "CANCER SUSPECT AGENT."
(b) Posting
In all areas where occupational exposure to glycidyl ethers occurs, 
warning signs that bear the name of the ether and information on its 
effects on human health shall be prominently displayed. The information on 
these signs may be arranged as in the following example.
NAME OF ETHER 
(synonym)
WARNING!
COMBUSTIBLE (or FLAMMABLE, as appropriate)
MAY CAUSE SKIN SENSITIZATION 
OR OTHER ALLERGIC RESPONSE
Many glycidyl ethers are combustible or flammable, and this 
information, when appropriate, shall be included on the sign directly under 
the word "WARNING." Signs for areas where DGE is used shall also include 
the words "CANCER SUSPECT AGENT."
Section 4 - Personal Protective Clothing and Equipment
Engineering controls and work practices shall be used to keep
concentrations of airborne glycidyl ethers at or below the recommended
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ceiling concentrations and to prevent skin and eye contact with glycidyl 
ethers. In addition, employers shall provide protective equipment and 
clothing to employees when necessary.
(a) Protective Clothing
(1) The employer shall provide appropriate clothing, 
including gloves, aprons, suits, boots, and faceshields (8-inch minimum), 
made of materials impervious to glycidyl ethers, eg, milled butyl rubber or 
polyvinyl alcohol, and shall ensure that such clothing is worn by every 
employee to prevent skin contact. The protective clothing shall also be 
fire-resistant. Gloves shall be of sufficient length to protect the
forearms of the employees.
(2) The employer shall ensure that a change of clothing is
immediately available to any employee whose clothes become grossly 
contaminated with glycidyl ethers.
(3) Leather articles, such as belts or shoes, that become 
contaminated with glycidyl ethers shall be rendered unfit for use and 
discarded.
(4) The employer shall provide separate storage facilities
for work clothes and for street clothes and shall ensure that employees do 
not remove protective clothing from the workplace.
(5) The employer shall inform persons involved in
laundering or handling the contaminated clothing of the hazardous 
properties of glycidyl ethers.
(6) Safety showers and eyewash fountains shall be provided 
in appropriate areas. This equipment shall be checked periodically to 
ensure that it is in proper working condition.
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(b) Eye and Face Protection
Chemical safety goggles (splashproof) or face shields (8-inch 
minimum) with goggles meeting the requirements listed in 29 CFR 1910.133 
and ANSI Z87.1-1968 shall be provided by the employer and shall be worn 
during any operation in which there is a reasonable possibility of a 
glycidyl ether being splashed into the eyes.
(c) Respiratory Protection
Engineering controls shall be used when needed to keep concentrations 
of airborne glycidyl ethers at or below the ceiling concentrations 
specified in Section 1(a). When a local exhaust ventilation system is 
used, it shall be of sparkproof design and maintained to prevent the 
accumulation or recirculation of glycidyl ether vapors in the workplace and 
to remove them effectively from the breathing zone of employees. Exhaust 
ventilation systems discharging into outside air must conform with 
applicable local, state, and Federal air pollution regulations and must not 
constitute a hazard to employees or to the general population. Ventilation 
systems shall be given regular preventive maintenance and cleaning to 
ensure effectiveness. This shall be verified by measurements that 
demonstrate system efficiency, eg, air velocity, static pressure, or air 
volume, taken at least every 3 months, or more frequently if required for 
the safe and efficient operation of a particular system. Measurements of 
system efficiency shall also be made as soon as possible after any change 
in production, process, or control that might result in an increase in the 
concentration of airborne glycidyl ether.
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(1) Compliance with the recommended workplace environmental 
limit may be achieved by the use of respirators only under the following 
conditions:
(A) During the installation, testing, maintenance, 
or repair of the required engineering controls.
(B) For operations such as nonroutine maintenance 
and repair activities causing brief exposures at concentrations in excess 
of the workplace environmental limit.
(C) During emergencies.
(2) When a respirator is permitted by paragraph (c)(1) of 
this section, it shall be selected and used in accordance with the 
following requirements:
(A) The employer shall establish and enforce a 
respiratory protective program. The requirements for an adequate program 
can be found in 29 CFR 1910.134.
(B) The employer shall provide respirators in
accordance with Tables 1-1, 1-2, 1-3, and 1-4 and shall ensure that
employees use the respirators properly when the concentrations of airborne 
glycidyl ethers exceed the ceiling concentrations recommended in Section 
1(a). The respirators shall be those approved by NIOSH or the Mine Safety 
and Health Administration (MSHA). The employer shall ensure that 
respirators are properly cleaned, maintained, and stored when not in use.
(C) Protective equipment suitable for emergency 
entry shall be located at clearly identified areas outside the work area.
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TABLE 1-1
RESPIRATOR* SELECTION GUIDE FOR ALLYL GLYCIDYL
ETHER AND ISOPROPYL GLYCIDYL ETHER
Concentration (mg/cu m)
Respirator Type Approved 




equal to 470 4,700
470 4,700Greater than 
or
Emergency (entry into area of
unknown concentration 
for emergency purposes 
such as firefighting)
(1) Chemical cartridge respirator 
with full facemask and organic 
vapor cartridge
(2) Gas mask with full facepiece and 
chin-type organic vapor canister
(3) Gas mask with full facepiece and 
front- or back-mounted organic vapor 
canister
(4) Supplied-air respirator with 
full facepiece operated in the 
pressure-demand mode
(5) Supplied-air respirator with 
full facepiece, hood, helmet, or 
suit, operated in the pressure-demand 
or continuous-flow mode
(6) Powered air-purifying res­
pirator with organic vapor canis­
ter and full facepiece, hood, or 
helmet
(7) Self-contained breathing appara­
tus with full facepiece, operated
in the pressure-demand mode
(1) Self-contained breathing appara­
tus with full facepiece, operated
in the pressure-demand or other 
positive pressure mode
(2) Combination Type C supplied-air 
respirator with full facepiece, 
operated in the pressure-demand mode 
and equipped with an auxiliary self- 
contained air supply




RESPIRATOR* SELECTION GUIDE FOR PHENYL GLYCIDYL ETHER
Concentration 
(mg/cu m)
Respirator Type Approved 
under Provisions of 30 CFR 11
Less than or (1) Chemical cartridge respirator
equal to 250 with full facemask and organic vapor 
cartridge
(2) Gas mask with full facepiece and 
chin-type organic vapor canister
(3) Gas mask with full facepiece and 
front- or back-mounted organic vapor 
canister
(4) Supplied-air respirator with full 
facepiece operated in demand mode
(5) Self-contained breathing appara­
tus with full facepiece operated in 
demand mode
Greater than (1) Supplied-air respirator with full
250 or facepiece operated in pressure-demand
Emergency mode
(2) Supplied-air respirator with full 
facepiece, hood, helmet, or suit op­
erated in pressure-demand or continu- 
ous-flow mode
(3) Powered air-purifying respirator 
with organic vapor canister and full 
facepiece, hood, or helmet




RESPIRATOR* SELECTION GUIDE FOR n-BUTYL GLYCIDYL ETHER
Concentration 
(mg/cu m)
Respirator Type Approved 
under Provisions of 30 CFR 11
Less than or 
equal to 5,000
Supplied-air respirator with full 
facepiece, hood, helmet, or suit, 
operated in pressure-demand or 
continuous-flow mode
Greater than 5,000 
or Emergency
(1) Self-contained breathing appara­
tus with full facepiece operated in 
pressure-demand mode
(2) Combination Type C supplied-air 
respirator with full facepiece oper­
ated in pressure-demand mode
and equipped with auxiliary self- 
contained air supply




RESPIRATOR* SELECTION GUIDE FOR D I (2,3-EPOXYPROPYL)ETHER
Concentration 
(mg/cu m)
Respirator Type Approved 
under Provisions of 30 CFR 11
Greater than 1.0 or 
Emergency
(1) Self-contained breathing appara­
tus with full facepiece operated
in pressure-demand or other posi­
tive pressure mode
(2) Combination Type C supplied-air 
respirator with full facepiece oper­
ated in pressure-demand or other 
positive pressure mode and auxili­
ary self-contained breathing ap­
paratus operated in pressure-demand 
or other positive pressure mode
*Full-body protective clothing shall also be worn whenever a respirator is 
required.
Section 5 - Informing Employees of Hazards
(a) Employees working in an area that may involve occupational 
exposure to glycidyl ethers shall be informed of the hazards of such 
employment, the appropriate emergency procedures to use, and the proper 
procedures for safe handling and use of glycidyl ethers.
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(b) The employer shall institute a continuing education program, 
conducted by persons qualified by experience or training, to ensure that 
employees have current knowledge of job hazards, proper maintenance and 
cleanup methods, and proper respirator use. The instructional program 
shall also include a description of the general nature of the medical 
surveillance procedures and of the advantages to the employee of undergoing 
the examinations recommended. Educational programs for employees engaged 
in maintenance and repair shall include instruction on those work 
situations in which they will be occupationally exposed to glycidyl ethers.
(c) Instructional material in written or published form shall be 
kept on file at each establishment or department where employees are 
occupationally exposed to glycidyl ethers. Each employee shall be informed 
of the availability of the required information, which shall include, as a 
minimum, that prescribed in Appendix IV.
(d) Required information shall be recorded on the "Material Safety 
Data Sheet" shown in Appendix IV or on a similar form approved by the 
Occupational Safety and Health Administration, US Department of Labor, and 
shall be kept on file, readily accessible to employees.
Section 6 - Work Practices
(a) Storage and Handling
(1) The handling and storage of liquid glycidyl ethers 
shall comply with the provisions of 29 CFR 1910.106 for flammable or 
combustible liquids.
(2) Fire extinguishers approved for use in fighting fires
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supported by Class II and Class III combustible or Class I-C flammable 
liquids, eg, dry chemical extinguishers, shall be available in areas where 
glycidyl ethers are loaded, unloaded, or stored. Fire extinguishers shall 
be inspected annually by qualified personnel and recharged or replaced if 
necessary.
(3) In case of a leak, loading or unloading operations, as 
appropriate, should continue as rapidly as possible to drain the tank or 
permit necessary repairs if it is safe to make them. If the leak is 
severe, causing unsafe conditions, loading or unloading operations should 
cease and emergency procedures should be instituted.
(4) Whenever flammable or combustible liquids are 
transferred from one container to another, both containers must be 
effectively bonded and grounded to prevent the buildup and discharge of 
static electricity.
(b) Cleanup and Waste Disposal
Spills of large amounts of glycidyl ethers shall be washed with water 
into an appropriate drainage system as soon as possible where the ethers 
can be safely stored until they are either recovered or discarded. 
Discarding of waste shall conform to applicable Environmental Protection 
Agency (EPA) standards and must not constitute a hazard to employees or to 
the population at large. When it is not possible to wash a spill with 
water, the area should be cordoned off until cleanup operations have been 
completed. If a vacuum truck is used to remove the glycidyl ether, there 
should be no sources of ignition in the vicinity of the spill and 
sufficient flashback prevention devices shall be provided.
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(c) Entry into Confined Spaces
(1) Entry into confined spaces, such as tanks, pits, and 
process vessels, that have contained glycidyl ethers shall be controlled by 
a permit system. Permits shall be signed by an authorized representative 
of the employer to certify that preparation of the confined space, 
precautionary measures, and personal protective equipment are adequate and 
that the prescribed procedure will be followed.
(2) All lines shall be disconnected or blocked while 
process vessels are being cleaned. All valves or pumps leading to and from 
the vessel shall be locked in the off position and tagged with a sign 
stating that work is in progress or other similar message.
(3) A confined space that has contained glycidyl ethers 
shall be washed with water or some other appropriate agent and purged with 
air or with nitrogen followed by air before any employee enters it. 
Provision shall be made for adequate ventilation of the confined space to 
provide sufficient oxygen for employees working inside.
(4) A calibrated combustible gas meter shall be used to 
check for explosion hazard. The test shall be performed by a person 
trained in the use of the combustible gas meter. When it is possible that 
airborne glycidyl ether vapors could increase in concentration within the 
confined space, this test shall be repeated every 30 minutes.
(5) The vessel shall then be checked for concentrations of 
airborne glycidyl ethers, possible oxygen deficiency, and concentrations of 
other likely contaminants. A positive pressure respirator shall be used 
during this checking procedure.
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(6) The interiors of tanks or vessels shall be illuminated 
by reflected light or explosion-proof light sources during cleaning or 
repairs. Only nonferrous (sparkproof) tools are permitted to be used in 
these operations.
(7) No employee shall enter any tank or vessel that does
not have an entrance large enough to admit an employee equipped with safety 
harness, lifeline, and appropriate respiratory equipment. The employee
shall be able to leave the tank or vessel by the same opening.
(8) Employees entering contaminated tanks or vessels shall 
wear full-body protective clothing until inspection and testing assure 
safety for personnel in the tank.
(9) When an employee is working in a confined space,
another employee shall be stationed at the entrance to keep the first
employee under constant observation, and one or more additional employees
shall be readily available in case of an emergency. A positive pressure 
respirator with safety harness and lifeline shall be located outside the 
tank or vessel for emergency use.
(d) General Work Practices
(1) Smoking, matches, open flames, and spark-producing 
devices shall be prohibited in areas where glycidyl ethers are handled. 
Tools used in these areas shall be sparkproof.
(2) Employers shall ensure that workers do not carry 
smoking materials into areas where glycidyl ethers are handled. If smoking 
areas are provided, they should be located at a safe distance from glycidyl 
ether work and storage areas.
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(e) Emergency Procedures
The employer shall formulate emergency evacuation, medical, and 
firefighting procedures and shall ensure that they are posted in all work 
areas where emergencies involving glycidyl ethers might occur and that 
employees are instructed in these procedures.
(1) Procedures shall include prearranged plans for 
obtaining first-aid and emergency medical care and for transportation of 
injured workers.
(2) Firefighting procedures shall be established and 
implemented. The glycidyl ether sources shall be clearly marked, and 
workers and emergency personnel shall be instructed in proper shutoff 
procedures. The instructions shall include procedures for emergencies 
involving the release of vapors of glycidyl ethers. In case of fire, 
glycidyl ether sources shall be shut off or removed. Containers shall be 
removed or cooled with water. Chemical foam, water, carbon dioxide, or dry 
chemicals shall be used for fighting glycidyl ether fires, and proper 
respiratory protection and protective clothing shall be worn by employees 
engaged in firefighting.
(3) Approved eye, skin, and respiratory protection, as 
specified in Section 4, shall be used by personnel engaged in emergency 
operations.
(4) Nonessential employees shall be evacuated from exposure 
areas during emergencies. During an emergency, perimeters of hazardous 
areas shall be roped off, posted, and secured.
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(5) Personnel who may be required to shut off sources of 
glycidyl ethers, clean up spills, and repair leaks shall be properly 
trained in the appropriate procedures.
Section 7 - Sanitation
(a) Food or beverage preparation, storage, dispensing (including
vending machines), and consumption shall be prohibited in work areas where 
glycidyl ethers are present.
(b) Adequate facilities with soap and water for handwashing shall 
be made available to employees who work with glycidyl ethers.
(c) Employees shall be cautioned not to touch or rub their eyes
with hands that may be contaminated with glycidyl ethers.
(d) The employer should recommend that all employees wash their
hands before using toilet facilities or eating.
Section 8 - Monitoring and Recordkeeping Requirements
Each employer with a place of employment where glycidyl ethers are 
present shall conduct an industrial hygiene survey to determine whether 
exposure to glycidyl ethers may occur. Surveys shall be repeated at least 
semiannually and within 30 days after any process change likely to result 
in increased concentrations of airborne glycidyl ethers. Records of these 
surveys, including the basis for concluding that concentrations of airborne 
glycidyl ethers are at or below the ceiling concentration limits specified 
in Section 1(a), shall be maintained.
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(a) Personal Monitoring
(1) If it is determined that exposure to airborne glycidyl 
ethers has occurred, a program of personal monitoring shall be instituted 
to identify and measure, or permit calculation of, the exposure of all 
employees who are occupationally exposed to glycidyl ethers. Monitoring of 
employee exposure to airborne glycidyl ethers shall be conducted at least 
semiannually. If monitoring reveals that an employee is exposed to 
glycidyl ethers at concentrations in excess of the recommended ceiling 
concentration limits specified in Section 1(a), control measures shall be 
initiated, the employee shall be notified of the exposure and of the 
control measures being implemented to correct the situation, and the 
exposure of that employee shall be monitored at least once every 30 days. 
Such monitoring shall continue until two consecutive evaluations, at least 
30 days apart, indicate that the employee's exposure no longer exceeds the 
recommended ceiling concentration limits. Semiannual monitoring may then 
be resumed.
(2) In all personal monitoring, samples of air
representative of the breathing zones of the employees shall be collected.
(3) For each determination, a sufficient number of samples 
shall be taken to characterize the employee's exposure during each 
workshift. Variations in work or production schedules and in employee 
location and job function shall be considered in choosing sampling times, 
locations, and frequency.
(b) Recordkeeping
Records of environmental monitoring and exposure information shall be 
kept by the employer for at least 30 years after the employee's last
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occupational exposure to glycidyl ethers. These records shall include the 
dates of measurements, job function and location of the employees at the 
worksite, sampling and analytical methods used, number, duration, and 
results of the samples taken, ceiling concentrations estimated from these 
samples, type of personal protective equipment in use at the time of 
sampling, and identification of exposed employees. Employees shall have 
access to information on their own environmental exposures. Environmental 
monitoring records shall be made available to designated representatives of 
the Secretary of Labor, the Secretary of Health, Education, and Welfare, 
the employer, and the employee or former employee.
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II. INTRODUCTION
This report presents the criteria and the recommended standard which 
were prepared to meet the need for preventing occupational disease and 
injury arising from exposure to glycidyl ethers in the workplace. The 
criteria document fulfills the responsibility of the Secretary of Health, 
Education, and Welfare under Section 20(a)(3) of the Occupational Safety 
and Health Act of 1970 to "...develop criteria dealing with toxic materials 
and harmful physical agents and substances which will describe exposure 
levels...at which no employee will suffer impaired health or functional 
capacities or diminished life expectancy as a result of his work 
experience."
After reviewing data and consulting with others, NIOSH formalized a 
system for the development of criteria upon which standards can be 
established to protect the health and provide for the safety of employees 
exposed to hazardous chemical and physical agents. Criteria for a 
recommended standard should enable management and labor to develop better 
engineering controls resulting in more healthful work environments, and 
simply complying with the recommended standard should not be the final 
goal.
These criteria for a recommended standard for glycidyl ethers are 
part of a continuing series of criteria developed by NIOSH. The 
recommended standard applies to the handling, processing, manufacture, use, 
and storage of the glycidyl ethers. The standard was not designed for the 
population-at-large, and any extrapolation beyond workplace exposures is 
not warranted. The standard is intended to (1) protect against the
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development of local irritation of the skin and eyes, (2) protect against 
skin sensitization and the development of systemic toxicity, (3) be 
measurable by techniques that are valid, reproducible, and available to 
industry and government agencies, and (4) be attainable with existing 
technology.
The primary effects of glycidyl ethers on workers reported to date 
are irritation and skin sensitization. There is also some evidence that 
cross-sensitization occurs between the glycidyl ethers and their 
polymerized forms (unmodified epoxy resins). Glycidyl ethers have caused 
cytotoxic effects and have been mutagenic in bacteria, and n-butyl glycidyl 
ether was mutagenic to mice in the dominant lethal test. Another glycidyl
ether, di(2,3-epoxypropyl) ether, has induced skin papillomas in mice, and
triethylene glycol diglycidyl ether induced lung adenomas in rats given 
high doses by intraperitoneal injection.
The chief use of glycidyl ethers is as reactive diluents in epoxy 
resin systems. However, because information on the composition of certain 
epoxy resins is proprietary, it is often difficult to obtain information
about the glycidyl ether or ethers that are present in a particular epoxy
resin. Furthermore, exposure to the epoxide moeity in both glycidyl ethers 
and epoxy resins can occur until the resin is completely cured. Thus, 
workers must be considered to be at risk of exposure to glycidyl ethers 
from the time the ethers are synthesized until the curing process of the 
epoxy resin is completed. In addition, since irritation, skin 
sensitization, and cross-sensitization can occur, it is necessary to take 
steps to ensure that workers have minimal contact with glycidyl ethers or 
their vapors.
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There is a great need for further research on the metabolism and 
toxicity of individual glycidyl ethers. Lack of data makes it impossible 
to determine truly safe exposure concentrations for a number of the ethers 
used in industry today. Studies of eye and skin irritation and of the
effects of inhalation of glycidyl ether vapors by both humans and
experimental animals are needed. Epidemiologic studies are necessary to 
assess the possible effects of long-term exposure of populations of workers 
on their health and longevity. There is an urgent need for studies on the 
carcinogenic potential of the glycidyl ethers, especially since some 
glycidyl ethers are cytotoxic, mutagenic, or tumorigenic.
There are no validated methods for the sampling and analysis of any 
of the diglycidyl ethers. It is important that such methods be devised and 
tested, since di(2,3-epoxypropyl) ether is potentially carcinogenic. The
validated methods that do exist for some of the glycidyl ethers have not
been validated at the limits recommended in this standard. They may be 
adequate, with certain adjustments, for lower limits and for all glycidyl 
ethers, but this needs to be demonstrated.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Although many glycidyl ethers could theoretically be synthesized, 
relatively few are used in industry today. The current toxicologic data on 
most of these ethers are incomplete, and it is therefore necessary to draw 
inferences based on their physical, chemical, and toxicologic
characteristics to assess their potential health hazards.
All glycidyl ethers are characterized by the presence of the 2,3-




H -C — C— C— O—  R\ /  I
O H
The monoglycidyl ethers discussed in this document can be represented by 
the formula B-O-R, and the diglycidyl ethers by B-(O-R)n-O-B, where B is 
the 2,3-epoxypropyl group, 0 is oxygen, R can range from a simple alkyl to 
a complex hydrocarbon group, and n = 0 to 3. No polymerized forms, such as 
occur in cured epoxy resins, are included. Glycidyl ethers on which 
toxicologic data have been found are listed in Table XIV-1, with names
conforming to the nomenclature of the International Union of Pure and
Applied Chemistry (IUPAC), other synonyms, and structural formulas. 
Physical and chemical properties of some glycidyl ethers are presented in 
Table XIV-2 [1-5].
The three-membered ring that oxygen forms by bridging between two 
adjacent carbon atoms makes up the epoxide or oxirane ring. Because this 
ring is highly strained, epoxide-containing compounds will react with
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almost all nucleophilic (electron-donating) substances [6,7]. Ring opening 
will occur when the compounds are treated with halogen acids, sulfonic 
acids, bisulfite, thiosulfate, carboxylic acids and anhydrides, hydrogen 
cyanide, water, alcohols, amines, aldehydes, and the like [7]. These 
reactions are described in more detail in Appendix V.
Glycidyl ethers have become important because of their high 
reactivity. In organic synthesis, epoxides are used as chemical reagents 
in the manufacture of a wide variety of materials [7]. The glycidyl ethers 
most commonly used today include allyl glycidyl ether (AGE), n-butyl 
glycidyl ether (BGE), o-cresyl glycidyl ether (CGE), isopropyl glycidyl 
ether (IGE), phenyl glycidyl ether (PGE), resorcinol diglycidyl ether, 1,4- 
butanediol diglycidyl ether, alkyl or aliphatic glycidyl ethers and 
diphenylol propane diglycidyl ether. The last compound is the oligomer 
with the lowest molecular weight of the diglycidyl ether of bisphenol A, 
probably the most common component of uncured epoxy resins. Resorcinol 
diglycidyl ether is a solid; the other glycidyl ethers listed are liquids, 
but most have low vapor pressures at ambient temperatures. However, most 
reactions with glycidyl ethers occur at higher than ambient temperatures, 
so that the vapor pressures become appreciable.
Because of its toxicity, di(2,3-epoxypropyl) ether (also called 
diglycidyl ether or DGE) does not appear to be generally used outside of 
experimental laboratories. It is included in this document, however, 
because it is the simplest of the diglycidyl ethers and is therefore 
representative of that group of compounds.
Triethylene glycol diglycidyl ether has been used as an
antineoplastic agent [8-16]. Some data concerning this glycidyl ether have
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been included in this chapter to aid in relating the structures and 
toxicities of the various glycidyl ethers.
Extent of Exposure
The major use of the glycidyl ethers is as reactive diluents in epoxy 
resin systems. After all the components of an epoxy resin system have been 
mixed, the epoxide groups react to form cross-linkages within the resin. 
In a completely cured epoxy resin, glycidyl ethers no longer exist [17(p 
79)]. However, because epoxy resins have such a wide range of 
applications, workers often must handle glycidyl ethers and the uncured 
resins containing them in processes like tooling and molding, manufacturing 
and using adhesives, roof and floor construction, and applying protective 
coatings [17(pp 25,153),18]. Uncured resins used in protective coatings 
are often applied by spraying, so that the applicators could be exposed to 
large quantities of vapors and mists containing glycidyl ethers. Work 
practices appropriate for handling glycidyl ethers should be adhered to in 
processes involving an uncured epoxy resin system.
Glycidyl ethers such as PGE and BGE are synthesized by adding the 
appropriate alcohol to epichlorohydrin in the presence of a catalyst. The 
intermediate chlorohydrin is not isolated and undergoes dehydrochlorination 
to yield a glycidyl ether [17 (p 152)]. Commercial manufacture of glycidyl 
ethers takes place within an enclosed system, but workers may be exposed to 
glycidyl ethers during drumming operations at the end of the process [17(p 
154)]. Very small quantities of glycidyl ethers are used for other 
purposes, most of which are proprietary in nature [17(pp 25,153)]; in these 
instances, identification of exposed workers and estimation of their extent 
of exposure become difficult.
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NIOSH estimates that 118,000 workers in the United States are exposed 
to glycidyl ethers and that an additional 1,000,000 workers are exposed to 
epoxy resins. Occupations involving potential exposure to glycidyl ethers 
are listed in Table XIV-3 [17(pp 11,25,153),19-22] .
Effects on Humans
The only studies found describing biologic effects on humans of the 
glycidyl ethers used commercially in the United States concern dermatitis, 
sensitization, irritation, and allergic reactions following skin contact. 
No studies of the effects of inhalation of any of the glycidyl ethers by 
humans have been found.
In 1956, Hine et al [23] reviewed the medical records of workers 
exposed to glycidyl ethers and of all workers requiring first-aid treatment 
at one plant between 1947 and 1956. Exposure to PGE involved approximately 
20 workers for about 2 months each year. No worker had more than 600 hours 
of cumulative exposure. Exposure to AGE was at about half this rate; 
exposure to DGE and IGE had been limited to a few man-months, and exposure 
to BGE had involved about eight men for 3 months. Ten cases of 
occupational dermatitis resulting from exposure to AGE and 13 resulting 
from exposure to PGE were reported in this group of workers. No cases of 
dermatitis from IGE, BGE, or DGE were reported.
The symptoms and signs of dermatitis resulting from exposure to AGE 
were tenderness, reddening, itching, swelling, blister formation, and 
whitish macules [23]. In one instance, there was eye irritation from AGE 
vapor. The signs of dermatitis resulting from exposure to PGE were more 
severe, consisting of second-degree burns, blister formation, brownish
28
lesions, diffuse erythematous rash, erythematous vesicular rash, dry and 
defatted areas, watery discharge from the affected area, macular rash and 
papules, swelling of connective tissues, and edema.
The 10 patients with dermatitis from exposure to AGE were treated by 
the first-aid nurses a total of 26 times and were referred to physicians a 
total of 7 times [23] . The duration of treatment ranged from 1 to 8 days. 
The 13 episodes of dermatitis from exposure to PGE required 118 first-aid 
visits and were referred to physicians a total of 36 times. The duration 
of treatment for these complaints ranged from 1 to 56 days. Three cases of 
dermatitis did not respond readily to treatment, and these workers were 
referred to dermatologists. In most cases, the absence of immediate pain 
or burning resulted in a delay in initial treatment, and, in one case, the 
worker's failure to remove socks contaminated with PGE for several days 
increased the severity of the burn [23]. Four of the 23 workers with 
occupational dermatitis developed sensitivity reactions to AGE or PGE.
Both AGE and PGE caused irritation and sensitization, but the data 
presented by Hine et al [23] indicated that the effects of PGE were more 
persistent and less responsive to treatment. The authors stated that 
repeated contact with any of the compounds would probably give rise to 
dermatitis, although no human effects have been reported from exposure to 
DGE, IGE, or BGE. The severity of injury from PGE was increased when the 
compound was not immediately removed from contact with the skin. The 
authors also pointed out that the vapor of AGE was irritating to the eyes. 
The information presented indicates that these glycidyl ethers are 
potentially irritating to the eyes and skin after minimal contact and that 
they are probably irritating to the respiratory tract as well.
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Hine and colleagues [23] noticed that they suffered from irritation 
of the eyes, nose, and respiratory tract when exposed to the glycidyl 
ethers during experiments with animals. These exposures occurred at room 
temperature. The investigators used AGE, BGE, IGE, PGE, and DGE in their 
studies, and they did not indicate which glycidyl ethers were the most 
irritating.
In 1965, Zschunke and Behrbohm [24] observed 15 cases of occupational 
dermatitis in workers exposed to PGE, which was being added to 
"chloroparaffins" and polyvinyl chloride as a stabilizer, in two cable- 
manufacturing plants. In one plant, 12 of 18 workers developed eczema. In 
another plant, only the three persons referred to a physician because of 
suspected occupational eczema were examined. In these patients, the eczema 
had developed on areas of the hands, the lower arms, and the right side of 
the abdomen, which had come into contact with cable-coating material 
containing PGE. Workers with abdominal skin irritation had carried large 
pieces of sheathing material pressed tightly against their torsos while 
they were feeding the cable-sheathing machine. The reddened areas 
contained papules and papulo-vesicles, and the patients complained of 
severe itching. Ten of these 15 cases of occupational dermatitis were 
severe enough to cause the workers to miss 11-68 days of work (mean 30.5 
days). Eight of the 15 patients reacted positively to 24-hour patch tests 
with PGE in concentrations of 1.0-0.001% in 70% ethanol or peanut oil. The 
authors conducted further tests with both industrial and high-purity grades 
of PGE. The results of these tests were described as identical, leading 
the authors to exclude the possibility that impurities in the industrial- 
grade PGE might have been the cause of the dermatitis. The authors
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believed that the concentration of PGE used might have been too low to 
demonstrate sensitivity in the seven workers whose patch tests were 
negative, since the concentration at which they were occupationally exposed 
was about 3%.
Patch tests with 0.01% PGE were also performed on 58 persons 
considered not to have been exposed previously to the glycidyl ether, and 
no positive reactions were observed [24] . In seven other patients with 
eczema who had contact with epoxy resins but no known exposure to PGE, the 
tests were positive. These data indicate either that the epoxy resins to 
which the patients were exposed contained PGE as a reactive diluent or that 
cross-sensitization to PGE from the reactive diluent used in the resins had 
occurred.
Kligman [25], in 1966, tested the sensitization potential of a number 
of compounds, including BGE. BGE, 1 ml of a 10% suspension in mineral oil 
or petrolatum, was applied to the forearms or lower legs of 25 healthy 
adults on a cloth patch, 1.5 inches square, that was covered with plastic 
tape for 48 hours. A 24-hour rest period was allowed between each of five 
exposures. After the final induction exposure, the subjects were 
challenged with 0.4 ml of 10% BGE in petrolatum on a 1-inch-square patch on 
the lower back or forearm for 48 hours. The author classified BGE as a 
strong sensitizer because 19 of 24 subjects became sensitized to it (a 
strong sensitizer was defined as one that sensitized 14-20 of 25 subjects) 
[25].
Lea et al [26] have also examined the irritating and sensitizing 
properties of BGE. Pure BGE was applied to the backs of five persons on 
cotton patches that were covered with cellophane and held in place with
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adhesive tape for 48 hours, unless discomfort caused earlier removal. They 
developed skin irritation characterized by erythema, edema, multiple 
vésiculation, and superficial ulceration. When lower concentrations of the 
ether were tested, 17 of 25 persons (68%) reacted to a 10% suspension of 
BGE in petrolatum, 8 of 25 (32%) reacted to a 5% suspension, 1 of 25 (4%)
reacted to a 2.5% suspension, and none of 25 (0%) reacted to a 1.25% 
suspension. The reactions to the various dilutions of BGE ranged from mild 
erythema to the severe reaction described above and demonstrated that the 
irritation potential was dose dependent. Two weeks after these irritancy 
studies were completed, sensitization tests were performed with a 1.25% 
suspension, the concentration previously determined to be nonirritating. 
The results of the patch tests were checked at 24 hours, 48 hours, and 5 
days. Five of 25, or 20%, had become sensitized to BGE. The induction 
methods reported by Lea et al [26] were less stringent than those reported 
previously by Kligman [25], and the challenge concentration was lower. 
This probably accounts for the differences in sensitization rates reported 
in the two papers. This study [26] provides further evidence that the 
sensitizing effects as well as the irritative effects of BGE, and possibly 
of all glycidyl ethers, are dose dependent.
In 1964, Fregert and Rorsman [27] tested the allergenic properties of 
AGE, BGE, and PGE on people who were known to have contact allergies to 
epoxy resins of the diglycidyl ethers of bisphenol A. The test compounds 
were diluted to 0.25% in acetone before being used in the patch tests. The 
type of patch and the length of time it was left in place were not 
specified. The authors also performed a study to determine the 
concentration of PGE that could be used in a patch 1:est without producing
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primary irritation in individuals not allergic to epoxy resins, so that 
sensitization or allergic response could be distinguished from irritation.
Fourteen of 20 persons reacted to PGE, 3 of 20 to BGE, and 2 of 20 to 
AGE [27] . Four persons who reacted positively to PGE were also tested with 
CGE to determine whether these two glycidyl ethers, which were very similar 
in structure, had similar effects. All four reacted positively to CGE. 
Ten persons not allergic to epoxy resins were patch-tested with 1.0% PGE in 
acetone (a concentration at which no primary irritation occurred). Two 
became sensitized. The authors classified PGE as a very strong sensitizing 
agent. This study shows that persons exposed to epoxy resins, presumably 
only in the uncured state, may develop sensitivities to glycidyl ethers, 
and that cross-sensitization between the glycidyl ethers may occur.
Lundin and Fregert [28], in 1977, reported that 34 workers who had 
developed allergic contact dermatitis were patch-tested with different 
oligomers of the diglycidyl ether of bisphenol A. No experimental details 
were given. All of them developed positive reactions to the smallest 
oligomer (diphenylol propane diglycidyl ether), with a molecular weight of 
340, but none reacted to the oligomer with a molecular weight of 624. 
Lundin and Fregert [28] suggested that the oligomer with a molecular weight 
of 340 was a stronger allergen and that the workers had been exposed to it 
more extensively, since it makes up a large proportion of many low- 
molecular-weight resins. Workers who had become sensitized to low- 
molecular-weight epoxy resins also had positive reactions to a resin with 
an average molecular weight of 1,850 [28]. Lundin and Fregert believed 
that these were reactions to the small amounts of the oligomer with a 
molecular weight of 340 that were present in the high-molecular-weight
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resin. They noted that the amount of the small oligomer in this resin was 
usually not sufficient to induce sensitization but might be sufficient to 
produce a reaction in a person who had previously become sensitized.
In 1977, Malten [29] reported that diphenylol propane diglycidyl 
ether had been used in a standard European patch-test series since 1974. 
Persons suffering from eczema were patch-tested with this compound, and 
about 2% had positive skin reactions. Malten said that most of these 
people were women, but it was not clear whether this referred to the 
persons with eczema or only to those with positive reactions in the skin 
tests. In general, the causes of their sensitivity could not be 
identified.
In a 1976 report from Procter and Gamble Limited [30], data were 
presented for human sensitization to two alkyl glycidyl ethers. Procter 
and Gamble Epoxide No. 7 (R group predominantly C8 and CIO alkyl groups) 
caused sensitization at concentrations of 10% in mineral oil in "several" 
of 12 persons during a pilot study. Epoxide No. 8 (R group predominantly 
C12 and C14 alkyl groups) was tested on 57 persons. Each subject received 
nine induction applications of the glycidyl ether as a 10% solution in 
diethyl phthalate. A challenge application of the same substance 14 days 
later produced a questionable response in one individual. No other 
sensitization was reported, and another challenge on this individual and 
nine other subjects 6 weeks later produced no evidence of sensitization. 
Details of the experimental procedures were not reported in this 
communication. These results indicated that the C8-C10 alkyl glycidyl 
ether was a human skin sensitizer but the C12-C14 alkyl glycidyl ether was 
not, under these experimental conditions; however, the report noted that
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the latter compound was considered to be a potential skin sensitizer 
because of positive results obtained in animal studies by Thorgeirsson et 
al [31] .
No reports describing systemic effects in humans occupationally 
exposed to glycidyl ethers have been found. However, toxic side effects 
have been described in patients who received triethylene glycol diglycidyl 
ether as an antitumor agent. This substance has been used in cancer 
therapy in Europe and Australia since the 1960's. When triethylene glycol 
diglycidyl ether was administered by intravenous (iv) injection, 
intraarterial infusion, or bladder infusion in repeated doses totaling 75- 
800 mg/kg, leukopenia and bone marrow depression have been the most 
consistent effects noted [11-13,15,16]. In one study [16], a dose-related 
incidence of leukopenia was observed, with the condition occurring in 11 of 
13 patients given weekly iv injections of 100 mg/kg, in 4 of 6 treated with 
50 mg/kg, and in none of 6 at 10 mg/kg. Hypotension and loss of 
consciousness [13], drowsiness and lethargy [16], and nausea and vomiting 
[13,16] have also been reported. Intraarterial administration has produced 
edema [12,32] and hair loss [12,13,15,16] in the region of the injection, 
and dysuria has been reported following bladder infusion [11].
The results of the human studies indicate that the glycidyl ethers 
are sensitizers and irritants and that these effects are dose dependent. 
The relative sensitization potentials appear to be PGE and CGE > BGE > AGE. 
There is insufficient information to include DGE, IGE, or diphenylol 
propane diglycidyl ether (the diglycidyl ether of bisphenol A) in a series 
based on relative potencies. Systemic toxicity was also observed after 
high, repeated doses by intrarterial or iv infusion of triethylene glycol
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diglycidyl ether. The systemic effects included nausea and vomiting, 
cardiovascular and bone marrow depression, hair loss, and irritation and 
edema. These results suggest that all of the lower-molecular-weight
glycidyl ethers are irritants and sensitizers and that they may attack 
rapidly dividing tissues.
Epidemiologic Studies
No epidemiologic studies of workers occupationally exposed to
glycidyl ethers have been found in the literature.
Animal Toxicity
Toxicologic data on only a few glycidyl ethers have been found, and
much of this work has been done by the same few investigators. Studies of
carcinogenicity, mutagenicity, and effects on reproduction are especially 
scarce.
(a) General Toxicity
Range-finding studies have provided data on the toxicities of several
glycidyl ethers in various animal species. These are summarized in Table
XIV-4. Hine et al [23] evaluated the effects of AGE, BGE, IGE, PGE, DGE,
and, in a separate study [33], resorcinol diglycidyl ether. Smyth et al
[34] and Czajkowska and Stetkiewicz [35] have also reported acute toxicity
data on PGE, and Soellner and Irrgang [36] compared the toxicities of PGE
and CGE. BGE and butanediol diglycidyl ether were evaluated in a study of
uncured epoxy resins by Cornish and Block [32]. Weil et al [37] also
tested BGE, and a study by Procter and Gamble Limited [30] compared the
toxicities of BGE and of two alkyl glycidyl ethers containing alkyl
radicals in the ranges C8-C10 and C12-C14. Hine et al [23,33] used Long-
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Evans rats (body weight 89-150 g), Webster mice (16-22 g) , and albino 
rabbits (2.0-3.2 kg); Smyth et al [34] and Weil et al [37] used Carworth-
Wistar rats (90-120 g) and albino rabbits; Cornish and Block [32] used
Sprague-Dawley rats (150-250 g) and albino rabbits; and Czajkowska and 
Stetkiewicz [35] used Wistar rats (280-350 g).
Toxicity was evaluated in single-dose oral studies by administering 
the material by gastric intubation. In dermal studies, test material was 
kept in contact with the shaved skin under a plastic sleeve for 24 hours 
[32,34] or 7 hours [23]. Soellner and Irrgang [36] administered a single
subcutaneous (sc) injection of the test substances to mice. Acute
inhalation hazard was evaluated by determining the longest single exposure 
at concentrations near saturation that permitted all animals to survive for 
14 days [32,34], or by using nominal concentrations and calculating the 
resulting LC50's for 4-hour or 8-hour exposures [23]. Mortality during a 
14-day observation period was the basis for all calculations except those 
of Hine et al [33] on resorcinol diglycidyl ether, which were based on 
mortality within 10 days of exposure.
DGE and AGE were the most toxic of the glycidyl ethers tested when 
administered in a single oral dose (Table XIV-4). LD50 values for other 
glycidyl ethers with molecular weights of less than 250 were similar; they 
were generally in the range of 2-4 g/kg in rats, indicating that these 
compounds are only slightly hazardous by this route [38]. The two alkyl 
glycidyl ethers (C8-C10 and C12-C14) and diphenylol propane diglycidyl 
ether, which have molecular weights of more than 300, were much less toxic 
than the other compounds.
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Hine et al [23,33] also administered two of the glycidyl ethers 
intraperitoneally (ip). BGE administered ip to groups of five rats (121— 
161 g) and five mice (21-29 g) gave LD50's of 1.14 and 0.70 g/kg, 
respectively. These LD50 values showed a relatively small decrease (2.4 
and 2.0 times, respectively) by this route, which, according to the 
authors, suggested ready absorption from the gastrointestinal tract [23]. 
However, ip administration of resorcinol diglycidyl ether gave LD50's of 
0.178 g/kg in rats and 0.243 g/kg in mice, a decrease of approximately 
14.5-fold in rats and 4-fold in mice, indicating that this aromatic 
glycidyl ether was less readily absorbed when administered orally than when 
injected ip [33]. Unfortunately, Hine et al [33] did not present data on 
the LD50 of resorcinol diglycidyl ether by percutaneous absorption. The 
LD50's obtained by painting glycidyl ethers on the skin of rabbits were
generally similar to the oral LD50's, suggesting that these materials are 
readily absorbed through the skin.
In acute inhalation exposures (Table XIV-4), DGE was by far the most 
lethal to mice, with an LC50 of 30 ppm (160 mg/cu m ) , but it was nonlethal 
to rats at the highest concentration tested, 200 ppm (1,060 mg/cu m) [23]. 
BGE was more lethal to rats than to mice, while AGE and IGE showed no
marked species differences; LC50's for PGE were not obtained. Hine et al
[23] reported that the LC50 for PGE was greater than 100 ppm (600 mg/cu m ) . 
However, their calculations were based on a vapor pressure of 0.1 mmHg for 
PGE; other investigators have reported that this is an erroneous figure, 
the actual vapor pressure being estimated to be 0.01 mmHg at 25 C [39,40]. 
The latter figure yields a theoretical saturated air concentration of 13 
ppm (80 mg/cu m) at 25 C. Hence, throughout this document, the
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concentration of PGE vapor obtained by Hine et al is corrected to "about 10 
ppm" (60 mg/cu m ) .
Smyth et al [34] determined that the maximum period for which rats 
could tolerate exposure to "concentrated" PGE vapor with no mortality was 8 
hours; Cornish and Block [32] reported values for butanediol diglycidyl 
ether and BGE of 8 and 2 hours, respectively, and Weil et al [37] also 
reported 2 hours for BGE. It should be noted that the theoretical 
saturated air concentration for BGE at 25 C is about 4,000 ppm (21,300 
mg/cu m) while that for PGE is only 13 ppm (80 mg/cu m ) .
(b) Dermal Effects
The irritant effects of several of the glycidyl ethers have been 
studied in single- and repeated-application experiments [23,30,32- 
35,37,41,42]. In the single-application studies, 0.5 ml of the undiluted 
compounds was applied to the clipped skin of albino rabbits on two abraded 
and two intact sites, according to the method described by Draize [43]. 
The test compounds were left in contact with the skin for 24 hours. In 
repeated-application studies, the undiluted test compounds were applied to 
the clipped skin of rabbits for 1 [23] or 7 hours [33]. Applications were 
repeated 5 days/week until maximum eschar formation or signs of systemic 
toxicity were noted.
Results of these skin application studies are summarized in Table 
XIV-5. All the glycidyl ethers tested produced moderate or severe skin 
irritation under these conditions. DGE was the most irritating of the 
compounds, and it also produced severe irritation in both rabbits and rats 
when the duration of skin contact was reduced to 7 hours [23,41]. It was 
followed in irritant potential by resorcinol diglycidyl ether [33], AGE and
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IGE [23], butanediol diglycidyl ether [32], and the C12-C14 and C8-C10 
alkyl glycidyl ethers [30]. BGE [23,30,32,37,42] and PGE [23,30,34], 
produced widely disparate degrees of skin irritation, ranging from very 
mild to severe, in tests by different investigators using similar 
methodology.
In a 1977 study designed to determine the effects of repeated 
exposure to airborne PGE at concentrations close to the 1976 TLV of 10 ppm 
(60 mg/cu m ) , Terrill and Lee [39] found hair loss and associated skin 
damage in exposed rats. Groups of 32 rats of each sex and 6 male beagles
were exposed to PGE at 0 (controls), 1, 5, and 12 ppm (6, 30, and 70 mg/cu
m) for 6 hours/day, 5 days/week, for 90 days. Chamber concentrations were 
monitored by ultraviolet analysis of impinger samples taken hourly and were 
determined as TWA concentrations. Animals were weighed twice weekly, and 
blood and urine samples were taken for analysis from 20 rats from each 
group and from all dogs on days 30, 60, and 90 of exposure and 30, 60, and 
90 days after exposure ended. Twelve rats from each exposure group were 
killed at days 30, 60, and 90 of exposure and 28 days after exposure ended, 
and three dogs from each group were killed at the end of exposure and 90 
days later, for examination of all major organs.
The only effect seen in any of the test animals was hair loss in the
rats exposed at 5 and 12 ppm (30 and 70 mg/cu m ) , affecting 10% of the
males and 25% of the females by the 90th day of exposure [39]. Microscopic 
examination of the skin showed inflammatory cellular infiltration of the 
dermis, damaged hair follicles, and hyperkeratosis. The authors concluded 
that these conditions were attributable to chemical irritation of the skin 
and not to systemic toxicity. They concurred with the observations of Hine
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et al [23] that dermatitis is the principal hazard associated with exposure 
to PGE and suggested that a TLV of 1 ppm (6 mg/cu m) might be necessary to 
protect workers against skin irritation.
Several glycidyl ethers have been evaluated for their allergenic 
activity in skin sensitization tests. Thorgeirsson et al [31,44] and 
Lundin and Fregert [28] investigated the ailergenicity of several glycidyl 
ethers using the guinea pig maximization test described by Magnusson and 
Kligman [45] . Groups of 10-20 guinea pigs were exposed to the glycidyl 
ethers in a two-stage induction process. In the first stage, test 
materials were administered by intracutaneous injection in a shaved area on 
the animal's back. Each guinea pig received three pairs of injections: 
(1) 0.1 ml of the test substance in propylene glycol at a dilution
previously found not to cause severe irritation or serious systemic 
toxicity; (2) 0.1 ml of the glycidyl ether solution mixed with 0.1 ml of
Freund's complete adjuvant; (3) 0.1 ml of Freund's adjuvant blended with 
0.1 ml of water. Control animals were inoculated only with Freund's 
adjuvant, an emulsion of paraffin oil and water containing heat-killed 
tubercule bacteria [46], which has increased the sensitivity of guinea pigs 
to allergens so that it approximates that of humans [45] . In the second 
stage of induction, conducted 1 week later, a 2 x 4-cm piece of filter 
paper saturated with the 10% glycidyl ether in propylene glycol was placed 
on the skin of the animals, covering the original injection sites, and 
occluded for 48 hours. Two weeks later, the animals were challenged by 
applying 1 drop of the test substances, at a dilution previously found to 
be nonirritating, to the shaved skin of the flank, with occlusion for 24 
hours [31] . Some compounds were also tested for their ability to induce
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cross-sensitization by challenging with glycidyl ethers other than the one 
used in the induction procedure. Twenty-four hours after removal of the 
patches, the challenge sites were shaved and evaluated for redness and 
swelling.
All animals exposed to the alkyl glycidyl ether became sensitized to 
the substance; 75% of the test animals were cross-sensitized to an epoxy 
resin of bisphenol A, and 33% were sensitized to BGE and CGE [31]. 
Diphenylol propane diglycidyl ether (the diglycidyl ether of bisphenol A 
with a molecular weight of 340) produced sensitization in 80-100% of the 
test animals, but exposure to the oligomer of this glycidyl ether with a 
molecular weight of 624 produced only 56-60% positive reactions, and 
oligomers with molecular weights of 908 and 1,192 produced no 
sensitization. Of the animals sensitized to the oligomer with a molecular 
weight of 624, 30% reacted to that having a molecular weight of 340, but no 
reciprocal cross-sensitivity was observed. One animal sensitized with the 
oligomer having a molecular weight of 908 cross-reacted to that having a 
molecular weight of 624. Neopentyl glycol diglycidyl ether produced 
sensitization in 87% of the test animals, CGE in 75%, and butanediol 
diglycidyl ether in 60% [28] . Only 50% of the animals exposed to BGE had a 
positive response to the challenge dose of BGE, but all reacted positively 
to the C12-C14 alkyl glycidyl ether and 67% to CGE; none reacted to an 
epoxy resin of bisphenol A [31].
Thorgeirsson et al [44] also found that, although a single 
intradermal injection of the diglycidyl ether of bisphenol A was sufficient 
to sensitize 30% of the guinea pigs tested, no sensitization was produced 
by topical application alone. However, when the skin was pretreated with
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sodium lauryl sulfate to produce irritation, 47% of the animals were 
sensitized, indicating that skin irritation enhanced the development of 
sensitization. None of the oligomers of bisphenol A studied were primary 
irritants; patch tests with 25% solutions of each of them caused no
irritation. These data suggest that workers who come in contact with these 
oligomers are much more likely to become sensitized if their skins are 
irritated.
Weil et al [37] reported that BGE had sensitized 16 of 17 guinea pigs
tested with the material 3 weeks after being given a series of 8
intracutaneous injections; PGE sensitized 1 of 18 animals in a similar 
test. Zschunke and Behrbohm [24] reported probable sensitization to PGE in 
guinea pigs induced by repeated topical applications, but they did not 
obtain positive reactions to PGE at low challenge concentrations.
Sensitization studies in guinea pigs have shown that all the glycidyl 
ethers tested that had molecular weights of 624 or less caused some degree 
of allergic response. The sensitizing capacity of oligomers of the 
diglycidyl ether of bisphenol A decreased with increasing molecular weight 
[44]; however, the oligomer of bisphenol A with a molecular weight of 340 
(diphenylol propane diglycidyl ether) and the C12-C14 alkyl glycidyl ether 
were more allergenic than the low-molecular-weight glycidyl ethers tested. 
Thorgeirsson et al [31] postulated that one factor making the alkyl 
glycidyl ether a more active sensitizer than BGE was its longer aliphatic 
chains, which caused it to be more lipid soluble; thus, it could penetrate 
the skin more readily.
Although the C12-C14 alkyl glycidyl ether and diphenylol propane 
diglycidyl ether were the most active sensitizers, they are relatively low
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in acute toxicity [30,37] and have low irritation potential [30,44]. The 
very limited animal toxicity data available are not sufficient for an 
attempted correlation of sensitization and irritation potentials. The most 
severe irritant, DGE, has not been examined for sensitization potential.
(c) Eye Effects
The abilities of glycidyl ethers to irritate the eyes have been 
evaluated in direct-application studies on rabbits [23,30,32-35,37,41,42]. 
The undiluted glycidyl ethers were introduced into the conjunctival sac of 
one eye of each animal, while the other eye served as a control. Eye 
irritation was scored at intervals after application by the method 
described by Draize [43] or by Smyth et al [34].
Results of these studies are presented in Table XIV-5. From these 
findings, the eye irritant potentials of the glycidyl ethers tested can be 
ranked in descending order as follows: DGE, AGE, butanediol diglycidyl
ether, resorcinol diglycidyl ether, IGE, and the C8-C10 and C12-C14 alkyl 
glycidyl ethers. Irritation produced by PGE in different tests was 
reported to range from mild to severe, and that for BGE ranged from mild to 
moderate. None of the glycidyl ethers used in these tests caused permanent 
damage to the eye.
In 1962, Mettier et al [47] studied the effects of a 4-hour exposure 
to DGE at concentrations of 20-27 ppm (106-144 mg/cu m ) , average 24 ppm 
(128 mg/cu m ) , on intact corneal epithelium, on deepithelialized cornea, 
and on the regeneration of corneal tissue of 3-month-old male white 
rabbits. Airborne DGE vapor was produced by volatilizing the pure material 
at a constant rate. The rate of regeneration of corneal epithelium was 
measured by the time required for regeneration of an area (7-10 mm in
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diameter) of cornea denuded of epithelium by trephination. In both 
untrephined and trephined rabbits exposed to DGE, there was an almost total 
loss of adhesion between the corneal epithelium and the stroma [47]. This 
effect was very severe, but it did not seem to increase the regeneration 
time of the epithelium. The exposure did produce a dense, milky 
opacification of the corneal stroma, resulting in permanent corneal 
scarring and new vessel formation. The iritis and keratitis that resulted 
appeared to be related to exposure, but the trauma of removal of the 
epithelium may also have been a factor.
Hine et al [23] also noted eye irritation from some glycidyl ethers 
during exposures to the airborne vapors. Corneal opacity was seen in some 
rats after a single 8-hour exposure to AGE and IGE at unspecified
concentrations, but not in rats exposed for 8 hours to BGE, PGE, or DGE.
In rats exposed to AGE for 7 hours/day, 5 days/week, corneal opacity 
developed in all 10 animals exposed at 900 ppm (4,200 mg/cu m) for 5 weeks, 
in 6 of 10 exposed at 600 ppm (2,800 mg/cu m) for 5 weeks, and in 1 of 10 
exposed at 400 ppm (1,870 mg/cu m) for 10 weeks. No eye damage was 
reported in rats exposed to AGE at 260 ppm (1,210 mg/cu m) for 10 weeks. 
Slight eye irritation was also observed in rats exposed to IGE at 400 ppm 
for 10 weeks, but only "minimal signs" of eye irritation were observed in
rats exposed to PGE at a concentration of about 10 ppm (60 mg/cu m ) . In
another study [41], rabbits exposed to DGE for 24 hours at 3, 6, 12, or 24 
ppm (16-128 mg/cu m) developed erythema and edema of the conjunctiva at all 
concentrations. In those exposed at 24 ppm (128 mg/cu m ) , corneal opacity 
appeared by the 3rd day.
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Corneal opacity has also occurred after cutaneous applications of DGE 
to the shaved backs of rats at a dose of 125 mg/kg/day, 5 days/week, for 4 
weeks [41]. Six such applications at 250 and 500 mg/kg/day also produced 
corneal opacity. Animals in this study were not caged individually, and 
the application sites were not covered, permitting the eyes of the animals 
possibly to touch the application areas on other animals. Thus, the eye 
effects may have resulted from direct ocular contact with DGE.
All the glycidyl ethers tested produced some degree of primary eye 
irritation when applied directly to the eyes. DGE, AGE, and IGE have been 
reported to affect the eyes of animals exposed to their airborne vapors 
[23,41].
(d) Systemic Effects
The toxic effects resulting from acute exposure to DGE, AGE, BGE, 
IGE, PGE [23], and resorcinol diglycidyl ether [33] were described by Hine 
et al. In the former study [23], all the compounds produced labored 
breathing and CNS depression when administered orally. This was preceded 
by incoordination, reduced motor activity, and, with BGE, by agitation and 
excitement. The animals were usually comatose at the time of death. 
Animals that survived exposure to PGE showed reversal of depression, with 
increased CNS activity. Watering of the eyes was noted in animals given 
AGE. With dermal application, signs of toxic activity were described as 
minimal. Depression was noted only with DGE and PGE. Death usually 
occurred within 17 hours, but was delayed for up to 5 days in some cases. 
The most frequent effect produced by inhalation of the glycidyl ethers was 
irritation of the lungs. Microscopic examination of stained sections 
showed pneumonitis. Discoloration of the liver and kidneys was frequently
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noted in exposed animals, but microscopic examination of sections of these 
organs did not show consistent tissue changes. Focal inflammatory cells 
and moderate congestion were seen in the livers of some rats after 
administration of AGE, BGE, and IGE. Gross examination also showed 
hyperemia of the adrenal gland and adhesions of the stomach to adjacent 
tissues after oral administration.
Orally administered resorcinol diglycidyl ether also produced few 
evident effects [33] . The authors reported moderate CNS depression, 
slightly labored breathing, and, in surviving animals, loss of weight and 
diarrhea. Findings from gross examination of organs were described as 
nonspecific, with local irritation being the principal effect. There were 
no notable specific differences among rats, mice, and rabbits.
In a study designed to compare effects of different routes of 
administration of PGE, Czajkowska and Stetkiewicz [35] described the toxic 
effects occurring in rats as a result of single oral and dermal exposures. 
The organs of animals that died as a result of exposure or that were killed 
6-72 hours or 14 days after exposure were examined for gross changes. 
Tissue samples for microscopic examination were taken from the cerebrum, 
cerebellum, lungs, heart, spleen, liver, kidneys, stomach, intestines, 
bladder, and skin.
In rats given PGE orally, deaths occurred within 6-24 hours, while 
those exposed dermally died after 12-48 hours [35]. Narcosis was observed 
in both groups. With both routes of exposure, gross and microscopic 
examination showed hyperemia of internal organs, especially the liver and 
kidneys, hemorrhages in the submeningeal and subpleural regions, and 
darkening of the epithelium in the kidney tubules and in liver tissue.
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Rats receiving PGE orally also showed necrotic foci in the mucous membranes 
of the stomach. The most apparent changes from exposure by this route were 
in the liver. Rats dying 6-8 hours after oral administration had acute 
degenerative changes, including necrosis in the subcapsular region of the 
liver where it contacted the stomach wall; after 20-72 hours, the necrosis 
in this area of the liver was extensive. After 14 days, adhesion of the 
liver to the stomach wall was macroscopically evident; microscopically,
there were necrotic foci in the subcapsular region separated from the
remaining parenchyma by a fibrous band of tissue composed largely of
uninuclear cells and offshoot noduli, which indicated that regeneration was 
occurring. After dermal application, the major changes were in the skin, 
which showed hyperemia and necrosis involving the subcutaneous layers. In 
two rats that died after 18 and 20 hours, extravasation within the
peritoneal cavity indicated sites of damage to the internal organs. One of 
these animals had necrosis of the subcapsular region of the liver, and the 
other had a hyperemic and hemorrhagic loop of the small intestine. After
14 days, no effects were observed in the internal organs of the surviving
rats, and the skin showed evidence of regeneration and scar formation.
The authors [35] concluded that PGE had a strong toxic effect at the
site of administration, resulting in necrosis of the mucous membranes or
skin, and was able to penetrate such barriers and damage underlying or con­
tiguous tissue. They noted that systemic effects with both routes of admin­
istration included circulatory disorders resulting in hyperemia, increased 
permeability of the capillaries, and damage to parenchymatous organs.
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These authors [35] also calculated the rate of skin absorption of 
PGE, using a total of eight rabbits and five rats. The material was placed 
in contact with the skin for 1-4 hours by one of two methods: (1) Petri
dishes filled with cotton saturated with PGE were applied to the abdominal 
skin of rabbits, and the difference in weight of the petri dish at the 
beginning and end of exposure was used to calculate the absorption rate;
(2) gauze saturated with 900-1,200 mg of PGE was applied to the skin of 
rats and rabbits, and the amount absorbed was calculated as the difference 
between the amount applied and the amount determined titrametrically at the 
end of the experiment. In both cases, evaporation was prevented by 
covering the area with foil and an elastic bandage. The calculated 
absorption rates were 4.2 mg/sq cm/hour for rabbits and 13.6 mg/sq cm/hour 
for rats. Using the dermal LD50 determined in this study (2.16 g/kg), the 
authors calculated that a rat weighing 250 g with an exposed surface of 16 
sq cm would absorb a lethal dose within about 2 hours. They postulated 
that, assuming 100% absorption from the lungs, a rat with a pulmonary 
ventilation rate of 73 ml/minute exposed to airborne PGE vapors at 0.6 
mg/liter (600 mg/cu m; 100 ppm) for 8 hours would absorb 0.084 g/kg, about 
1/30 of the LD50. However, it is very rare for all of an inhaled substance 
to be absorbed from the lungs.
Because of its low toxicity and low vapor pressure, the authors [35] 
concluded that PGE presents little risk from acute inhalation exposure 
under industrial conditions, although they cautioned that this does not 
apply where aerosols of PGE are released into the air. They deemed 
irritative effects and dermal absorption to be the major risks to workers 
occupationally exposed to PGE.
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Effects of repeated exposures to the glycidyl ethers were also 
evaluated in the studies by Hine et al [23,33]. For the long-term 
inhalation studies [23], groups of 10 rats were exposed to vapors of AGE or 
IGE at 400 ppm (1,870 and 1,900 mg/cu m, respectively) for 7 hours/day, 5 
days/week, for 10 weeks or to PGE on the same schedule at a concentration 
approaching saturation, approximately 10 ppm (60 mg/cu m ) . In another 
experiment, groups of 10. rats received, on the same schedule, exposures to 
AGE at 260, 600, and 900 ppm (1,210, 2,800, and 4,200 mg/cu m) [23].
Severe toxic effects made it necessary to terminate the study after 25 
exposures to AGE at 600 and 900 ppm, but the group exposed at 260 ppm 
(1,210 mg/cu m) received 50 exposures. The rats were observed throughout 
the exposure period and were weighed weekly. Control groups were exposed 
to uncontaminated air. All survivors were killed at the end of the 
experiment, and blood samples were collected for hemoglobin determinations. 
At necropsy, lung, liver, and kidney weights were recorded, and sections of 
these organs and of the brain, thyroid, thymus, heart, stomach, intestine, 
pancreas, adrenals, testes, and bladder from alternate animals were 
prepared for microscopic examination.
Only AGE was lethal in this inhalation test; at 600 and 900 ppm
(2,800 and 4,200 mg/cu m ) , 7 or 8 of 10 animals in each group died between
the 7th and 21st exposures and, at 400 ppm (1,870 mg/cu m ) , one rat died
after the 18th exposure. [23]. AGE caused decreased weight gain (P<0.01)
at all concentrations. At 260 ppm (1,210 mg/cu m ) , the only other changes
observed were slight eye irritation and respiratory distress persisting
throughout the exposure period. The only statistically significant change
in organ/body weight ratio was that for the kidneys of the animals exposed
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to AGE at 400 ppm (P<0.01). Because only a few animals survived exposure 
to AGE at 600 and 900 ppm, statistical comparisons could not be made. 
Animals exposed to IGE showed slight eye irritation and respiratory 
distress [23] . They also had a significant decrease in mean weekly weight 
gains (P<0.01). Concentrations of hemoglobin in the blood increased in 
rats exposed to all compounds except AGE, but there was no evidence that 
red blood cell production in the bone marrow or extramedullary hemopoietic 
centers had been affected.
Necropsy of rats exposed to AGE at 400 ppm (1,870 mg/cu m) showed a 
greater decrease in peritoneal fat than was found in rats exposed to IGE 
[23]. Necropsy of one rat that died after the 18th exposure revealed 
severe emphysema, a mottled liver, and enlarged and congested adrenal 
glands; emphysema, bronchiectasis, and bronchopneumonia were each seen in 
single rats that survived the entire exposure period. Rats exposed to AGE 
at 600 and 900 ppm (2,800 and 4,200 mg/cu m) had more severe abnormal 
changes in the lungs, including bronchopneumonic consolidation, severe 
emphysema, bronchiectasis, and inflammation. Necrotic spleens were found 
in two of the rats exposed to AGE at 900 ppm.
Weight gain in rats exposed to PGE was similar to that in controls 
[23]. The tissues of these rats did not differ in appearance from those of 
control animals, except that two rats showed peribronchial and perivascular 
pulmonary infiltration by inflammatory cells and "cloudy swelling" (early 
stage of necrosis) in their livers.
The chronic toxicity of resorcinol diglycidyl ether was also 
evaluated by repeated inhalation studies in rats [33]. Ten male Long-Evans 
rats, 80-104 g, were exposed 7 hours/day, 5 days/week, for 10 weeks to air
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described as saturated with resorcinol diglycidyl ether. The authors did 
not report the concentration of airborne resorcinol diglycidyl ether, but 
since it is a solid at room temperature, the concentration at saturation in 
air would probably be low. Ten control rats were exposed to uncontaminated 
air. The only toxic effect observed in exposed rats was slight
encrustation of the eyelids of some animals. No gross or microscopic
lesions were found, and exposed animals did not differ significantly from 
controls in weight gain or organ weight/body weight ratios.
Soellner and Irrgang [36] reported that CGE and PGE had antispasmodic 
and muscle relaxant effects in animals. These glycidyl ethers were 3-40 
times more effective than their corresponding glycerol ethers in relieving 
spasms induced in guinea pig small intestine with barium chloride, 
acetylcholine, or histamine. Muscle relaxant effects were investigated in 
revolving drum tests with mice. By sc injection, the minimum effective 
doses that caused mice to lose their ability to remain in the drum were 430
mg/kg for PGE and 390 mg/kg for CGE, indicating only slight muscle relaxant
effects.
Kodama et al [48] and Hine et al [41] investigated effects on the 
hemopoietic system in animals exposed to glycidyl ethers. In the first 
study [48], groups of five male Long-Evans rats weighing 151 ±32 g received 
intramuscular (im) injections of BGE, PGE, or AGE at 400 mg/kg/day or DGE 
at 25 mg/kg/day. Rats that served as negative controls received injections 
of propylene glycol at 230 mg/kg/day, and positive control animals received 
a single im injection of a known alkylating agent, either busulfan at 10 
mg/kg or mechlorethamine hydrochloride at 0.5 or 5 mg/kg. Blood samples
were analyzed, and sections of bone marrow, lungs, liver, kidneys,
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adrenals, thymus, spleen, and testes were examined microscopically as well.
Since both BGE and PGE had minimal toxic effects, and the leukocyte 
counts in the rats rose rather than fell after three injections [48], no 
further work was done with these compounds. Rats that received four 
injections of AGE had swelling at the injection site and lost weight [48]. 
Two rats died, and post-mortem examination showed pulmonary congestion in 
one and a small spleen and no visible thymus in the other. The three 
surviving rats had involuted thymuses at necropsy. Microscopic examination 
showed atrophy or loss of lymphoid tissue, focal necrosis of the pancreas 
and testes, hemorrhage into the thymus, hemorrhage into the periphery of 
the liver, and pneumonia. The leukocyte count was significantly reduced in 
all animals. Bone marrow contained a normal number of nucleated cells, but 
the myeloid-to-erythroid ratio was low. The rats that received six
injections of DGE gained weight normally, and none died. Edema at the 
injection site was the only grossly observable effect. The leukocyte count 
was significantly decreased. Bone marrow was not examined in these 
animals.
Negative controls gained weight normally and showed no signs of 
intoxication, but their mean leukocyte count rose almost 40% [48]. The
positive control animals that received busulfan continued to gain weight, 
and none died. The mean leukocyte count, the number of nucleated marrow 
cells, and the ratio of myeloid to erythroid cells were decreased. Animals 
that received mechlorethamine lost weight, and three died. Nucleated 
marrow cells and the myeloid-to-erythroid ratio decreased.
The absence of hemopoietic effects with BGE and PGE was considered by
the authors [48] to indicate that monofunctional alkylating agents are
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considerably less active than polyfunctional alkylating agents. The 
activity of AGE was attributed to the reactive sites on the double-bonded 
carbon rather than to the epoxide moiety.
In a more extensive study of the effects of DGE on the hemopoietic 
system, Hine et al [41] administered the compound by several routes to 
three species of animals, using both single and repeated exposures. 
General chronic toxicity of the compound was also evaluated in rats exposed 
to the vapor at low concentrations. Male Long-Evans rats (115-145 g) 
received single and repeated cutaneous applications to their shaved backs 
and repeated vapor exposures. Male New Zealand rabbits (1.9-4.2 kg) were 
given single applications on their shaved backs, single and repeated iv
injections, and single vapor exposures. A total of 14 mongrel dogs were 
administered the material by im or iv injections. Hematologic examinations 
were the same as those used by Kodama et al [48].
Single cutaneous applications of DGE at 0.5 and 1 g/kg to groups of
five rats each and of 1.13 g/kg to four rabbits produced a reduction in the 
leukocyte count and weight loss in all three groups [41] . The rabbits 
showed a decrease in hemoglobin concentration, and one died on day 11.
Repeated cutaneous applications of 125 mg/kg, 5 days/week, for 4 weeks 
killed two of five rats. Six applications of 250 or 500 mg/kg in 11 days 
killed four rats and produced weight loss, enlarged myeloid cells, 
reductions in number of leukocytes and increases in percentages of 
polymorphonuclear cells, hemorrhage of the adrenal medulla, increased 
myeloid-to-erythroid ratios among the nucleated cells of the bone marrow, 
corneal opacity, and swollen forepaws. Necrosis was seen in microscopic
examination of sections of the skin, proximal convoluted tubules, lymphoid
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tissue, and testes of these rats. Focal necrosis of the pancreas and 
lymphoid atrophy of the thymus were found in rats exposed at 500 mg/kg.
A second 4-week series of cutaneous applications to rats was 
conducted with DGE, 10% in acetone [41]. This series resulted in focal 
inflammation of the epithelium in animals given 15, 30, and 60 mg/kg. In 
animals given 30 and 60 mg/kg, weight gain was retarded, and there was a 
decrease in the percentage of polymorphonuclear cells but no decrease in 
total leukocyte counts. According to the authors, 15 mg/kg appeared to be 
the no-effect level for repeated cutaneous applications.
Groups of three rabbits were exposed by inhalation for a single 24- 
hour period to DGE at 3, 6, 12, or 24 ppm (16, 32, 64, or 128 mg/cu m)
[41]. Body weights, leukocyte counts, and percentages of polymorphonuclear 
cells were checked weekly for 3 weeks after exposure. Corneal opacity 
appeared by the 3rd day in rabbits exposed at 24 ppm. Two of these rabbits 
died on the 5th day, the third died on the 7th day, and all three lost 30- 
35% of body weight before they died. There were increases in total 
leukocytes and percentage of polymorphonuclear cells prior to death; 
thrombocytosis was noted on the 3rd day. Necropsies on the two rabbits 
that died first showed purulent lungs with pericardial adhesions in one and 
peribronchiolitis in the other; both had atrophied testes. Microscopic 
examination revealed bronchopneumonia, serous hepatitis, focal atelectasis, 
peribronchiolitis, and focal hemorrhages in lungs and kidneys in one animal 
or the other. Some basophilia at 6 ppm and possibly increased thrombocyte 
counts at 12 ppm were seen. Conjunctival erythema and edema with 
respiratory distress and nasal discharge were seen in all groups.
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Rats exposed to DGE 3 or 4 times at 20 ppm (106 mg/cu m) for 4 hours 
lost weight, and 3 of 30 rats died [41]. Lung edema and congestion were 
seen in two that died and in one of the survivors. Blood changes seen in 
the rats included intense cytoplasmic basophilia, grossly distorted 
lymphocytic nuclei with indistinct cellular membranes, and lowered 
leukocyte and marrow cell counts.
In chronic inhalation experiments, groups of 30 male rats each were 
exposed to DGE at nominal concentrations of 3 and 0.3 ppm (16 and 1.6 mg/cu 
m) , 4 hours/day, 5 days/week, for 19 exposures in 29 days and 60 exposures
in 90 days, respectively [41]. The authors reported that the actual 
concentrations in the higher-exposure experiments ranged from 1.3 to 2.5 
ppm (7-13 mg/cu m); for exposure at 0.3 ppm, the true value was estimated 
on the basis of "occasional" analysis to vary within ±0.2 ppm (±1 mg/cu m ) .
Five rats died during exposure at 3 ppm (16 mg/cu m) [41]. One had 
bronchopneumonia and necrosis of the pancreas and spleen and another had 
pneumonia. After the final exposure, 15 rats were killed and examined; 
autopsy showed one rat with necrosis of the testicular tubules and one with 
inflammation of the larynx. Seven of the 15 experimental animals and 4 of 
10 unexposed controls had peribronchiolitis. The exposed animals differed 
significantly from controls (P<0.05) in the following criteria: decreased
body weight and organ weight/body weight ratios of thymus and spleen; 
decreased leukocytes, polymorphonuclear cells, and marrow nucleated cells; 
increased erythrocytes and myeloid-to-erythroid ratio; and increased 
mortality. The other 10 rats were killed 1 year after exposure; their 
weight gain and blood and bone marrow findings were within the expected
normal range. One had acute inflammation of the large bronchi and
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"atypical epithelium of neoplastic appearance"; three had peribroncholitis; 
and one had fatty dystrophy of the liver.
None of the rats exposed to DGE at 0.3 ppm died (1.6 mg/cu m) [41]. 
One case of pneumonia was the only abnormality in 10 rats killed for 
autopsy after 20 exposures. After 60 exposures, 5 of 10 rats examined had 
"poorly defined" focal degeneration of the germinal epithelium and 1 had 
acute periobronchiolitis. Exposed animals had reduced weight gain and 
lower leukocyte counts than controls, but the differences were not 
significant. The blood of two animals showed eosinophilia in over half the 
polymorphonuclear cells. The remaining 10 experimental and 10 control rats 
were killed 1 year after exposure ended. Two control rats and one 
experimental rat had bronchopneumonia, and one reticulum-cell sarcoma was 
reported in an experimental rat. All blood values were normal.
Hine et al [41] concluded that exposure to DGE at 3 ppm (16 mg/cu m) 
depressed the hemopoietic system in rats, but that exposure at 0.3 ppm (1.6 
mg/cu m) did not. They noted that testicular necrosis occurred at both 
exposure levels. It is difficult to evaluate the significance of the 
damage to the testes seen at 0.3 ppm from the description provided by the
authors, but it is noteworthy that this effect was seen in 5 of 10 animals
after 60 exposures at this low concentration. The authors considered that 
the bronchopneumonia might be related to the regimen forced upon the rats, 
but they concluded that the "possible neoplasms" were not attributable to 
exposure to DGE.
Hine et al [41] also administered DGE by iv injection to dogs and
rabbits. Two of three dogs receiving weekly injections of 25 mg/kg died of
pnemonia; one had loss of bone marrow with fat replacement after three
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injections, and the other had massive infarction in the lungs, slight 
glycogen degeneration of the renal tubules, and hyaline degeneration of the 
testicular tubules after three injections. All three dogs at this dose 
showed significant decreases in leukocytes (P<0.01). Three dogs given 
injections of 12.5 mg/kg showed no gross signs of systemic toxicity, but 
irritation at the injection site occurred in two. Leukocyte counts 
decreased in all three but returned to normal after 1-5 weeks. These dogs 
were killed for autopsy after one to three series of three injections. 
Their bone marrows were normal, and the only abnormalities noted were 
hemorrhage into the spleen in one and "possible testicular atrophy" in 
another.
Rabbits given four weekly iv injections of DGE at 25 mg/kg had slight 
decreases in leukocyte counts [41]. Higher iv doses, 50-200 mg/kg, caused 
decreases in leukocyte counts, severe lung congestion, kidney ischemia, 
ascites, and death.
The most consistent systemic effects reported in animals exposed to 
glycidyl ethers have been in rapidly dividing tissues, ie, the bone marrow
[23.41.48] and the germinal epithelium of the testes [33,41,48,49]. At 
higher doses, glycidyl ethers have produced more severe tissue damage; 
irritation, congestion, and necrotic changes were observed in many organ 
systems, generally appearing first at or near the site of administration
[23.35.41.48] .
(e) Carcinogenesis, Mutagenesis, Teratogenesis, and Effects 
on Reproduction
Investigations of carcinogenic activity have been found only for DGE, 
resorcinol diglycidyl ether, hydroquinone diglycidyl ether, diphenylol
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propane diglycidyl ether, and triethylene glycol diglycidyl ether. Many 
glycidyl ethers have been assessed for their ability to induce mutations 
and chromosomal aberrations, but studies of teratogenic and reproductive 
effects are scarce.
In 1957, McCammon et al [50] tested a number of compounds thought to 
be present in the air pollutants that result from the oxidation of
aliphatic hydrocarbons in gasoline and diesel fuels. Twenty compounds were 
evaluated for their tumorigenic potentials in C57B1 mice by painting on the 
interscapular skin three times/week. In addition, Long-Evans rats received 
three of the compounds by sc injection. The authors reported that 
resorcinol diglycidyl ether was tumorigenic in both mice and rats. DGE was 
said to be tumorigenic only in mice, but the authors did not indicate
whether it was tested in rats. These compounds also produced sebaceous 
gland suppression, intense hyperkeratosis, parakeratosis, and epithelial 
hyperplasia in mice. Because this report was an abstract, details of the 
study were not given. One of the authors (HL Falk, personal communication, 
May 1978) has indicated that the data from this study have been lost, but
that the tumors produced were benign papillomas.
In a 1963 report on the tumorigenic potential of selected epoxides, 
Kotin and Falk [51] provided additional information on the tumorigenicity 
of glycidyl ethers in mice [50]. Twenty C57BL mice were used in each 
treatment group. In the animals exposed to DGE at a total dose of 0.75 
millimole in acetone, the first tumor appeared after 5 months; A of the 10 
animals (A0%) surviving at this time developed skin tumors. One mouse (8%) 
in the group exposed to DGE at 0.25 millimole and 1 of 14 surviving mice 
(7%) exposed to resorcinol diglycidyl ether at 0.75 millimole developed
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skin tumors. Resorcinol diglycidyl ether at 0.25 millimole and 
hydroquinone diglycidyl ether at 1 millimole caused no skin tumors in any 
of the mice. No malignant lymphomas or pulmonary adenomas were produced by 
any of these diepoxides. In a written communication (January 1978), Falk 
noted that the skin tumors produced by the glycidyl ethers in this study 
were all benign papillomas and that controls receiving only acetone did not 
develop any papillomas.
In 1963, Weil et al [37] tested the effects of diphenylol propane 
diglycidyl ether on mice in a lifetime carcinogenicity study. The compound 
was tested in trials on two groups of mice by painting the undiluted 
compound on the shaved backs of 90-day-old C3H mice three times/week. Up 
to 40 mice were used in each trial, but the exact number was not specified. 
The mice were painted for up to 23 months. Positive controls were treated 
similarly with a 0.2% solution of methyl cholanthrene in acetone. At the 
end of 12 months, 26 mice from one trial and 36 from the other were still 
alive. At the end of 17 months, 14 and 26 remained alive, and at the end 
of 24 months, 1 and 0 were alive. No carcinomas were found in these mice; 
the only tumor, a papilloma, appeared in one group after 16 months of 
exposure. The positive control substance produced an unspecified number of 
tumors in mice, with a mean latent period of 3-5 months.
Shimkin et al [52], in 1966, reported the results of a study designed 
to show the carcinogenic potential of several alkylating agents, including 
triethylene glycol diglycidyl ether. Mice of the A strain received 12 ip 
injections, 3 times/week for 4 weeks, at 5 different total doses ranging 
from 56 to 7,208 mg/kg. Each group contained 15 mice of each sex. During 
the experimental period, untreated controls were maintained and killed at
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monthly intervals to determine the incidence of spontaneous pulmonary
tumors. An additional control group received only the vehicle (water) by 
ip injection. The duration of the experiment was 39 weeks.
A slight increase in lung tumors over the expected spontaneous
incidence was observed (37% or a mean of 0.48 tumors/mouse for males, 27% 
or 0.29 tumors/mouse for females) [52], At the highest dose (7,208 mg/kg), 
the tumor incidence was 70%, with 1.2 tumors/mouse. At total doses 
estimated by the authors to be below 3,777 mg/kg, the tumor incidence 
decreased to expected spontaneous levels. The spontaneous incidence was 
estimated from a mathematical relationship between the logarithm of the 
number of lung tumors and the logarithm of the dose that best represented 
the point at which one lung tumor/mouse would be predicted. The authors 
concluded that triethylene glycol diglycidyl ether was only weakly 
carcinogenic at the highest doses used. However, this study lasted for 
only about 9 months, whereas assays of carcinogenic potential with this 
strain commonly are conducted for 18-20 months. The authors also reported 
that testicular atrophy with decreased spermatogenic activity was seen in 
mice 39 weeks after treatment with this compound at high doses.
Cytotoxic effects on mammalian bone marrow cells have been observed
with AGE and DGE [41,48]. Studies with other cell types have also shown
cytotoxic effects of glycidyl ethers. Loveless [6] found that treating 
root-tip meristems of the broad bean, Vicia faba, with DGE or resorcinol 
diglycidyl ether produced radiomimetic effects. He defined a radiomimetic 
agent as one that acted upon the resting cell to produce chromosomal 
aberrations apparent in subsequent cell divisions. Other studies have also
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demonstrated chromosomal aberrations produced by DGE in the broad bean 
[53,54] and other plant species [55] .
Certain glycidyl ethers have damaged mammalian tumor cells. 
Triethylene glycol diglycidyl ether has been used therapeutically as an 
antitumor agent [11-13,15,16]. Hendry et al [56] have shown tumor 
inhibition and radiomimetic effects of diethylene glycol diglycidyl ether 
and butanediol diglycidyl ether in an in vivo study. Rats were implanted 
with Walker tumors, and the compounds to be tested were injected ip during 
a 10- to 12-day period after tumor implantation. According to the authors, 
there was a correlation between tumor inhibitory activity of the glycidyl 
ethers and the ability to induce chromosomal changes of the radiomimetic 
type in the implanted tumors. Diethylene glycol diglycidyl ether at a 
total ip dose of 1.5 mg/g inhibited tumor growth by 84% compared with that 
in controls. At a daily dose of 0.4 mg/g, some inhibition of mitosis was 
seen in the tumor as well as in the bone marrow. "Exploded" metaphases 
were seen in the tumor and chromosome fragmentation and pyknotic nuclei 
were seen in the bone marrow at this dose. At 0.2 mg/g/day, there was 
almost complete inhibition of mitosis with a few chromosome fragments, but 
only partial inhibition of mitosis with some pyknotic nuclei was seen in 
the bone marrow. A dose of 0.1 mg/g/day caused a few pyknotic nuclei in 
the bone marrow. Tumors in rats exposed to diethylene glycol diglycidyl 
ether at doses of 0.4 and 0.1 mg/g/day showed an increased number of 
anaphases (over control values) after 24 hours, indicating that the 
compound caused specific chromosomal damage in tumor tissue in rats with 
the Walker tumor.
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Butanediol diglycidyl ether at a total dose of 1.2 mg/g caused a 74% 
inhibition in tumor growth compared with controls [56]. Doses of 0.2 
mg/g/day caused "exploded" metaphases in the tumor and true chromosome 
bridges and chromosome fragmentation in the bone marrow. At a dose of 0.1 
mg/g/day, no cytotoxic effects were observed in the tumor. However, 
chromosome bridges and fragmentation were found in the bone marrow. After 
24 hours, an excess number of anaphases with chromosome damage in tumor 
tissue was noted at both daily dose levels.
In a study from El du Pont de Nemours and Company [49] , Terrill 
reported no increase in chromosomal aberrations in the bone marrow cells of 
rats exposed to PGE at concentrations up to 11.2 ppm (68.8 mg/cu m) 6 
hours/day for 19 consecutive days.
Wade et al [57] examined the mutagenicity of AGE, BGE, DGE, 
diphenylol propane diglycidyl ether, and the diglycidyl ether of 
substituted glycerin with Salmonella typhimurium. They used the histidine- 
dependent mutant strains TA98, which is reverted to histidine independence 
by frameshift mutation, and TA100, which is reverted by base-pair 
substitution. The compounds were tested with and without the addition of 
liver microsomal extract from rats pretreated with phénobarbital. A 
substance was considered mutagenic in this test if it produced histidine- 
independent revertants at two or more times the spontaneous rate.
When 10 mg of the glycidyl ether was applied to the center of agar 
plates containing bacteria of the TA100 strain, AGE and BGE caused 
mutations at over 10 times the spontaneous rate, and the diglycidyl ether 
of substituted glycerin increased the mutation rate about 4 times [57].
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Diphenylol propane diglycidyl ether showed no mutagenic activity at this 
dose. None of these four glycidyl ethers produced an increase in mutations 
when 50 jug was spotted on the agar plates. DGE was toxic to bacteria even 
at this low dose, reducing the number of revertant colonies/plate to below 
spontaneous levels. When DGE was incorporated directly into the medium in 
quantities of 50-500 /¿g/plate, it produced a dose-dependent mutagenic 
effect in strain TA100, with the highest dose inducing mutations at about 
10 times the spontaneous rate. Addition of the liver microsomal extract 
generally produced a decrease in the mutagenic activity of DGE, to about 5 
times the spontaneous rate at the highest dose. Liver microsomes had 
little effect on the mutagenic activity of the other glycidyl ethers 
tested. Results of these tests are summarized in Table XIV-6.
The glycidyl ethers did not show mutagenic activity in strain TA98, 
indicating that they act by causing base-pair substitutions [57] . Since 
diphenylol propane diglycidyl ether and two higher-molecular-weight 
oligomers of this compound (the diglycidyl ether of bisphenol A) were 
nonmutagenic, the authors suggested that the size of these molecules may 
have inhibited uptake by the bacteria or caused decreased rates of reaction 
with genetic material because of steric hindrance. This view is supported 
by the fact that glycidyl ether of the next-highest molecular weight, the 
diglycidyl ether of substituted glycerin (molecular weight 300), induced 
fewer revertant colonies than AGE or BGE (molecular weights 114 and 130).
In a 1977 report prepared for Dow Chemical USA by Pullin and Legator 
[58], the mutagenic potential of BGE, CGE, the C12-C14 alkyl glycidyl 
ether, neopentyl glycol diglycidyl ether, diphenylol propane diglycidyl
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ether, and dicyclopentadiene glycidyl ether were examined. The 
mutagenicity testing program evaluated the compounds in six microbial and 
mammalian test systems:
(1) The microbial mutagenic assay (Ames test) determined 
activity in reverting histidine-requiring mutant strains of Sj_ typhimurium 
to histidine independence. The compounds were tested at 0.5-2.0 
^moles/plate, both with and without a microsomal extract from the livers of 
rats pretreated with phénobarbital or Aroclor.
(2) In the body-fluid analysis, the urine of mice treated 
with the glycidyl ethers was tested for mutagenic activity against S . 
typhimurium both with and without the addition of beta-glucuronidase. The 
mice received the glycidyl ethers orally in doses of 125-1,000 mg/kg/day 
for 4 days before urine was collected for testing.
(3) The host-mediated assay is designed to determine the
effects of in vivo metabolism of a compound on its mutagenicity. Mutant 
strains of S_̂  typhimurium were injected into the peritoneal cavity of mice 
that had been given glycidyl ethers in oral doses of 125-1,000 mg/kg/day
for 5 days. Six hours after inoculation, exudate was withdrawn from the
peritoneal cavity and plated in serial dilutions to determine the frequency 
of mutations to histidine independence.
(4) In the micronucleus test, the bone marrow from mice 
that had received glycidyl ethers orally for 5 days was examined 
microscopically for the presence of micronuclei.
(5) To study the induction of DNA repair, glycidyl ethers 
were incubated at 37 C with human mononucleated white blood cells (G-0 
phase) and tritiated thymidine. Cells were analyzed for incorporation of
tritiated thymidine by liquid scintillation counting and autoradiography.
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(6) The dominant lethal assay tested mutagenic effects of
glycidyl ethers on the reproductive cells of mice. Male B6D2F1 hybrid 
mice, 8-10 weeks old, were bred to three virgin females each week for 2 
weeks to provide baseline information on the fertility of each male, litter 
size, and spontaneous fetal deaths. The male mice were then treated 
topically with undiluted glycidyl ethers on their shaved and chemically 
depilated backs three times/week for a minimum of 8 weeks. Groups of 10 
male mice of proven fertility received BGE, CGE, or neopentyl glycol 
diglycidyl ether at 1.5 g/kg, the alkyl glycidyl ether or dicyclopentadiene 
glycidyl ether at 2.0 g/kg, or diphenylol propane diglycidyl ether at 3 
g/kg. Two other groups were treated with saline, as a negative control, or 
with triethylene-melamine, as a positive control. The exposed mice were 
caged individually with three 8- to 10-week-old virgin females each week 
for 2 weeks. All females were killed for examination of their uteri 13-14 
days after presumptive mating. The percentage of pregnancies, total number 
of implants, and number of fetal deaths were used as criteria of dominant 
lethality.
Results of these tests are summarized in Table XIV-6. All of the 
glycidyl ethers tested showed some activity in the Ames test with S . 
typhimurium strain TA1535, which is reverted by base-pair substitution, but 
not with strain TA98 [58] . One glycidyl ether was minimally active in the 
body-fluid analysis, and three showed some activity in the host-mediated 
assay, which the authors attributed to decreased growth of microorganisms 
in the host animals. Three diglycidyl ethers produced an increase in
unscheduled DNA synthesis in human white blood cells, but none produced
excess micronuclei in the bone marrow cells of mice.
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Only BGE was significantly mutagenic to mice in the dominant lethal 
test, causing a significant increase in the number of fetal deaths (P=0.04) 
[58]. The number of pregnancies was significantly less than in the control 
group (P=0.05), but pretreatment data also showed significantly fewer 
pregnancies in the test group than in the controls. In the Ames test, BGE 
produced mutations at 4-13 times spontaneous rates, and its mutagenic 
activity was markedly decreased by the addition of microsomes. BGE also 
caused a significant increase (P<0.05) in unscheduled DNA synthesis in 
white cells. The authors classed this compound as mutagenic and suggested 
that the lack of activity of BGE in the body-fluid analysis, host-mediated 
assay, and micronucleus test might have resulted from the low doses used in 
these tests. Since BGE was detoxified by mammalian microsomes in the 
microbial assay but was apparently not deactivated by metabolism in the 
dominant lethal test, they concluded that the metabolic properties of the 
liver homogenate did not "truly reflect the complex and dynamic metabolic 
processes of an intact animal." The authors emphasized that BGE posed a 
hazard through percutaneous absorption, a common route of exposure for the 
worker. However, the dosage of BGE used in the dominant lethal test was 
very high.
CGE and neopentyl glycol diglycidyl ether were classified as weakly 
mutagenic on the basis of these test results [58]. CGE was the most 
mutagenic of the compounds in the Ames test, producing mutations at up to 
58 times the spontaneous rates, but it was deactivated to control levels in 
the presence of microsomes. Neopentyl glycol diglycidyl ether caused 
mutations in Ŝ _ typhimurium at up to 7 times the spontaneous rate, and 
addition of microsomes had no consistent effect on its activity. In the
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body-fluid analysis, both compounds had minimal mutagenic effects only in 
the presence of betaglucuronidase. Both caused significant unscheduled DNA 
synthesis in human white blood cells (P<0.05).
Dicyclopentidiene glycidyl ether and diphenylol propane diglycidyl 
ether were mutagenic in bacteria but not in animal systems [58]. In the 
absence of mammalian microsomes, they produced mutations in S . typhimurium 
at about 2-4 times the spontaneous rate; effects of adding microsomes were 
inconsistent, but diphenylol propane diglycidyl ether at 2.0 ¿¿moles/plate 
was activated by liver microsomes from Aroclor-pretreated rats. Diphenylol 
propane diglycidyl ether also increased mutation frequencies in the host- 
mediated assay. The authors described these two glycidyl ethers as 
minimally mutagenic in humans.
The C12-C14 alkyl glycidyl ether was minimally active in the 
microbial assay only in the presence of microsomes from Aroclor-pretreated 
rats [58]. It also showed minimal activity in the host-mediated assay. The 
authors classified this glycidyl ether as nonmutagenic.
Results of these screening tests [58] suggest that all these glycidyl 
ethers have some mutagenic potential. Only BGE was reported to be a 
mammalian mutagen on the basis of the results of the mouse dominant lethal 
test. However, only a single negative control group of 10 rats was used in 
this test, and several of the test groups differed significantly from 
controls in pretreatment data for the criteria used as indicators of 
dominant lethality. Despite these shortcomings in experimental design, 
there were significant differences (p = .04) between the control groups and 
the BGE-treated group in the proportion of deaths/pregnancy.
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In a 1974 study from El du Pont de Nemours and Company [49], Barsky 
reported mutagenicity tests of PGE in Sj_ typhimurium. PGE was tested at 
concentrations of 25-300 ng/plate without rat liver homogenate and 500-
10,000 /ng/plate in the presence of the homogenate. PGE was mutagenic in 
strains TA1535 and TA100 both with and without metabolic activation, but it 
showed some increase in activity in the presence of the liver homogenate 
(Table XIV-6). At the highest concentration used in the activated assay, 
PGE produced mutations in strain TA100 at nearly 70 times the spontaneous 
rate. No mutagenic activity was observed in strains sensitive to 
frameshift mutation.
In the same laboratory report [49], Terrill described a two- 
generation reproduction and mutagenesis study in rats exposed to PGE vapor. 
Three groups of eight male ChR-CD rats (360 g) were exposed to PGE at 1.75, 
5.84, or 11.20 ppm (10, 33, or 71 mg/cu m) 6 hours/day for 19 consecutive 
days. A fourth group of rats served as controls. The male rats were mated 
for 6 consecutive weeks to three females/week. One of each group of three 
females was killed on the 18th day of pregnancy and examined for 
implantations, resorptions, and any abnormalities of the ovaries, uterus, 
or fetuses. The two remaining females were allowed to raise their pups, 
which were then paired for mating, and the offspring of these rats were 
also examined for abnormalities. Exposed males were killed for autopsy 
after the mating trials, and the testes and epididymides were examined 
microscopically. Eight first-generation offspring of each sex were also 
killed for autopsy.
No significant increases in fetal deaths or preimplantation loss were 
seen in females bred to mice exposed to PGE, indicating that PGE did not
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produce dominant lethal mutations [49] . The only abnormality noted in the 
autopsies was focal degeneration of the seminiferous tubules in 1 of 8 rats 
exposed at 1.75 ppm (10 mg/cu m) , 1 of 8 at 5.84 ppm (33 mg/cu m ) , and 3 of 
8 at 11.20 ppm (71 mg/cu m ) . Personnel evaluating these slides felt that 
the evidence of degeneration was inconclusive and might have resulted from 
improper sectioning. Statistical analysis of the incidence of testicular 
atrophy using the Fisher exact test showed no significant treatment-related 
effect in any exposed group. The author concluded that the testicular 
effects were not treatment-related. However, since testicular degeneration 
has also been reported in animals exposed to DGE at low concentrations or 
to AGE, DGE, or triethylene glycol diglycidyl ether at high doses
[41,48,52], the effects seen in this study [49] may be related to exposure 
to PGE.
The teratogenic potential of PGE was also evaluated by Terrill in 
this study [49] . Four groups of 25 female ChR-CD rats (200 g) were exposed 
to PGE vapor at 1.7, 5.7, or 11.5 ppm (10, 35, or 71 mg/cu m) for 12 days, 
beginning on the 4th day of gestation. No abnormal signs were observed in 
the exposed females. They were killed on the 20th day of gestation, and 
the corpora lutea and fetuses were enumerated. All the fetuses were 
examined for visible defects. Two-thirds of the fetuses were fixed and 
cleared and their skeletons stained in situ to show any variations and 
anomalies of ossification. The other fetuses were fixed and sectioned for 
examination. There were no significant differences between the control 
group and experimental groups in maternal body weight, mortality, early 
delivery, gross pathology, implantation efficiency, fetal survival, size, 
sex, ossification variations, or malformations. The author [49] concluded
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that, under the test conditions, PGE was not teratogenic.
Of the few glycidyl ethers that have been investigated for their 
carcinogenicity, only two were demonstrated to produce an increased 
incidence of tumors in animals. Triethylene glycol diglycidyl ether 
injected ip at very high doses produced an excess of lung tumors in mice 
[52]. DGE at a concentration of 0.75 millimole produced papillomas in 4 of 
10 mice when painted on the skin 3 times/week in a lifetime study [50] . In 
similar skin painting tests, resorcinol diglycidyl ether [50] and 
diphenylol propane diglycidyl ether [37] each produced only one papilloma 
in 14 and 40 mice, respectively, and hydroquinone diglycidyl ether [50] 
produced no tumors.
All glycidyl ethers that have been tested have shown mutagenic 
activity in bacteria [49,57,58]. Data from these studies permit the 
compounds to be ranked in descending order approximately as follows on the 
basis of their activity in the Ames assay: CGE and DGE > BGE > PGE >
neopentyl glycol diglycidyl ether > dicyclopentadiene glycidyl ether > the 
diglycidyl ether of substituted glycerin > diphenylol propane diglycidyl 
ether > the C12-C14 alkyl glycidyl ether. The four most active compounds 
showed reduced mutagenic activity in the presence of a mammalian liver 
homogenate, a 10-fold reduction in the case of CGE; the two least mutagenic 
compounds showed a slight increase in activity when the liver homogenate 
was added, and the activity of the other glycidyl ethers was generally 
unaffected.
Only one glycidyl ether, BGE, was mutagenic in mammals in the 
dominant lethal test [58] . BGE also induced unscheduled DNA synthesis in 
human white blood cells, as did CGE and neopentyl glycol diglycidyl ether.
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(f) Metabolism
Little is known about specific pathways for catabolism of glycidyl 
ethers. Since glycidyl ethers contain the epoxide ring, it seems 
reasonable to assume that they have common pathways with other epoxide 
compounds. Glycidyl ethers are highly reactive in biologic systems. One 
demonstration of such activity is a short biologic half-life. Duncan and 
Snow [59] injected rats iv with 300 mg/kg of triethylene glycol diglycidyl 
ether. After 1 minute, less than 10% of the dose could be found in the 
blood, and its metabolic half-life was calculated to be about 12 minutes. 
Only 0.4% of the administered dose was excreted unchanged.
Three types of metabolic reactions have been proposed for epoxide 
compounds [60]. These are shown in Figure III-l.
Two of these conversions are enzymatic. Oesch et al [60-63] have 
isolated an enzyme that they called epoxide hydrase from the livers of 
various species of animals, including rats, guinea pigs, monkeys, and 
humans. The enzyme reduced epoxides to their corresponding diols. BGE and 
PGE were among the glycidyl ethers acted upon by epoxide hydrase. Soellner 
and Irrgang [36] presented evidence that CGE was metabolized to its 
corresponding diol, which was apparently more neurotoxic than the parent 
compound.
The second enzymatic reaction is a conjugation of epoxides with 
glutathione. Glutathione-S-epoxide conjugase has been isolated from the 
livers of rats and ferrets [64] and of several wild birds [65]. Boyland 
and Williams [64] reported activity with PGE, substituted PGE's, resorcinol 
diglycidyl ether, 1-napthyl glycidyl ether, and 4,4'-bisglycidyl bisphenyl 
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Mukhtar and Bresnick [66] demonstrated that pretreatment of rats with 3- 
methylcholanthrene and phenobarbital enhanced glutathione-S-epoxide 
conjugase activity by 40%-60%.
The nonenzymatic reactions of epoxides are covalent bonding to 
proteins [60] . Loveless [6] has proposed a mechanism that would explain 
the high degree of biologic activity demonstrated by epoxidee. He 
suggested that the "strained" character of the epoxide ring caused it to 
undergo an SN1 type of reaction in which the ring opened under the 
polarizing influence of a reactant, forming a carbonium ion which then 
reacted with water, proteins, or such nucleophilic compounds as RNA, DNA, 
histones, or proteins. The bulk of the available evidence on humans 
occupationally exposed to glycidyl ethers indicates that these substances 
reacted with skin proteins, giving rise to a contact skin sensitivity [24- 
28,30]. In animal experiments, only when large amounts contaminated the 
skin or were absorbed into the body was there evidence that glycidyl ethers 
reacted with nuclear elements to induce hemopoietic effects, mutations, or 
neoplasms [11-13,15,37,54,58,67].
Correlation of Exposure and Effect
Adverse effects reported in humans exposed to glycidyl ethers have 
generally been limited to irritation and sensitization. PGE [23] and BGE 
[26] have produced severe skin irritation in humans, causing vesiculation, 
blistering, burns, and ulceration. The response to BGE was dose-dependent, 
with no irritation observed at 1.25%. AGE has produced skin irritation and 
eye irritation in humans [23].
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Sensitization tests in humans with glycidyl ethers have been positive 
for all compounds tested, including PGE [24], BGE [25,26], and the C8-C10 
alkyl glycidyl ether [30]. Cross-sensitization to CGE has occurred in 
humans sensitive to PGE, and sensitivity to AGE, BGE, and PGE has been 
demonstrated in humans occupationally exposed to epoxy resins of bisphenol 
A [27].
In patients treated with the antitumorigenic drug triethylene glycol 
diglycidyl ether, CNS effects, leukopenia, bone marrow depression, and 
regional edema and hair loss have been reported as side effects of therapy 
[12,13,16]. These systemic effects occurred following iv or intraarterial 
injection of repeated doses, and no comparable effects have been reported 
after occupational exposure to other glycidyl ethers.
Several glycidyl ethers have produced irritation and sensitization in 
animals. All the glycidyl ethers tested (DGE, AGE, IGE, PGE, BGE, 
resorcinol diglycidyl ether, butanediol diglycidyl ether, and diphenylol 
propane diglycidyl ether) were skin irritants in tests on guinea pigs, 
ranging from mild to very severe [28,31,44]. In addition, all of those 
tested for skin sensitization (BGE, PGE, CGE, the C12-C14 alkyl glycidyl 
ether, diphenylol propane diglycidyl ether, neopentyl glycol diglycidyl 
ether, and butanediol diglycidyl ether) gave positive results 
[24,28,30,31,37,44]. Eye irritation in animals resulted from exposure to 
airborne AGE, IGE, and DGE [23,41,47] and from direct instillation of these 
compounds or of PGE, resorcinol diglycidyl ether, butanediol diglycidyl 
ether, or the C8-C10 and C12-C14 alkyl glycidyl ethers [23,30,32-35,37].
In animals, glycidyl ethers have produced CNS effects, including
muscular incoordination, reduced motor activity, agitation and excitement,
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deep depression, narcotic sleep, and coma [23,33,35]. The route of 
administration plays an important role in the onset, duration, and severity 
of CNS effects. Each of the following, DGE, AGE, BGE, IGE, PGE, and 
resorcinol diglycidyl ether, produced CNS depression when administered 
orally [23,33,35], whereas only DGE and PGE [23,35] produced depression 
with dermal administration; after inhalation exposures, CNS depression was 
reported to have occurred immediately before death, appearing earlier only 
with BGE and AGE [23] . The progression of signs was usually from muscular 
incoordination and reduced motor activity to moderate depression (and, with 
BGE, agitation and excitement) to deep depression and coma before death. 
Animals that survived exposure to PGE showed a reversal of the progression 
[23]. CGE at very high doses has had antispasmodic and muscle relaxant 
effects in animals [36].
Many of the glycidyl ethers produced widespread systemic effects,
such as necrosis, edema, inflammation, hyperemia, hemorrhaging, and tissue
degeneration. The most frequent effect produced by inhalation of DGE, AGE,
BGE, IGE, or PGE was lung irritation, specifically pneumonitis [23]. Rats
exposed to AGE at 400 ppm (2,000 mg/cu m) for 7 hours/day, 5 days/week, for
10 weeks had abnormal changes in the lungs, such as severe emphysema,
bronchiectasis, and bronchopneumonia; those exposed to PGE at about 10 ppm
(50 mg/cu m) on the same schedule had peribronchial and perivascular
pulmonary inflammatory cell infiltration [23]. Resorcinol diglycidyl ether
did not produce any lung anomalies in rats exposed to an airstream
saturated with it for 7 hours/day, 5 days/week, for 10 weeks; the
concentration of airborne resorcinol diglycidyl ether was not reported, but
it would have been very low, since this glycidyl ether is a solid at room
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temperatures [33]. No gross changes were noted in the lungs of rabbits 
exposed to DGE at 3, 6, or 12 ppm (16, 32, or 64 mg/cu m) for 24 hours. At 
24 ppm (128 mg/cu m) for 24 hours, DGE caused purulence in the lungs, with 
pericardial adhesions, peribronchiolitis, bronchopneumonia, focal 
atelectasis, and focal hemorrhages in rabbits. DGE also caused pneumonia 
and massive infarction in the lungs of one of three dogs injected iv at a 
dose of 25 mg/kg [41] . Intramuscular injections of 400 mg/kg of AGE 
produced pulmonary congestion in one rat after the second daily injection; 
microscopic examination confirmed pneumonia [48].
The effects of glycidyl ethers in organ systems were primarily 
irritation and necrosis. Local and widespread inflammation, congestion, 
and necrosis resulted after exposure of rats to DGE, AGE, IGE, PGE, and BGE 
by the oral, inhalation, or dermal routes [23,35,41,48]. The organs and 
tissues affected were the adrenal gland, liver, lungs, stomach, kidneys, 
brain, skin, peritoneum, small intestine, thymus, spleen, lymph nodes, 
testes, and pancreas.
Circulatory system disorders were also evident in animals exposed to 
PGE and included hyperemia and increased permeability of the capillaries 
[35]. AGE given by im injection to rats produced significantly reduced 
leukocyte counts and a decreased myeloid-to-erythroid ratio, although the 
number of nucleated cells in the bone marrow and the percentage of 
polymorphonuclear cells was normal [48] . Animals given im injections of 
IGE, PGE, and BGE did not show evidence of hemopoietic changes [23,48].
In rabbits, DGE produced decreases in leukocyte counts and
percentages of polymorphonuclear cells at iv doses of 50, 100, or 200 mg/kg
[41] . By inhalation, DGE at 24 ppm (128 mg/cu m) caused an increase in
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leukocytes and polymorphonuclear cells prior to death; thrombocytosis was 
also noted. At DGE concentrations of 12 ppm (6A mg/cu m ) , thrombocyte
counts were increased, and at 6 ppm (32 mg/cu m ) , some basophilia was seen.
In rats, three or four exposures to DGE at 20 ppm (110 mg/cu m) for A hours
produced intense cytoplasmic basophilia, grossly distorted lymphocytic
nuclei with indistinct cellular membranes, and lowered leukocyte and marrow 
cell counts. Long-term exposures of rats for A hours/day, 5 days/week to 
DGE at 3 ppm (16 mg/cu m) for 19 exposures in 29 days caused decreases in 
leukocyte counts, polymorphonuclear cells, and marrow nucleated cell
counts. Blood cell morphology was normal in rats exposed at 0.3 ppm (1.6 
mg/cu m) for 20 exposures, but over half the polymorphonuclear cells of two 
rats contained eosinophilic granules after 60 exposures.
A summary of the effects of dermal contact with glycidyl ethers on 
humans is presented in Table III-l. A summary of the effects of exposure 
to glycidyl ethers on animals is presented in Table III-2.
Carcinogenicity, Mutagenicity, Teratogenicity, and Effects on Reproduction
No reports of the carcinogenic, mutagenic, teratogenic, or
reproductive effects of the glycidyl ethers on humans were found in the 
literature. However, such effects have been investigated in animals for 
some of the glycidyl ethers.
The carcinogenic potentials of DGE, resorcinol diglycidyl ether,
diphenylol propane diglycidyl ether, and hydroquinone diglycidyl ether have 
been studied in skin painting tests on animals [37,50,51]. No malignant 
tumors have been observed with any of these compounds. DGE at a total dose
of 0.75 millimole produced skin papillomas in A of 10 surviving mice
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painted with the compound 3 times/week, with the first tumor appearing
after 5 months; DGE at 0.25 millimole produced a papilloma in one test
animal [51]. Resorcinol diglycidyl ether was said to be carcinogenic in 
both mice and rats, but no supporting data were provided [50]. A later
paper by the same investigators showed that resorcinol diglycidyl ether had 
induced a benign tumor in 1 of 14 test animals at a dose of 0.75 millimole 
and produced no tumors at 0.25 millimole [51]. Undiluted diphenylol
propane diglycidyl ether painted on the skin three times/week produced 1
papilloma in 40 surviving mice after 16 months [37]. Hydroquinone
diglycidyl ether at a dose of 1 millimole caused no skin tumors in mice
[51].
Triethylene glycol diglycidyl ether, which has been used as an
antitumor agent, has been found to be carcinogenic in mice at very high ip 
doses [52]. A total dose of 7,208 mg/kg over a 4-week period produced a 
70% incidence of lung tumors. The authors calculated that the lowest dose 
that would raise the incidence of tumors above spontaneous levels was 
greater than 3.7 g/kg.
Several glycidyl ethers have produced effects described as 
radiomimetic or cytotoxic. As in the case of triethylene glycol diglyicdyl 
ether, diethylene glycol diglycidyl ether and butanediol diglycidyl ether 
have had antitumorigenic effects [56] . Diethylene glycol diglycidyl ether 
injected ip at a total dose of 1.5 mg/g caused an 84% inhibition of 
implanted Walker tumors in rats. This compound produced chromosomal 
aberrations and inhibition of mitosis in the tumor cells and bone marrow at 
doses of 0.1-0.4 mg/g/day. Butanediol diglycidyl ether at a total dose of 
1.2 mg/g caused a 74% inhibition in tumor growth. At 0.2 mg/g, this
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compound caused chromosomal aberrations in tumor and bone marrow cells, and 
at 0.1 mg/g, the only cytotoxic effects seen were chromosome bridges and 
fragmentation in the bone marrow.
Exposure to AGE and DGE caused decreased leukocyte counts attributed 
to cytotoxic effects on the bone marrow in rats, rabbits, and dogs [41,48]. 
In the same study [48] , BGE and PGE did not produce a decrease in 
leukocytes when administered to rats by ip injection. Rats exposed to PGE 
by inhalation at up to 11.2 ppm (68.8 mg/cu m ) , 6 hours/day for 19 days, 
had no increase in chromosomal aberrations in the bone marrow [49] . None 
of six glycidyl ethers tested, including BGE and CGE, produced micronuclei 
in the bone marrow cells of mice [58] . DGE and resorcinol diglycidyl ether 
have produced radiomimetic effects in plant cells [6,53-55].
Several glycidyl ethers have been tested for mutagenic activity (see 
Table XIV-6). AGE, BGE, CGE, DGE, PGE, neopentyl glycol diglycidyl ether, 
dicyclopentadiene diglycidyl ether, and the diglycidyl ether of substituted 
glycerine all produced a mutagenic response in Salmonella typhimurium in 
the Ames assay [49,57,58]. Diphenylol propane diglycidyl ether gave weakly 
positive results in this test in one study [58] and negative results in 
another [57] . The C12-C14 alkyl glycidyl ether showed weak mutagenic 
activity only when activated by the addition of a rat-liver microsomal 
extract [58] . Metabolism by mammalian microsomes decreased the activity of 
BGE, CGE, DGE, and PGE and had little or no effect on the mutagenicity of 
the other compounds tested [49,57,58]. None of the compounds tested showed 
definite mutagenic activity in the host-mediated assay test [58].
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Urinary metabolites of CGE and neopentyl glycol diglycidyl ether 
caused a weak mutagenic response in Salmonella in the mouse body-fluid 
analysis, but other glycidyl ethers were not active in this test [58]. 
These two compounds and BGE also induced unscheduled DNA synthesis in human 
mononucleated white blood cells [58]. Only BGE has shown mutagenic 
activity in mice in the dominant lethal test [58]. When this compound was 
painted on the skin of male mice at 1.5 g/kg, it produced a significant
increase in the number of fetal deaths in females to which they were
subsequently bred.
Only PGE has been studied for its teratogenic effects, and it 
produced no teratogenesis in the offspring of female mice exposed at 11.5 
(68.8 mg/cu m) ppm during days 4-15 of gestation [49].
Testicular degeneration has been noted in several animal species 
after exposure to AGE, DGE, PGE, and triethylene glycol diglycidyl ether
[41,48,49,52]. Necrosis of the testes was reported in rats that received 
six dermal applications of DGE at 250 or 500 mg/kg [41] or four im 
injections of AGE at 400 mg/kg [48]. Testicular atrophy with decreased 
spermatogenic activity was seen in mice receiving high ip doses of
triethylene glycol diglycidyl ether [52]. Atrophied testes were found in
two rabbits that died after a single 24-hour exposure to DGE at 24 ppm (128 
mg/cu m) and possibly in a dog that received six 12.5 mg/kg iv doses of 
this compound [41]. In chronic inhalation experiments, 1 of 15 rats 
exposed to DGE at 3 ppm (16 mg/cu m) had necrosis of testicular tubules 
after 19 exposures; 5 of 10 rats exposed at 0.3 (1.6 mg/cu m) had "poorly 
defined" focal degeneration in the testes after 60 exposures [41]. In rats 
exposed to PGE at 1.75-11.2 ppm (10-71 mg/cu m) for 19 days, focal
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degeneration of the seminiferous tubules was observed in 5 of 24, but the 
investigator considered that this damage was of questionable significance 
and was probably not treatment related [49] . Only in the PGE study was any 
attempt made to correlate testicular damage with effects on reproduction, 
and this study showed no significant mutagenic or reproductive effects 
[49].
Lack of data on most of the glycidyl ethers makes it difficult to 
correlate variations in the results of tests of their mutagenicity and 
carcinogenicity with differences in the structure of particular compounds 
within the class. Thus, only tentative conclusions can be drawn about the 
potential of glycidyl ethers to cause cancer or mutations.
Because of the presence of epoxide groups, the glycidyl ethers would 
be expected to be biologically active; epoxides have been shown to be 
mutagenic and carcinogenic [37,56], and epoxide intermediates have been 
identified or postulated as the mutagenic or carcinogenic metabolites of 
other compounds [68] . However, the limited data available on metabolism of 
glycidyl ethers indicates that they are rapidly metabolized to less 
cytotoxic substances [36,59,60]. They conjugate readily with proteins, and 
are thus active skin sensitizers, but the available evidence indicates that 
effects that might result from conjugation with nuclear macromolecules 
occurred only at very high dose levels, when detoxification mechanisms may 
have been overwhelmed.
Because diglycidyl ethers include twice as many of the hypothetically 
active epoxide moieties, they might be expected to have greater 
carcinogenic or mutagenic potential than monoglycidyl ethers. All 10 
compounds that have been tested showed mutagenic activity in bacterial
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tests [49,57,58]. The most active mutagens, however, were monoglycidyl 
ethers. The quantitative difference in activity and the varying effects 
produced by the addition of mammalian liver microsomes suggest differences 
in metabolic pathways for the glycidyl ethers. Their mutagenic activity 
was also variously affected by test systems involving in vivo mammalian 
metabolism. BGE, a monoglycidyl ether, was the only glycidyl ether shown 
to be a mammalian mutagen in the mouse dominant lethal test, and it was not 
the most active compound in bacterial tests; BGE was also partially 
deactivated by mammalian microsomes in vitro and showed no mutagenic 
activity in the body-fluid test, host-mediated assay, or micronucleus test 
[58]. Since the only data found on tumorigenicity testing concerned 
diglycidyl ethers, no direct evidence is available on their activity 
relative to that of monoglycidyl ethers. However, Weil et al [37] found 
that 5 of 17 diepoxide compounds tested were tumorigenic to mice, while 
none of 11 monoepoxides were. They concluded that the "currently 
prevalent" generalization that diepoxides are carcinogenic was not 
supported. Because no generalizations about the carcinogenic hazards of 
working with epoxy compounds could be made from the existing data, they 
emphasized that each compound must be individually tested for its 
carcinogenic potential.
Shimkin et al [52] have pointed out certain structural factors that 
may affect the carcinogenic potential of alkylating agents such as the 
glycidyl ethers. They suggest that those that are stable enough to survive 
the transfer to a susceptible organ and that structurally resemble a 
naturally occurring substrate tend to be the most active.
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Such diversity in results after testing various monoglycidyl and 
diglycidyl ethers only serves to emphasize the necessity to avoid making 
generalizations regarding the potential of an individual glycidyl ether to 
be mutagenic or carcinogenic. However, these findings, together with 
studies indicating that DGE, and possibly resorcinol diglycidyl ether and 
neopentyl glycol diglycidyl ether, can produce skin tumors [50,51], 
indicate that gross skin contact with glycidyl ethers may represent an 
important hazard to worker health. Because of their low vapor pressures, 
most of these compounds are unlikely to be present in workplace air at 
concentrations sufficient to permit their reaching the nuclei of somatic or 
reproductive cells and causing neoplastic or mutagenic effects. However, 
because of their demonstrated mutagenicity, the glycidyl ethers should, in 
the absence of adequate carcinogenicity test data on individual compounds, 
be regarded as potentially serious hazards.
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TABLE III-l







AGE - 300 hr Dermatitis in 10/20 23
BGE - 3 mo Dermatitis in 0/8 23
I I 100% 48 hr Severe irritation in 5/5 26
I I 10% - Positive patch-tests with 
10% BGE in 19/24
25
f  1 10% 48 hr Irritation in 17/25; posi­
tive patch tests with 1.25% 
BGE in 5/25
26
fl 5% I I Irritation in 8/25 26
I I 2.5% I t Irritation in 1/25 26
11 1.25% I I Irritation in 0/25 26
DGE - a few mo No dermatitis reported 23
IGE - 11 11 23
PGE - 600 hr Dermatitis in 13/20 23
1! 3% Dermatitis in 12/18; posi­
tive patch-tests with 
















AGE Death Rats 2,800 mg/cu m 5 wk inhalation 23
11 I I Mice 1,260 mg/cu m 4 hr I t 23
«1 Decreased weight gain Rats 1,210 mg/cu m 10 wk t t 23
I I Lung damage t t 1,870 mg/cu m 10 wk t t 23
I I Testicular degeneration t t 400 mg/kg/d 3-4 d lm 48
I I Decreased leukocytes 11 I I 11 i t 48
I t Skin Irritation Rabbits Undiluted - dermal 23
I f Eye Irritation t t t t - ocular 23
f t ii Rats 1,200 mg/cu m 10 wk inhalation 23
BGE Death I I 5,500 mg/cu m 8 hr - t l 23
I t Dominant lethal Mice 1,500 mg/kg/d 24 d dermal 58
I I Increased leukocytes Rats 400 mg/kg/d 3 d lm 48
I I Sensitization Guinea
pigs
10Z 8 d dermal 31
I I Skin Irritation babbits Undiluted - dermal 23,30,
32,42
t t Eye irritation II t t - ocular 23,32
CGE Death Mice 980 mg/kg 1 dose sc 36
t t Muscle relaxation Rats 390 mg/kg t t " 36















DGE Death Mice 160 mg/cu m 4 hr Inhalation 23
tl tt Rabbits 128 mg/cu m 24 hr 11 41
tl tt Rats 106 mg/cu m 3-4 d 11 41
tt II II 200 mg/kg/d 6 d dermal 41
II Organ damage Rabbits 128 mg/cu m 24 hr inhalation 41
II Lung damage Rats 106 mg/cu m 3-4 d II 41
II Testicular degeneration Rabbits 128 mg/cu m 24 hr 11 41
rr tt Rats 1.6 mg/cu m 60 d tt 41
it Weight loss Rabbits 128 mg/cu m 24 hr II 41
it tl Rats 106 mg/cu m 3-4 d II 41
tt 11 tt 250 mg/kg/d 6 d dermal 41
tt Decreased weight gain tt 32 mg/kg/d 6 d II 41
tt Decreased leukocytes 11 16 mg/cu m 19 d inhalation 41
tt tt 11 500 mg/kg 1 dose dermal 41
li M 11 200 mg/kg d 6 d tt 41
it Skin tumors Mice 0.25 mM 8 wk tt 41
ti Skin irritation Rabbits Undiluted - tt 41
tt Eye irritation II II - ocular 23
ir tt Rata 250 mg/kg/d 6 d dermal 41
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TABLE III-2 (CONTINUED)











IGE Death Mice 7,130 mg/cu m 4 hr inhalation 23
» t l Rats 5,230 mg/cu m 8 hr II 23
t l Decreased weight gain I t 1,900 mg/cu m 10 wk H 23
t t Respiratory distress I t f t I f I t 23
I I •Skin Irritation Rabbits Undiluted - dermal 23
t t Eye Irritation t l t t - ocular 23
I t I f Rats 1,900 mg/cu m 10 wk Inhalation 23
PGE Death Rabbits 3,000 mg/kg 1 dosç dermal 23
t l Organ necrosis Rats 2,200 mg/kg II I t 35
t t Muscle relaxation t l 430 mg/kg t t S C 36
I t Lung Irritation II 60 mg/cu m 10 wk inhalation 23,39
t t Testicular degeneration t t 10 mg/cu m 19 d I t 49
t t Increased leukocytes t t 400 mg/kg/d 3 d im 24
t t Sensitization Guinea
pigs
Undiluted 7 d dermal 24
t l Skin irritation Rats 70 mg/cu m 3 mo inhalation 39
t t II Rabbits Undiluted - dermal 23,34
35
I t Eye irritation II t l - ocular 23,34
35





5-25% - dermal 28
TABLE III-2 (CONTINUED)













Death Rats 1,130 mg/kg 1 dose dermal 32
II Bone marrow cytotoxicity It 100 mg/kg tt i p 56





10Z - dermal 28
II Skin irritation Rabbits Undiluted - It 32
11 Eye Irritation tt II - ocular 32
Diethylene glycol Bone marrow cytotoxicity 
diglycidyl ether
Rats 100 mg/kg 1 dose i p 56





Death Rabbits 22,000 mg/kg 1 dose dermal 37
II Sensitization Guinea
pigs
5% - II 7
II Skin irritation Rabbits Undiluted - It 37
II Eye irritation II h - ocular 37
Resorcinol 
diglycidyl ether
Death II - 7 d dermal 33
II Skin tumors Mice 0.75 aM 8 wk tl 51
II Skin irritation Rabbits Undiluted - It 33
Triethylene glycol 
diglycidyl ether
Lung tumors Mice 7,200 mg/kg 
(total dose)
- i p 52




Most glycidyl ethers are liquids with low vapor pressures, ranging 
from 0.01 mmHg at 25 C for PGE to 3.2 mmHg for BGE, 4.7 mmHg for AGE, and 
9.4 mmHg for IGE at 25 C. The vapor pressures for BGE, AGE, and IGE are 
great enough to permit vapor concentrations of up to 4,000, 6,000, and
12,000 ppm, respectively. Glycidyl ether vapors are generated in certain 
processes, such as resin curing, and the inhalation of these vapors may be 
a health hazard. Engineering controls must therefore be installed wherever 
possible to maintain the concentration of glycidyl ethers at or below the 
recommended environmental limits. Closed-system operations should be used 
whenever feasible to control exposure to vapors produced during the 
manufacture or use of glycidyl ethers. Closed-system operations are 
effective only when the integrity of the system is maintained, so the 
equipment should be inspected frequently for leaks, and any that are found 
should be promptly repaired.
A sparkproof ventilation system may be required where a closed system
proves to be impractical and is desirable as a standby if the closed system
should fail. Industrial Ventilation— A Manual of Recommended Practice
[69], published by the American Conference of Governmental Industrial
Hygienists, and Fundamentals Governing the Design and Operation of Local
Exhaust. Systems, ANSI Z9.2-1971 [70], published by the American National
Standards Institute, provide useful guidelines for the design and
installation of adequate ventilation systems. The air intake for
ventilation systems should be sited so that exhaust air is not recirculated
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in the work area. Ventilation systems will require regular inspection and 
maintenance to facilitate effective operation, and a regular schedule for 
inspections and repair should be established. These routine checks should 
include face velocity measurements of the collecting hood, inspection of 
the air mover, ducts, and collector, and measurements of airborne 
concentrations of glycidyl ethers in the workroom. Any process changes 
that may affect the ventilation system or the operations being ventilated 
must be assessed promptly to ensure that engineering controls will continue 
to provide adequate protection for employees.
If it is determined that glycidyl ether vapors are generated in a 
particular process in amounts sufficient to create a possible fire or 
explosion hazard, several precautions should be taken. If a fan is located 
in ductwork and the air concentration of glycidyl ether vapors may exceed 
25% of the lower flammable limit, the rotating element should be 
constructed of nonsparking material and the casting should also be 
constructed of a nonsparking material. Devices to prevent flashback should 
be installed along the entire length of the ventilation system.
The addition of glycidyl ethers and other components to epoxy resin 
systems immediately before the resins are to be used should be done in a 
ventilated hood. Unnecessary worker exposure to and contamination of the 
physical plant by glycidyl ethers can be minimized by using separate areas 
of the plant for mixing, molding, and curing the resins [71,72].
Sampling and Analysis
Only a few reports describing procedures for the sampling and
analysis of glycidyl ethers have been found. The sampling and analytical
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methods recommended in Appendices I, II, and III have not been validated 
for detecting glycidyl ethers at concentrations as low as the recommended 
limits. Further testing of these methods is an important need.
The Intersociety Committee of the American Public Health Association,
Inc., has reported an analytical method for organic solvent vapors in air
[73]. The method was tested for AGE, BGE, and IGE; these compounds were 
reported to have greater than 80% desorption efficiency by this method. 
Air samples were collected with a charcoal tube and an air-sampling pump. 
The tube was glass, 7 cm long, with a 6-mm outer diameter and a 4-mm inner 
diameter, and contained two sections of 20/40-mesh activated charcoal 
separated by a 2-mm portion of urethane foam. After a known volume of air
was drawn through the tubes at a specific flowrate (50-200 cc of
air/minute), the collected organic vapors were desorbed separately from 
each section of charcoal in the tube with carbon disulfide and analyzed by 
gas chromatography with flame ionization detection. The area of the peaks 
was compared with a standard curve to determine the concentration of the 
samples.
High humidity and high temperatures were reported to interfere with 
the adsorption capacity of the activated charcoal [73]. The precision of 
the method was limited by the reproducibility of the pressure drop across 
the tubes, and the amount of sample collected was limited by the adsorption 
efficiency of the charcoal. Advantages of the method are that the sampling 
device is small, portable, and requires no liquids, and there are few 
interferences; these can usually be eliminated by altering the gas 
chromatographic operating conditions.
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Little information has been found on portable direct-reading 
instruments that can be used to perform immediate evaluations of 
concentrations of glycidyl ethers in the workplace. The Wilks Miran 1A is 
a portable instrument that uses infrared absorbance to detect many air 
contaminants. The reported minimum detectable concentrations for AGE and 
BGE were 0.07 ppm (0.33 mg/cu m) and 0.05 ppm (0.27 mg/cu m) , respectively
[74]. It is possible that this instrument might be useful for detecting 
other glycidyl ethers, but no data concerning the performance of the 
instrument with them are currently available.
In 1977, Terrill and Lee [39] described a paired sampling and 
analysis regimen for PGE and phenol. The sampling device was a midget 
impinger containing 15 ml of a 0.1 N sodium hydroxide solution in equal 
parts of ethyl alcohol and water. A 10-liter air sample was collected at a 
sampling rate of 1 liter/minute, and ultraviolet analysis was performed on 
it. A 5-ppm v/v solution of PGE had an absorbance of 0.4 (1-cm cell) at a 
maximum of 270 nm. Phenol had a lambda maximum at 288 nm and could be 
detected when the phenol concentration was 5% or more of the PGE 
concentration. The relative proximity of the two lambda maximums is a 
factor that limits the minimum detectability for the system. When phenol 
concentrations were greater than or equal to 0.05 ppm, 0.25 ppm, and 0.6 
ppm, the minimum sensitivities for PGE were 1, 5, and 12 ppm (6, 30, and 74 
mg/cu m), respectively. The phenol concentrations were monitored because 
trace amounts of phenol (found by gas chromatographic analysis) were 
present in the PGE that was sampled.
Jungnickel et al [7] have reviewed several methods for the analysis 
of materials containing alpha-epoxide rings, a group common to all glycidyl
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ethers. The tendency of the epoxide group to react readily with
nucleophilic reagents is the basis for all of the methods. Hydrogen 
chloride (HC1) is added to a flask containing the sample material and 
allowed to react. This reaction can be represented schematically as 
follows:
Since each dissociated molecule of HC1 reacts with only one epoxide group, 
the calculated value for HC1 is a measure of the number of epoxide groups 
present. When monoglycidyl ethers are analyzed, the number of moles HC1 is 
equal to the amount of glycidyl ether in the sample. When diglycidyl
ethers are sampled, the number of moles of HC1 is equal to twice the number 
of moles of the diglycidyl ether in the sample.
The seven methods described by Jungnickel et al [7] differ
principally in the solvent for HC1, the temperature at which the reaction 
is carried out, the specific indicator, and the solvent (water or methanol)
in the solution of sodium hydroxide used as a titrant. The nature of the
sample is one of the factors to be considered when selecting a particular 
hydrochlorination method. The reagents chosen should be good solvents for 
the sample, especially if it is in solid form. The conditions under which 
the reaction is carried out are also important. The method that allows the 
smallest number of side reactions (such as isomerization to the
H H
>• r - o - c h 2- c - c h
OH Cl
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corresponding carbonyl compound) should be selected. The authors [7] 
reported that glycidyl ethers of very high purity were sampled quite
accurately unless alcoholic magnesium chloride hydrochlorinate was used as 
a reagent; then the results were 1-2% low. The authors did not report 
results of analysis of impure glycidyl ether samples, such as might be 
encountered in sampling workplace air. It can be seen, however, that any 
impurities that would react with the hydrochlorination agent or the 
glycidyl ether would affect the accuracy of the method. The possibility 
that other substances in the workplace environment will interfere with the 
determination of glycidyl ethers should be considered when the analyses are 
performed.
These hydrochlorination methods are not suitable for the sampling and
analysis of glycidyl ethers in workplace air for a number of reasons.
Solvent selection is extremely important and must be based on the knowledge 
of other substances that may be present as sample contaminants and the 
hydrochlorination reactions. Most of the solvents suggested (eg, dioxane, 
pyridine, diethyl ether) are toxic. Finally, because a dye is used as an
indicator, these methods should be routinely performed by the same 
technician to provide reproducible results.
NIOSH has validated methods for the sampling and analysis of BGE
[75], IGE [76], and PGE [77]. A draft report on validated sampling and 
analytical methods for AGE [78] indicates that the methods for these four 
glycidyl ethers are similar. The attempts to determine methods of sampling 
and analysis for DGE failed because desorption efficiency was not adequate 
to permit acceptable recovery [79].
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The method tested for DGE under the NIOSH Standards Completion 
Program involved the use of a charcoal tube to collect the vapors; 
methylene chloride was used to desorb the DGE from the charcoal [79]. The 
samples were then analyzed by gas chromatography. When the method was 
tested, 15-minute samples were collected from chambers containing 
concentrations of airborne DGE at 0.5, 1, and 2 times the current Federal 
standard (2.8 mg/cu m ) . The amounts recovered were 71.6, 75.6, and 68.8%, 
respectively, which were considered too low to be acceptable. For this 
reason, and because the experimental work exceeded the time allotted to the 
project, the method received a "failure report." A review of the data 
indicates that the desorption efficiency ranged from 0.783 to 0.976 when
0.02 to 0.85 mg of DGE was placed on, and desorbed from, charcoal. The 
experimenters inferred from preliminary data that desorption efficiency may 
be, to some extent, a function of storage temperature and time; the time 
allotted for the investigation did not allow the experimenters to ascertain 
and clarify the role of storage times and temperature. It is reasonable to 
conclude that if these variables are determined, as they have to be with 
any method relying on sorption on, and desorption from, charcoal, the 
method will be useful for sampling airborne DGE.
Because of the similarities in the chemical structures of all 
glycidyl ethers, the methods presented in Appendices I, II, and III may be 
adequate for sampling and analysis of any glycidyl ether if certain 
parameters, such as the desorption solvents and operating conditions for 
the gas chromatograph, are appropriately modified. These modifications 
have not yet been tested by NIOSH.
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To sample for concentrations of airborne BGE, IGE, and PGE, a known 
volume of air is drawn through a charcoal tube that traps the organic 
vapors. The analytes are desorbed with carbon disulfide and analyzed by 
gas chromatography. Further details of this procedure are presented in 
Appendix I .
To sample for concentrations of airborne AGE, a known volume of air 
is drawn through a Tenax-GC resin tube and the organic vapors are adsorbed 
on the resin. The sample is then desorbed with ether, and an aliquot is 
analyzed in a gas chromatograph. Further details of this procedure are 
presented in Appendix II.
To sample for concentrations of airborne DGE, a known volume of air 
is drawn through a charcoal tube that traps the organic vapors. The 
analyte is then immediately desorbed with methylene chloride and analyzed 
with a gas chromatograph. Further details of this procedure are presented 
in Appendix III.
Certain conditions may interfere with the analysis of these five 
glycidyl ethers. High humidity in the sampling environment may decrease 
the collection efficiency of the collecting tube, and the presence in the 
sample of compounds that have similar retention times at the prescribed 
operating conditions of the gas chromatograph will interfere with the 
detection of the ether being analyzed. If the possibility of interference 
exists, separation conditions (column packing, temperature, etc) must be 
changed to alter the retention times of the ether and the interfering 
compounds in order to circumvent the problem.
The upper limits of the ranges of the methods are dependent on the 
adsorptive capacity of the charcoal or Tenax-GC resin tubes. The
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efficiency of the collecting tubes will change drastically as the tube 
becomes heavily loaded with organic vapors. In practice, lower limits are 
often dependent on the desorption efficiency, ie, the percentage of the 
glycidyl ether that is desorbed and dissolved in the solvent. Desorption 
efficiency must be determined over the range used for each ether being 
analyzed.
The NIOSH recommended methods for the sampling and analysis of AGE, 
BGE, IGE, PGE, and DGE have several advantages over the other methods 
discussed in this section. The recommended sample tubes contain either 
activated charcoal or, for AGE, Tenax-GC, and both of these are solid 
sorbents. A method that requires no liquids during sampling eliminates the 
possibility of spills and evaporation. The chosen sorbents involve no 
exposure to a toxic chemical used as a sampling medium, such as the 
solvents required for the hydrochlorination methods [7]. The sampling 
device is small and portable. Furthermore, interferences are few, and 
those that occur can be eliminated by altering chromatographic conditions. 
In the hydrochlorination method [7], interferences during sampling may 
alter the reaction that is the basis of the analysis and invalidate the 
results of the titration. In ultraviolet analysis of a liquid sample [39], 
the limit of detectability for PGE was seriously affected by tb'i presence 
of phenol.
The primary disadvantage of the recommended sampling and analytical 
methods is that they have not been tested at the recommended sampling rate 
and size. However, the methods are capable of determining concentrations 
of airborne glycidyl ethers at the recommended limits. The method for DGE 
has the distinct disadvantage of requiring desorption immediately after
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sampling because desorption efficiency decreases with time. Immediate 
desorption creates a need for the proper packaging of the methylene 
chloride-desorbed analyte for shipment. The substitution of Tenax-GC for 
charcoal may eliminate the need for these procedures, but the recommended 
method has not been tested by NIOSH with Tenax-GC in the tube.
Environmental Data
A manufacturer of BGE and PGE used the NIOSH-validated sampling and 
analytical methods [75,77] to monitor these compounds during two production 
runs [17(p 155)]. Airborne concentrations below 1 ppm were recorded for
both ethers. During drumming operations at the same facility, airborne 
concentrations of BGE were determined to be 2-4 ppm. No other data on 
concentrations of airborne glycidyl ethers have been found.
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V. WORK PRACTICES
Human skin contact with glycidyl ethers has resulted in rashes, 
burns, and sensitization [23,25,80], and studies in animals indicate that 
skin irritation, sensitization, and systemic effects can result from dermal 
exposure to these compounds [23,31,32,34]. Glycidyl ethers have also 
caused hemopoietic and other systemic effects in animals exposed by 
inhalation [23,33,41], but, for glycidyl ethers other than DGE, these 
effects have occurred only at high concentrations. Eye irritation has 
resulted from both direct contact with liquid glycidyl ethers and exposure 
to airborne vapors [23,41,47]. Glycidyl ethers have proven to be cytotoxic 
or mutagenic or have caused radiomimetic effects in tests using several 
different routes of exposure, including dermal contact [56,58]. DGE and 
resorcinol diglycidyl ether have caused nonmalignant skin tumors in mice 
[51] , and triethylene glycol diglycidyl ether was carcinogenic to mice at 
very high doses [52].
Work practices and sanitation measures applied in the manufacture, 
handling, and storage of glycidyl ethers must therefore be designed to 
minimize or prevent inhalation of glycidyl ether vapors or mists and to 
protect workers' skin and eyes from contact with liquid glycidyl ethers. 
Most glycidyl ethers are liquids. All of them have relatively low vapor 
pressures (Table XIV-2), but because of their toxicity, precautions to 
prevent inhalation of vapors or mists should nevertheless be taken. 
Throughout the process of manufacturing epoxy resin systems, glycidyl 
ethers can be present along with other components of the system, such as
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amine hardeners. Good work practices designed to protect the worker from 
contact with glycidyl ethers should therefore be observed until the resin 
is fully polymerized. A fully polymerized resin has been considered to be 
inert [71,81,82], but wet or uncured resins, and the chemicals used to 
thin, strengthen, or harden them, should be considered hazardous substances 
[71]. Work practices appropriate for handling the other components of the 
epoxy resin system, such as the amine hardeners, should also be followed.
Workers should be provided with protective clothing that is 
impervious to glycidyl ethers and, if possible, fire-resistant. They 
should be protected against contact with liquids by the use of gloves, 
aprons, boots, faceshields (8-inch minimum), and other protective equipment 
or clothing. For processes in which manual dexterity requirements limit 
the types of gloves that can be worn, protective hand creams have been 
suggested as supplements to gloves that will permit the required dexterity 
[17(pp 5,141),83]. Extreme care should be taken to avoid contamination 
inside gloves. Tests done at Argonne National Laboratory in 1964 indicated 
that only 2 of 10 glove materials tested provide acceptable protection for 
work with AGE and PGE [84]. Milled butyl rubber and polyvinyl alcohol were 
found to be acceptable materials. Unacceptable glove materials were 
natural rubber (latex), neoprene-natural rubber (latex), milled neoprene, 
neoprene with nylon, milled Buna-N, vinyl and polyethylene (disposable) , 
and polyvinyl chloride [84] . Gloves made of polyvinyl chloride or 
polyethylene-coated fabric may be used for a single workshift exposure (BW 
Karrh, M.D., written communication, January 1978). Only adequate test data 
should be used as a basis for deciding which glove materials provide proper 
protection against specific glycidyl ethers. At the end of the workshift,
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workers should use conditioners to keep the skin on their hands and arms 
supple because absorption of, and sensitization to, glycidyl ethers occurs 
more readily through irritated or cracked skin [44,72]. Neutral or acid 
soaps that protect the skin from drying and cracking should be used instead 
of alkaline, powdered, and abrasive cleaning agents or lipid solvents 
[71,72].
Safety showers and eyewash fountains should be readily accessible to 
employees working in or near areas where splashes of glycidyl ethers are 
possible, and this equipment should be properly maintained. Handwashing 
facilities, with neutral or acid soap or an alternative cleanser, must be 
available to the employees, who shall be instructed to wash their hands 
before eating or using toilet facilities. The preparation, dispensing, 
consumption, or storage of food or beverages in exposure areas should be 
prohibited.
The effects of glycidyl ethers on workers are intensified by the 
penetration of the ethers into clothing and shoes, which act as reservoirs 
and prolong the contact [23]. For this reason, clothing contaminated with 
any of the ethers must be removed as soon as possible and stored in a 
closed container until it is either laundered or discarded. The employer 
should inform the persons laundering or otherwise handling the contaminated 
clothing of the hazardous properties of glycidyl ethers. Shoes or other 
leather apparel on which glycidyl ethers have been spilled should be made 
unfit for use and discarded [17 (p 5)].
To protect workers' eyes, the employer should provide chemical safety 
goggles (splashproof) meeting the requirements of 29 CFR 1910.133 and ANSI 
Z87.1-1968 and should ensure that they are worn whenever there is a
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reasonable probability that glycidyl ethers could be splashed into the 
eyes. Workers should be cautioned to avoid rubbing their eyes with hands 
that may be contaminated with glycidyl ethers. If eye contact occurs, the 
eyelid should be lifted, the eye should be flushed with copious amounts of 
water, and the worker should be referred to a physician.
When concentrations of airborne glycidyl ethers cannot be kept at or 
below prescribed limits by engineering controls, eg, because of spills or 
equipment failure or during maintenance or entry into confined spaces,
special respiratory protection is required. Employers should establish and 
enforce a respiratory protective program meeting the requirements of 29 CFR 
1910.134 and should provide proper respiratory devices as outlined in 
Tables 1-1, 1-2, 1-3, and 1-4.
Because the glycidyl ethers vary in their physical properties and 
toxic effects, no single respirator selection guide can be devised that 
would be applicable to all compounds. Instead, the selection of a
respirator that will provide adequate protection at a given concentration 
of airborne glycidyl ethers must be performed on a compound-by-compound
basis for each glycidyl ether. Respirator guidelines have been developed
for five of the glycidyl ethers, and these are presented in Tables 1-1, I- 
2, 1-3, and 1-4. These guidelines should not be followed in choosing 
respirators for use with other glycidyl ethers unless additional 
information indicates that there are very close similarities in their 
physical properties and toxic effects.
However, available information on the glycidyl ethers as a class 
permits certain general recommendations. Quarter-mask and half-mask 
respirators should not be used with any glycidyl ether because all of the
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compounds are potentially irritating to the eyes. Full-body protective 
clothing should also be provided in any situation that requires the use of 
a respirator because of the hazard of skin absorption and skin irritation 
and sensitization.
Protective clothing and equipment, including respirators, should be 
kept clean and maintained in good condition. This equipment should be 
cleaned and inspected by trained personnel after each use and should be 
replaced when necessary. The employer must ensure that all equipment is in 
working order and that it is stored properly when not in use.
If evacuation of the process or work area might be required in an 
emergency, a program permitting rapid egress from the area should be 
designed, and the employer should ensure that it is implemented. All 
potentially exposed employees must be aware of escape procedures, of the 
location of and proper use of respirators designated for emergency 
situations, and of firefighting methods. Instructions should be given for 
transporting injured employees to areas where emergency medical care can be 
given.
There is considerable variation in the fire and explosion hazards 
associated with the use, handling, and storage of various glycidyl ethers. 
IGE is classified, under the provisions of 29 CFR 1910.106, as a Class IC 
flammable liquid, which is a liquid with a flashpoint at or above 73 F 
(22.8 C) and below 100 F (37.8 C). AGE and BGE are Class II combustible 
liquids, and PGE is a Class III A combustible liquid. A Class II 
combustible liquid has a flashpoint at or above 100 F (37.8 C) and below 
140 F (60 C), and a Class III A liquid has a flashpoint at or above 140 F 
(60 C) and below 200 F (93.3 C) (29 CFR 1910.106). Whenever a combustible
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liquid is heated to within 30 F (16.7 C) of its flashpoint, the compound
should be handled as if it belonged to the next lower class (29 CFR
1910.106). No data were found on the other glycidyl ethers covered in this
document that would permit their classification as either flammable or 
combustible.
The vapor of IGE can easily form explosive mixtures in air; 
consequently, all sources of ignition must be controlled where IGE is used, 
handled, or stored. Furthermore, because this glycidyl ether is heavier 
than air, distant ignition sources can present problems [85]. Although the 
fire and explosion hazards associated with the use of AGE, BGE, and PGE are 
not as severe, it is necessary to ensure that flames or other sources of 
ignition, such as smoking, are not permitted in areas where these glycidyl 
ethers are used, stored, or handled. Should a fire involving glycidyl 
ethers occur, a medium such as water, carbon dioxide, or dry chemicals 
should be used to extinguish it [3]. Fire extinguishers should be readily 
accessible to all employees exposed to glycidyl ethers and should be 
maintained in good condition.
The storage of bulk amounts of glycidyl ethers must meet the
requirements for their classification (flammable or combustible as 
specified in 29 CFR 1910.106(f). There is evidence that PGE and BGE will 
undergo violent polymerization when subjected to high temperatures, whether 
alone or in the presence of catalysts or strong oxidizing agents such as 
acids, bases, and salts [17(pp 62,69)]. IGE will react in a similar 
fashion [85]. No data concerning violent polymerization by other glycidyl 
ethers have been found; nonetheless, since all glycidyl ethers have 
structural similarities, it seems reasonable to assume that at least some
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of the rest of the glycidyl ethers might also polymerize violently under 
similar circumstances. Consequently, glycidyl ethers should be stored in a 
cool place where they will not be subjected to extreme temperatures, and 
they should not be stored near acids, bases, and salts.
Special precautions are necessary for entering confined spaces, such 
as tanks or reaction vessels and enclosed application sites, that may
contain glycidyl ethers, for performing flame- or spark-generating
operations such as welding and cutting, and for transferring glycidyl 
ethers. Before any employee enters a vessel, all pipelines leading into or 
out of the vessel must be blanked to prevent the entry of liquid or vapors. 
The vessel interior should be rinsed with water and then purged with air or 
with nitrogen followed by air. After the purging, and during all
operations in the vessel, its atmosphere should be tested with an oxygen
meter, a combustible gas meter, and other approved instruments. No 
employee should enter any tank or vessel that does not have an entrance 
large enough to admit the employee equipped with safety harness, lifeline, 
and appropriate respiratory equipment. The employee must be able to leave 
the tank or vessel by the same opening. Employees entering contaminated 
tanks or vessels should wear full-body protective clothing until inspection 
and testing assure safety for personnel in the tank. When employees are 
working in confined spaces, another employee should be stationed at the 
entrance to keep them under constant observation, and one or more 
additional employees shall be readily available in case of an emergency. A 
positive pressure respiratory protective device with safety harness and 
lifeline should be located outside the tank or vessel for emergency use. 
The use of portable lights to illuminate the interior of tanks, vessels, or
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reactors when they are undergoing cleaning or repairs should be prohibited. 
Such interiors should be illuminated by reflected light or explosion-proof 
light sources. Only nonferrous (sparkproof) tools should be used for 
scraping away clinging residues or accumulated deposits, and rags and other 
materials used to wipe and absorb ethers should be placed in standard 
safety containers for subsequent disposal. Cutting or welding must be 
performed only after an authorized representative of the employer has 
signed a permit indicating that all actions prescribed in pertinent 
sections of 29 CFR 1910.252 have been taken.
Whenever flammable or combustible liquids are transferred from one 
container to another, both containers must be effectively bonded and 
grounded to prevent the buildup and discharge of static electricity.
The employer should assume responsibility for providing proper 
initial training and periodic retraining of employees on correct operating 
procedures and use of protective equipment. If all recommended work 
practices are observed, good engineering controls as discussed in Chapter 
IV are installed, and adequate educational programs are conducted, 
employees working with glycidyl ethers can be adequately protected from the 
hazards associated with them.
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VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1961, the American Conference of Governmental Industrial 
Hygienists (ACGIH) published tentative threshold limit values (TLV's) for a 
number of glycidyl ethers. The tentative TLV's were: AGE, 45 mg/cu m;
BGE, 270 mg/cu m; DGE, 55 mg/cu m; IGE, 240 mg/cu m; and PGE, 310 mg/cu m 
[86]. The ACGIH adopted these TLV's in 1962 [87].
In 1963, the ACGIH [88] recognized that TLV's expressed as 8-hour 
time-weighted average (TWA) concentrations did not provide a safety margin 
for certain fast-acting substances comparable with that provided by a TWA 
limit for slow-acting substances. A "C" or "ceiling" designation was 
therefore affixed to AGE and DGE, indicating that the limit should not be 
exceeded under any circumstances. The TLV for DGE was lowered to 2.8 mg/cu 
m at the same time. According to the 1966 Documentation of Threshold Limit 
Values [89], the earlier limits had been based on a single study by Hine et 
al [23] and a determination of the LD50 for PGE by Smyth et al [34]; no 
other data were available. The former report [23] described extensive
animal studies but contained limited human data. The change in the limit 
for DGE was based on a 1962 written communication to the ACGIH from NG 
White, who had concluded on the basis of industrial experience that the TLV 
was too high. The documentation indicated that animal studies suggested
that 2.8 mg/cu m would be a no-effect level.
In 1968, the TLV for PGE was lowered from 310 mg/cu m to 60 mg/cu m
[90]. In 1970, an intent to change the limit for AGE from 45 to 22 mg/cu m
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and to drop the ceiling designation was published [91].
The TLV's and accompanying notations for BGE, DGE, and IGE remained 
unchanged through 1971, and the 1971 Documentation of Threshold Limit 
Values for Substances in Workroom Air [92] used the previously cited study 
by Smyth et al [34] as the basis for the change in the limit for PGE and 
the study by Hine et al [23] as the basis for the proposed change for AGE. 
The earlier limits were not considered sufficiently low to protect against 
irritation or against systemic effects such as sensitization [92].
In 1972, the limit for AGE remained a ceiling concentration of 45 
mg/cu m [93]. In 1973, the ACGIH adopted the proposed TLV for AGE of 22 
mg/cu m without a ceiling designation [94], and in 1974 AGE was given a 
"skin" designation to indicate that skin contact should be prevented if 
possible and that contact with the skin should be considered in the 
evaluation of exposure [95]. ACGIH TLV's for BGE, DGE, IGE, and PGE have 
remained unchanged since 1968. However, tentative short-term exposure 
limits (STEL's) of 360 mg/cu m for IGE and 90 mg/cu m for PGE were proposed 
by ACGIH in 1976 [96]; these limits were for periods of up to 15 minutes, 
separated by at least 1 hour and not to exceed four such exposures in an 8- 
hour day. Changes in ACGIH TLV's for the glycidyl ethers are summarized in 
Table VI-1 [86,88,90,94,95].
According to the 1976 joint report of the International Labour Office 
(ILO) and the World Health Organization (WHO) [97], nine other contries 
have set limits to regulate exposure to the glycidyl ethers. These maximum 
allowable concentrations (MAC's) are presented in Table VI-1.
109
TABLE VI-1
PERMISSIBLE ENVIRONMENTAL LIMITS FOR GLYCIDYL ETHERS (MG/CU M)
Standard AGE BGE DGE IGE PGE
ACGIH TLV's
1962 45 270 55 240 310
1963 45 C* M 2 . 8 IT 1!
1968 11 fr II Î ! 60
1973 2 2 IT rr II II
1974 22 S* I t n Tl f t
Current US Federal Standard 45 C* 270 2 . 8 240 60
Foreign MAC’s**
Australia 22 C* 270 2 . 8 240 60
Belgium 22 H* » 1 f t II i r
Federal Republic of Germany 45 SP* - 2 . 8 IT 310 SP*
Finland 22 H* 270 2.8 C* II 60
Netherlands i r IÎ Î I I I 11
Rumania Average : 1 0 0 1 0 0 _ 50 75
Maximum: 2 0 0 2 0 0 2 . 0 1 0 0 1 0 0
Sweden - - 2.8 C* - -
Switzerland 22 H* 270 M 240 60 SP*
Yugoslavia 45 ÎI 2 . 8 II 60
*C ■ ceiling limit never to be exceeded; S = skin contact should be pre­
vented if possible and should be considered in evaluating exposure; H = 
skin irritant; SP = sensitization potential 
**Maximum Allowable Concentrations
Adapted from references 86,88,90,94,95,97
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Present Federal standards (29 CFR 1910.1000(a)), expressed as 8-hour 
TWA concentrations for the workplace environment, are BGE, 270 mg/cu m; 
IGE, 240 mg/cu m; and PGE, 60 mg/cu m. The present Federal standards for 
AGE and DGE, designated as ceilings, are 45 mg/cu m and 2.8 mg/cu m, 
respectively. These limits are based on the TLV's for workplace exposure 
adopted by the ACGIH in 1968.
Basis for the Recommended Standard
Adverse effects reported in humans occupationally exposed to glycidyl 
ethers have been limited to irritation of the skin and mucous membranes and 
sensitization, and systemic effects in animals have generally been reported 
only at relatively high concentrations or doses. However, the glycidyl 
ethers are biologically reactive compounds because of the presence of the
epoxide group. They have been shown to have cytotoxic effects and to be
mutagenic in bacteria and other test systems. At least one, DGE, should be 
regarded as a potential occupational carcinogen on the basis of animal 
tests. Because there is evidence that some glycidyl ethers have the 
potential to produce tumorigenic, mutagenic, or reproductive effects, and 
because few have been adequately tested for such effects, occupational
exposure to glycidyl ethers is defined in this document as work in any area 
where these substances are manufactured, stored, used, or handled. All
employees working in such areas should receive adequate medical 
surveillance and their environmental exposures should be evaluated. 
Appropriate engineering controls, monitoring and recordkeeping, sanitation 
procedures, work practices, protective clothing and equipment, and training
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programs should be used to keep worker exposure to the glycidyl ethers as 
low as is technically feasible.
(a) Permissible Exposure Limits
Data currently available make it possible to set environmental limits 
for only five of the glycidyl ethers. The primary effect of these 
compounds at relatively low concentrations is irritation of the skin, eyes, 
and respiratory system. To minimize irritative effects by preventing 
exposures at high concentrations of airborne glycidyl ethers, NIOSH 
recommends environmental limits as ceiling concentrations based on a 15- 
minute sampling period.
Although no data have been found on possible additive effects, 
employers should consider the possibility of such effects when employees 
are simultaneously exposed to more than one glycidyl ether. The following 
formula can be used to calculate the appropriate environmental limit when 
such additive effects may occur:
CPELn =  j  1 -  + . . . + - C- ~1 )  \ PE>-n
(  V PEL t PELnV  )
CPELn = conditional permissible exposure limit 
for the nth compound
p  *  p  *
1 n-1 = measured concentrations of compounds 1 to n-1
PEL-j to  PELn = permissible exposure limits for compounds 1 to n
(1) Allyl Glycidyl Ether (AGE)
Eye irritation has been noted by one worker and by 
experimenters exposed at unknown concentrations to AGE vapor [23] . Corneal 
opacity has been observed in rats exposed to AGE at vapor concentrations as 
low as 400 ppm (1,870 mg/cu m) for 7 hours/day, 5 days/week, for 10 weeks. 
This exposure also produced emphysema, bronchiectasis, and
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bronchopneumonia. Inflammation and congestion have been observed in 
various organ systems of rats after inhalation of AGE [23,48]. Inhalation 
exposure of rats at concentrations of 260 ppm (1,210 mg/cu m) for 7 
hours/day, 5 days/week, for 10 weeks caused decreased weight gain, slight 
irritation of the eyes, and mild respiratory distress for the duration of 
exposure [23]. AGE has shown mutagenic activity in bacteria [57], but 
mutagenicity has not been confirmed in other tests.
The limited data available suggest that the current Federal standard 
provides an adequate safety margin to prevent systemic effects from 
inhalation of AGE. NIOSH therefore recommends that worker exposure to 
airborne AGE be limited to 45 mg/cu m (9.6 ppm), measured as a 15-minute 
ceiling concentration.
(2) Isopropyl Glycidyl Ether (IGE)
No effects have been demonstrated in workers exposed to IGE
[23]. Inhalation exposure to IGE at a concentration of 400 ppm (1,900 
mg/cu m ) , 7 hours/day, 5 days/week, for 10 weeks caused only slight eye
irritation, respiratory distress, and decreased weight gain in rats [23].
Because only slight irritation was produced in these animals and 
because there are no reports of human effects, NIOSH recommends that the 
present Federal standard for IGE of 240 mg/cu m (50 ppm) be retained, but 
that it be changed from a TWA value to a ceiling concentration for a 15-
minute sampling period to provide adequate protection against irritative
effects.
(3) Phenyl Glycidyl Ether (PGE)
No reports were found of adverse effects in humans from
exposure to airborne PGE. Respiratory tract irritation [23] and skin
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irritation [39] have been reported in rats exposed repeatedly to airborne 
PGE at concentrations of 5-12 ppm (30-72 mg/cu m ) . Exposure to PGE at 12 
and 5 ppm caused skin damage and loss of hair in rats, but no effects were 
observed at 1 ppm (6 mg/cu m) [39] • The only effects reported in rats 
exposed to PGE at about 10 ppm (60 mg/cu m) 5 days/week for 10 weeks were 
respiratory tract inflammation and early stages of necrosis in the liver 
[23]. The weight gain and tissues of these animals did not differ from 
those of controls. PGE has shown mutagenic activity in bacteria, but it 
produced no dominant lethal or teratogenic effects in mice exposed at 11.5 
ppm (71 mg/cu m) for 12-19 days [49] . Inconclusive evidence of testicular 
degeneration was reported in some rats exposed to PGE at 1.75-11.20 ppm 
(11-71 mg/cu m) [49].
Because irritation has been observed in animals after exposure at 
concentrations as low as 5 ppm (30 mg/cu m ) , and in order to provide an 
adequate safety margin, NIOSH recommends that the environmental limit for 
PGE be set at 5 mg/cu m (1 ppm), designated as a ceiling concentration for 
a 15-minute sampling period.
(4) n-Butyl Glycidyl Ether (BGE)
No reports were found of adverse effects in humans from 
exposure to airborne BGE. In LC50 studies with BGE, some exposed rats 
developed focal inflammatory cells with moderate congestion in the liver 
and hyperemia of the adrenal glands at unspecified vapor concentrations 
[23]. The only other study found that investigated systemic effects of BGE 
reported minimal toxic effects and a slight increase in leukocyte counts in 
rats given three im injections of 400 mg/kg [48].
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BGE was mutagenic in microbial and mammalian test systems [57,58]. 
It produced a significant increase in the number of fetal deaths in the
dominant lethal test when applied to the skin of male mice in doses of 1.5
g/kg during an 8-week period [58].
No studies have investigated the effects of long-term inhalation of 
BGE at low concentrations in humans or animals; thus, calculation of a safe 
exposure concentration is not possible. However, BGE has been implicated
as a mammalian mutagen, and it has caused skin and eye irritation and
sensitization. NIOSH therefore recommends that the limit for worker 
exposure to BGE be set at the lower limit of detectability permitted by the 
NIOSH-recommended sampling and analytical method, 30 mg/cu m (4.4 ppm), as 
a ceiling concentration for a 15-minute sampling period.
(5) Di(2,3-epoxypropyl) Ether (DGE)
DGE is not widely used in industry, and no reports of effects 
on humans have been found. When tested in animals, it was the most 
irritating and the most toxic of the glycidyl ethers [23]. DGE has 
produced a 40% incidence of skin papillomas in those mice that survived a
dose of 0.75 millimole [51]. It has also shown mutagenic activity in
bacteria [57]. Corneal opacity has been reported in rabbits exposed to
airborne DGE at concentrations of 20-27 ppm (106-144 mg/cu m) [47]. In
single 24-hour exposures, DGE at 24 ppm (128 mg/cu m) killed three rabbits 
and produced changes in the lungs, liver, kidneys, and testes [41]. A 
similar exposure at 6 ppm (32 mg/cu m) produced basophilia in rabbits, but 
no effects were observed in those exposed at 3 ppm (16 mg/cu m ) .
Exposure to DGE at 3 ppm (16 mg/cu m) for 4 hours/day, 5 days/week,
for 19 exposures during 29 days killed 5 of 30 rats and caused
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bronchopneumonia, inflammation of the larynx, peribronchiolitis, and 
necrosis of pancreas, spleen, and testicular tubules [41]. Rats exposed at 
this concentration also showed significant decreases, compared with
controls, in weight gain, organ weight/body weight ratio of thymus and 
spleen, leukocyte count, percentage of polymorphonuclear cells, and bone 
marrow nucleated cells, and a significant increase in the ratio of myeloid 
to erythroid cells. Rats exposed to DGE at 0.3 ppm (1.6 mg/cu m) had no 
significant changes in weight gain, bone marrow, or blood; however, "poorly 
defined" degeneration of the testes was reported in 5 of 10 rats killed
after 60 exposures [41].
Because DGE has shown tumorigenic activity in mice and produced 
mutations in bacteria, it should be regarded as a potential occupational 
carcinogen. Exposure to DGE at 3 ppm (16 mg/cu m) has produced irritative 
and systemic effects in rats, including evidence of cytotoxicity, and 
testicular changes have been reported in rats exposed at concentrations as 
low as 0.3 ppm (1.6 mg/cu m ) . NIOSH therefore believes that the current 
Federal standard of 2.8 mg/cu m does not provide adequate protection and
recommends that exposure to airborne DGE not exceed 1.0 mg/cu m (0.2 ppm) 
as a ceiling concentration determined in a 15-minute sampling period.
(6) Other Glycidyl Ethers
Limited data are available on several other glycidyl ethers.
All glycidyl ethers that have been tested have been mutagenic in bacteria 
[49,57,58], and CGE and neopentyl glycol diglycidyl ether have also induced 
unscheduled DNA synthesis in human white blood cells [58]. Triethylene 
glycol diglycidyl ether, which is not currently used or manufactured in the
United States, has produced lung tumors in mice receiving ip doses in
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excess of 3.6 g/kg [52]. Resorcinol diglycidyl ether [51] and diphenylol 
propane diglycidyl ether [37] each produced a single skin papilloma in 
tests on mice. Only hydroquinone diglycidyl ether has given clearly 
negative results in a test of its tumorigenicity [51]. In addition, all 
glycidyl ethers that have been tested, including alkyl glycidyl ethers, 
diphenylol propane diglycidyl ether, neopentyl glycol diglycidyl ether, and 
butanediol diglycidyl ether, have produced sensitization [28,32,44].
The complete absence of inhalation toxicity data on these compounds 
makes it impossible to set limits for environmental concentrations. The 
vapor pressures of some of the compounds, such as diphenylol propane 
diglycidyl ether and resorcinol diglycidyl ether, are extremely low at 
ambient temperatures, so that the risk to workers from inhalation of these 
compounds is probably negligible. Other glycidyl ethers in this document 
may have appreciable vapor pressures at ambient or higher temperatures, but 
no data are currently available on which limits can be based.
Because the epoxide moiety is highly strained, all the glycidyl 
ethers are chemically reactive. In biologic reactions, the epoxide ring 
may cleave to form a carbonium ion, which can react with nucleophilic 
centers such as protein, RNA, and DNA [6]. For the diglycidyl ethers, this 
reaction may result in crosslinking of nucleophilic centers, which may be 
responsible for the high biologic activity of DGE. These considerations 
and the similar effects of the glycidyl ethers in producing sensitization 
and bacterial mutations suggest that the glycidyl ethers have the potential 
to produce harmful effects under occupational exposure conditions. 
Therefore, glycidyl ethers for which limits have not been recommended
should be treated with the same caution required for the manufacture,
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handling, and storage of those for which there are environmental limits.
(b) Sampling and Analysis
Little information on methods other than those recommended by NIOSH 
for the sampling and analysis of glycidyl ethers has been found in the 
literature.
To monitor the concentration of glycidyl ethers in the employee’s 
breathing zone, one must periodically take air samples. NIOSH recommends 
sampling by drawing a known volume of air, which will vary according to the 
ether being sampled, through a tube containing charcoal or, for AGE, resin, 
to adsorb any organic vapors that are present. The organic material should 
then be desorbed with carbon disulfide (for BGE, IGE, or PGE), diethyl 
ether (for AGE), or methylene chloride (for DGE), and an aliquot of this 
extract should be analyzed by gas chromatography. Because the other 
glycidyl ethers are structurally similar to AGE, BGE, and IGE, the method 
should be adequate for them as well if certain factors, such as solvents, 
adsorbents, and gas chromatographic conditions, are appropriately adjusted. 
The NIOSH-recommended method for these three compounds is presented in 
Appendix I, and the proposed NIOSH method for the sampling and analysis of 
AGE is presented in Appendix II. A similar method for DGE is described in 
Appendix III. These methods have not been validated for detecting these 
glycidyl ethers at the recommended ceiling concentrations. However, it is 
probable that their sensitivities can be increased by increasing the 
sampling rate, as is proposed in Appendix I. The method recommended for 
DGE was not validated by NIOSH because the recovery of DGE was unacceptably 
low [79]. Preliminary data indicated that desorption efficiency may be a
function of the temperature and length of storage. It is reasonable to
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assume that, when the roles of these variables have been determined so that
a standard procedure of maximal efficiency and reliability can be
established, this method will be useful for determinations of DGE at the 
recommended ceiling concentration.
(c) Medical Surveillance and Recordkeeping
Glycidyl ethers are primary skin and eye irritants and may sensitize 
the skin [23-26,30]; NIOSH recommends, therefore, that preplacement and 
periodic medical examinations, with special attention to the skin and eyes, 
be made available to all employees occupationally exposed to glycidyl
ethers. Although some glycidyl ethers had effects on the hemopoietic 
system [23,41,48], these have been observed only at high exposure 
concentrations or doses. Blood changes in workers would therefore be 
expected to appear only at exposure concentrations much higher than those 
that would produce irritation or sensitization of the skin. Because
important toxic effects of the glycidyl ethers on the lungs, CNS, and 
kidneys have been found in animals, examination of the functions of these 
systems is suggested as a part of the general medical examination.
During the medical examination, workers in places of employment where 
DGE or BGE is used should be warned that DGE was tumorigenic in mice and 
that BGE was mutagenic in tests on mice [49,50,52,57,58],
Pertinent medical and other records should be maintained for all 
employees occupationally exposed to glycidyl ethers. These records should 
be kept for at least 30 years after termination of employment.
(d) Personal Protective Equipment and Clothing
Because of the irritating and sensitizing potentials of glycidyl
ethers, personal protective equipment and impervious clothing should be
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worn to prevent skin and eye contact with the compounds or their vapors or 
mists. Gloves, boots, aprons, faceshields (8-inch minimum), and goggles or 
safety glasses with side shields are recommended. Tests performed at the 
Argonne National Laboratories in 1964 showed that protective, gloves made 
from natural rubber (latex), neoprene natural rubber (latex), milled 
neoprene, neoprene with nylon, milled Buna-1, vinyl and polyethylene 
(disposable), and polyvinyl chloride would not protect the skin dependably 
from contact by AGE and PGE [84]. Only milled butyl rubber and polyvinyl 
alcohol proved to be adequate. Gloves made of polyvinyl chloride or 
polyethylene-coated fabric may be used for a single workshift exposure. 
The employer should ensure that the gloves and protective clothing worn by 
the employees are impervious to glycidyl ethers and that they are 
maintained in good condition and replaced as necessary. An alternative and 
less desirable tactic is to issue new gloves each day.
The use of protective hand creams is suggested as a supplement to 
gloves where manual dexterity requirements limit the types of gloves that 
can be worn. Because absorption of and sensitization by glycidyl ethers 
occurs more readily through irritated and cracked skin, lipid solvents 
should not be used for cleaning the skin [28,45,71]. When leather clothing 
or equipment, such as belts or shoes, becomes obviously contaminated with a 
glycidyl ether, it should be made unfit for use and discarded [17(p 5)].
The employer should institute a respiratory protection program in 
accordance with 29 CFR 1910.134, and respirator types approved under 
provisions of 30 CFR 11 for the concentrations specified should be 
provided. Approved respiratory protective equipment, as shown in Tables I-
1, 1-2, 1-3, and 1-4, should be used during nonroutine maintenance,
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emergencies, or installation of equipment, and at any other time when 
employees are potentially exposed to glycidyl ethers at concentrations 
above the recommended ceiling concentrations. Because of the potential of 
these compounds for irritating and sensitizing the skin and eyes, full-body 
protective clothing should be worn in any situation in which a respirator 
is required. Workers should be properly trained in the use and care of all 
respirators assigned to them.
(e) Informing Employees of Hazards
The employer should initiate a continuing education program to ensure 
that employees have current knowledge of job hazards and of proper work 
practices and emergency procedures. Employees should also be informed 
before job placement that irritation and sensitization may result from 
exposure to glycidyl ethers and that DGE has caused skin tumors in mice and 
BGE has been found to be a mammalian mutagen.
(f) Work Practices
Glycidyl ethers are primary irritants and sensitizers, and several of 
them have been mutagenic or tumorigenic. Safe handling of these compounds 
depends, therefore, upon work practices and engineering controls that are 
designed to prevent or minimize inhalation of and skin and eye contact with 
them.
Many glycidyl ethers are combustible or flammable liquids, which can 
present a fire hazard. Many of them may polymerize violently after slight 
heating, so that precautions should also be taken to prevent fires and 
explosions. In the event of a fire, media such as water, carbon dioxide, 
or dry chemicals should be used to extinguish it [3]. Workers must also be
protected from the possible hazards of inhaling or ingesting or becoming
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contaminated with glycidyl ethers during fires or other emergencies.
To reduce the fire and explosion hazards, smoking and the carrying of 
open flames or ignition sources should be prohibited in the work area. 
Electrical wiring should comply with appropriate sections of the National 
Electrical Code as adopted by OSHA in 29 CFR 1910.309. The tools used to 
open containers should be of nonsparking materials, and the containers 
should be bonded and electrically grounded before glycidyl ethers are 
transferred.
To minimize inhalation of the chemicals, processes should be enclosed 
whenever possible. When this is not feasible, ventilation systems, such as 
specifically placed hoods, can be used. Epoxy-based adhesives containing 
glycidyl ethers should be used only with adequate ventilation.
To prevent the ingestion of glycidyl ethers, food and beverages 
should not be prepared, dispensed, consumed, or stored in work areas. 
Employees should be advised to wash their hands before eating or using 
toilet facilities. Employees should also be cautioned not to touch or rub 
their eyes with hands that may be contaminated with glycidyl ethers. These 
general practices, which are discussed in more detail in Chapter V, apply 
uniformly to the handling, storage, manufacture, and use of all glycidyl 
ethers.
(g) Monitoring and Recordkeeping Requirements
Workers are not considered to be overexposed to glycidyl ethers if 
industrial hygiene surveys show that the concentration of airborne glycidyl 
ethers in the employees' breathing zones are below the recommended ceiling 
concentrations. However, employee exposures to those glycidyl ethers for
which no environmental limits have been recommended should also be
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evaluated, and appropriate records of these exposures should be maintained.
Surveys to determine employee exposure should be repeated at least 
semiannually and within 30 days of any process change likely to result in 
increases in concentrations of airborne glycidyl ethers. For each ceiling 
determination, a sufficient number of samples should be taken and analyzed 
to characterize each employee's exposure during each workshift. Variations 
in work or production schedules and in employment location and job function 
should be considered in choosing sampling times, locations, and frequency.
If it is determined that an employee's exposure to a glycidyl ether 
exceeds the recommended ceiling concentration, control measures should be 
initiated, the employee should be notified of the exposure and of the 
control measures being implemented to correct the situation, and the 
exposure of that employee should be monitored at least once every 30 days. 
Such monitoring should continue until two consecutive determinations, at 
least 1 week apart, indicate that exposure no longer exceeds the 
recommended ceiling concentration. When no ceiling concentration has been 
recommended, the discovery of any free glycidyl ethers in the workplace 
should lead to an analysis of engineering controls, work practices, and 
sanitation procedures to determine that they are operating as effectively 
as possible, or that those practices and procedures in use are the most 
efficient ones for preventing access of the glycidyl ethers to the 
employee.
Records of environmental monitoring, including the basis for the 
determination that an employee's exposure is below the recommended ceiling 
concentration, and medical records should be kept for 30 years after
termination of employment. The Toxic Substances Control Act of 1976
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requires that "Records of...adverse reactions to the health of employees 
shall be retained for thirty years from the date such reactions were first 
reported to or known by the person maintaining such records." Because 
medical examinations will often provide the first recognized evidence of an 
adverse reaction, whether at the time of the examination or 
retrospectively, requiring medical records on glycidyl ether workers to be 
maintained for 30 years seems to be consonant with the Toxic Substances 
Control Act. Records of environmental exposures should be kept for the 
same period, to allow correlation of glycidyl ether workers' exposures with 
changes in their health status.
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VII. RESEARCH NEEDS
By current standards for appraising toxicologic and health hazards, 
the relevant information available on glycidyl ethers is limited. Dose- 
response information is especially scarce. No information on the possible 
carcinogenic and mutagenic hazards of these compounds in humans was found. 
This scarcity of reported effects is remarkable in light of the widespread 
use of glycidyl ethers. The number of persons exposed has gone from very 
few in the 1930's to more than 1,000,000 each year in the 1970's. Many 
glycidyl ethers are primary irritants, cause allergic reactions, and have 
the potential to cause cross-sensitization; however, the lack of reports of 
serious adverse effects in workers exposed to these compounds is 
encouraging.
The existing data, which come primarily from animal experiments, 
indicate that some glycidyl ethers are relatively toxic [23,25,27,41,48] 
and are potentially cytotoxic or mutagenic [6,56,58]. Only a few of the 
ethers have been assessed for toxicity, even though others, such as CGE, 
are used in industry. BGE has been shown to be mutagenic [58], and DGE and 
triethylene glycol diglycidyl ether, at high doses, were tumorigenic and 
carcinogenic, respectively [51,52]. Further studies of the toxicity of 
glycidyl ethers should therefore include examination of the carcinogenic, 
mutagenic, and teratogenic potential of each glycidyl ether that is widely 
used in industry. Information is especially needed on the effects of these 
compounds at low doses or concentrations. The similarity in structure of 
these compounds and the fact that they are potential alkylating agents give
reason for concern about their potential mutagenic and carcinogenic 
properties.
No epidemiologic studies of workers exposed to glycidyl ethers have 
been found. There are no existing data on human inhalation exposure to 
glycidyl ethers. Studies of effects on humans from inhalation exposure 
that include data on exposure durations and concentrations are needed. 
Epidemiologic studies that address the problems of sensitization and cross­
sensitization, the effects of long-term exposure to the glycidyl ethers, 
and the influence of age, sex, and other factors on the toxicologic effects 
of these compounds are also needed. These studies should be designed to 
investigate eye, respiratory, and skin irritation, in addition to other 
toxic effects. Although the sensitization potential of some of the 
glycidyl ethers has been examined in humans [25,27], more research is 
needed that examines allergic reactions and possible cross-sensitization in 
glycidyl ether workers with occupational dermatitis.
Sampling and analytical methods have been validated for only four of 
the glycidyl ethers— BGE [75], IGE [77], AGE [78], and PGE [76]. These 
methods have not been validated at concentrations as low as the recommended 
environmental limits, so further refinement of the methods is necessary. 
No sampling and analytical method has been validated for measuring DGE at 
the low concentrations at which toxic effects have been reported. Study of 
the influences of temperature and duration of storage of DGE samples on 
desorption efficiency may permit the establishment of an improved analytic 
method for this compound. Other glycidyl ethers, such as resorcinol 
diglycidyl ether and CGE, are used in industry, and methods of sampling and 
analysis need to be developed for them. Research to develop continuous
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monitoring techniques for the glycidyl ethers would be very desirable. 
Methods for biologic monitoring should also be developed to permit 
characterization of accumulated body burden.
Although it appears that there exist in humans two enzymes capable of 
metabolizing the glycidyl ethers [60,64], little is known about the fate of 
the ethers in the human body. More information about the metabolism of 
these compounds and on the toxicology of their metabolites is needed. 
Pharmacokinetic studies to characterize metabolic pathways would be 
valuable, especially in the interpretation of experimental data on 
cytotoxic and mutagenic effects and other aspects of systemic toxicity.
Research related to work practices is also needed. For example, 
materials impervious to glycidyl ethers and suitable for use in protective
clothing, aprons, and gloves need to be identified. Further data on the
toxic effects and physical and chemical properties of some of the ethers
used in industry are needed, so that appropriate respirator selection
guidelines can be developed for them.
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IX. APPENDIX I
SAMPLING AND ANALYTICAL METHOD FOR BGE, IGE, AND PGE
The following generalized sampling and analytical method for these 
glycidyl ethers is adapted from the NIOSH validated methods for these 
compounds [75,76,77]. If certain parameters are changed, such as solvents 
and gas-chromatograph operating conditions, it may also be suitable for 
other glycidyl ethers.
Principle of the Method
A known volume of air is drawn through a charcoal tube to collect the 
organic vapors. The charcoal is then transferred to a small, stoppered 
sample container and desorbed with carbon disulfide. An aliquot of the 
desorbed sample is injected into a gas chromatograph. The area of the 
resulting peak is determined and compared with areas obtained from the 
injection of standards.
Range and Sensitivity
This method was validated for each glycidyl ether at the limits 
presented in Table IX-1, but it is capable of measuring much smaller 
amounts if the desorption efficiency is adequate. Desorption efficiency 
must be determined over the range used.
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TABLE IX-1
RANGE, PRECISION, AND ACCURACY OF THE GAS CHROMATOGRAPH 























BGE 22 at 
767
133-542 30-810 0.074 20 75
IGE 21 at 
763
121-484 25-720 0.067 16 76
PGE 22 at 
766
31-121 6-180 0.057 3.4 77
*At current OSHA limit
The upper limit of the range of the method is dependent on the 
adsorptive capacity of the charcoal tube. This capacity varies with the 
concentration of a particular glycidyl ether and of other substances in the 
air. Experimental data on breakthrough are listed in Table IX-2.
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TABLE IX-2




















BGE 23 530 0.183 240* 75
IGE 21 480 0.183 240* 76
PGE 25 112 0.93 240* 77
*No breakthrough in time given
Interferences
When the amount of water in the air is so great that condensation 
actually occurs in the charcoal tube, organic vapors will not be trapped 
efficiently. Preliminary experiments using toluene indicate that high 
humidity severely decreases breakthrough volume.
When two or more compounds are known or suspected to be present in 
the air, such information, including the suspected identities of the 
compounds, should be transmitted with the sample. It must be emphasized 
that any compound that has the same retention time as the glycidyl ether at 
the operating conditions described in this method is an interference. 
Retention-time data on a single column cannot be considered proof of 
chemical identity. If the possibility of interference exists, separation 




The Coefficients of Variation (CVT) for the analytical and sampling 
method are listed in Table IX-1. The standard deviation at the OSHA 
standard level is also included in the table. It should be noted, however, 
that CVT's and standard deviations at environmental limits recommended in 
this document are not currently available.
Advantages and Disadvantages of the Method
The sampling method uses a small, portable sampling device that 
involves no liquids. Interferences are minimal, and most of those which do 
occur can be eliminated by altering chromatographic conditions. The tubes 
are analyzed by means of a quick instrumental method. The method can also 
be used for the simultaneous analysis of two or more substances suspected 
to be present in the same sample simply by changing gas-chromatographic 
conditions from isothermal to a temperature-programmed mode of operation.
One disadvantage of the sampling method is that the amount of sample 
that can be taken is limited by the number of milligrams that the tube will 
hold before overloading. When the sample value obtained from the backup 
section of the charcoal trap exceeds 25% of that found on the front 
section, the possibility of sample loss exists. The precision of the 
method is affected by the reproducibility of the pressure drop across the 
tubes. This drop will affect the flowrate and cause the volume to be 
imprecise, because the pump is usually calibrated for one tube only.
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Apparatus
(a) An approved and calibrated personal sampling pump whose flow 
can be determined within ±5% at the recommended flowrate.
(b) Charcoal tubes: glass tube with both ends flame sealed, 7-cm
long with a 6-mm outer diameter and a 4-mm inner diameter, containing two 
sections of 20/40 mesh activated charcoal separated by a 2-mm portion of 
urethane foam. The activated charcoal is prepared from coconut shells and 
is fired at 600 C prior to packing. The adsorbing section contains 100 mg 
of charcoal, the backup section 50 mg. A 3-mm portion of urethane foam is 
placed between the outlet end of the tube and the backup section. A plug 
of silylated glass wool is placed in front of the adsorbing section. The 
pressure drop across the tube must be less than 1 inch of mercury at a 
flowrate of 1 liter/minute.
(c) Gas chromatograph equipped with a flame ionization detector.
(d) Column (10-foot x 1/8-inch stainless steel) packed with 10% 
FFAP on 80/100 mesh, acid-washed DMCS Chromosorb W.
(e) An electronic integrator or some other suitable method for 
measuring.
(f) Microliter syringes: 10-jul, and other convenient sizes for
making standards.
(g) Pipets: 0.5-ml delivery pipets or 1.0-ml type graduated in
0.1-ml increments.
(h) Volumetric flasks: 10-ml or convenient sizes for making
standard solutions.




(a) BGE, IGE, or PGE, reagent grade.
(b) Carbon disulfide, chromatographic quality.
(c) Nitrogen, purified.
(d) Hydrogen, prepurified.
(e) Filtered compressed air.
Sampling Procedure
(a) Calibration of Personal Pumps. Each personal pump must be
calibrated with a representative charcoal tube in the line, as shown in 
Figure XIV-1. This will minimize errors associated with uncertainties in
the sample volume collected.
(b) Collection and Shipping of Samples.
(1) Immediately before sampling, break the ends of the tube 
to provide an opening at least one-half the internal diameter of the tube 
(2 mm).
(2) The smaller section of charcoal is used as a backup and 
should be positioned nearest the sampling pump.
(3) The charcoal tube should be placed in a vertical 
position during sampling to minimize channeling through the charcoal.
(4) Air being sampled should not be passed through any hose
or tubing before entering the charcoal tube.
(5) The sample size and sampling rate for BGE, PGE, and IGE
should be 15 liters sampled at 1 liter/minute. The sampling rates and
sample sizes have been changed from those reported for BGE [75] and PGE
[77] and the sample size for IGE [76]. This was done to adapt the methods
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to sample for ceiling rather than for TWA concentrations. These changes
should not affect the collection efficiency of the method and should
provide an adequate amount of sample for analysis, but they have yet to be 
tested.
(6) The temperature and pressure of the atmosphere being 
sampled should be recorded. If pressure reading is not available, record 
the elevation.
(7) The charcoal tubes should be capped with the supplied 
plastic caps immediately after sampling. Under no circumstances should 
rubber caps be used.
(8) One tube should be handled in the same manner as the 
sample tube (break, seal, and transport), except that no air is drawn 
through this tube. This tube should be labeled as a blank.
(9) Capped tubes should be packed tightly and padded before 
they are shipped to minimize tube breakage during shipping.
(10) A sample of the bulk material should be submitted to 
the laboratory in a glass container with a Teflon-lined cap. This sample 
should not be transported in the same container as the charcoal tubes.
Analysis of Samples
All glassware used for the laboratory analysis should be washed with 
detergent and thoroughly rinsed with tap water and distilled water.
(a) Preparation of Samples. In preparation for analysis, remove
the plastic cap used to close the tube after sample collection and remove 
and discard the glass wool. The charcoal in the first (larger) section is
transferred to a 1-ml stoppered sample container. The separating sections
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of foam are removed and discarded; the second section is transferred to 
another container. These two sections are then analyzed separately.
(b) Desorption of Samples. Prior to analysis of BGE, IGE, or PGE, 
0.5 ml of carbon disulfide is pipetted into each sample container. (All 
work with carbon disulfide should be performed in a hood because of its 
high toxicity.) Desorption should be done for 30 minutes. Tests indicate 
that this is adequate if the sample is stirred occasionally during this 
period.
(c) Gas-chromatographic Conditions. The typical operating 
conditions for the gas chromatograph are listed in Table IX-3.
TABLE IX-3
TYPICAL GAS CHROMATOGRAPH CONDITIONS FOR GLYCIDYL ETHERS
Glycidyl Column Ref-
Ether Packing Gas Flow (ml/min) Temperature (C) erence
Carrier In- Mani- Col-
Nitrogen Hydrogen* Air* jec- fold umn
(at 60 (at 24 (at 50 tor 
psig) psig) psig)





IGE " " " " 205 270 115 76
PGE " " " " 230 265 90 77
*Flow to detector
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(d) Injection. The first step in the analysis is the injection of 
the sample into the gas chromatograph. To eliminate difficulties arising 
from blowback or distillation within the syringe needle, one should employ 
the solvent-flush injection technique. The 10-/ul syringe is first flushed 
with solvent several times to wet the barrel and plunger. Draw 3 (il of 
solvent into the syringe to increase the accuracy and reproducibility of 
the injected sample volume. The needle is removed from the solvent, and 
the plunger is pulled back about 0.2 yul to separate the solvent flush from 
the sample with a pocket of air to be used as a marker. The needle is then 
immersed in the sample, and a 5-^1 aliquot is withdrawn, taking into 
consideration the volume of the needle, since the sample in the needle will 
be completely injected. After the needle is removed from the sample and 
prior to injection, the plunger is pulled back 1.2 jul to minimize 
evaporation of the sample from the tip of the needle. Observe that the 
sample occupies 4.9-5.0 ;il in the barrel of the syringe. Duplicate 
injections of each sample and standard should be made. No more than a 3% 
difference in area is to be expected.
(e) Area Measurement. The area of the sample peak is measured by 
an electronic integrator or some other suitable form of area measurement, 
and preliminary results are read from a standard curve prepared as 
discussed below.
Determination of Desorption Efficiency
(a) Importance of Determination. The desorption efficiency of a 
particular compound can vary from one laboratory to another and also from
one batch of charcoal to another. Thus, it is necessary to determine at
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least once the percentage of the specific compound that is removed in the
desorption process, provided the same batch of charcoal is used.
(b) Procedure for Determination. Activated charcoal equivalent to 
the amount in the first section of the sampling tube (100 mg) is measured 
into a 2.5-inch, 4-mm inner diameter glass tube, flame-sealed at one end.
This charcoal must be from the same batch as that used in obtaining the
samples and can be obtained from unused charcoal tubes. The open end is 
capped with Parafilm. A known amount of the glycidyl ether is injected 
directly into the activated charcoal with a microliter syringe, and the 
tube is capped with more Parafilm. The amount injected is equivalent to 
that present in a 15-liter liter air sample for BGE, IGE, and PGE, 
respectively, at the selected level. Six tubes at each of three levels 
(0.5, 1, and 2 times the recommended standard) are prepared in this manner
and allowed to stand at least overnight to assure complete adsorption of 
the glycidyl ether onto the charcoal. These tubes are referred to as the 
samples. A parallel blank tube is also prepared. The sample and blank 
tubes are desorbed and analyzed in exactly the same manner as the sampling 
tube described in Analysis of Samples. Two or three standards are prepared 
by injecting the same volume of compound into 0.5 ml of carbon disulfide 
with the same syringe used in the preparation of the samples. (All work 
with carbon disulfide should be performed in a hood because of its high 
toxicity.) These are analyzed with the samples. The desorption efficiency 
(DE) equals the average weight in mg recovered from the tube divided by the 
weight in mg added to the tube, or:
DE = Average weight (mg) recovered 
Weight (mg) added
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The desorption efficiency is dependent on the amount of glycidyl 
ether collected on the charcoal. The desorption efficiency is plotted 
against the weight of glycidyl ether found.
Calibration and Standards
It is convenient to express concentrations of standards in terms of 
mg/0.5 ml of carbon disulfide, because samples are desorbed in this amount 
of carbon disulfide. The density of the glycidyl ether is used to convert 
mg into ¡il for easy measurement with a microliter syringe. A series of 
standards, varying in concentration over the range of interest, is prepared 
and analyzed under the same gas-chromatographic conditions and during the 
same time period as the unknown samples. Curves are established by 
plotting concentration in mg/0.5 ml vs peak area. Note: Since no internal
standard is used in the method, standard solutions must be analyzed at the 
same time that the analysis of samples is done. This will minimize the 
effect of known day-to-day variations and variations during the same day in 
the gas-chromatographic detector response.
Calculations
The weight in mg corresponding to each peak area is read from the 
standard curve. No volume corrections are needed, because the standard 
curve is based on mg/0.5 ml of carbon disulfide and the volume of sample 
injected is identical with the volume of the standards injected.
Corrections for the blank must be made for each sample:
mg = mg sample - mg blank 
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where:
mg sample = mg found in front section of sample tube 
mg blank = mg found in front section of blank tube
A similar procedure is followed for the backup sections.
Add the weights found in the front and backup sections to get the 
total weight in the sample.
Read the desorption efficiency from the curve for the amount found in 
the front section. Divide the total weight by this desorption efficiency 
to obtain the corrected mg/sample.
Determine the volume (in liters) of air sampled at ambient conditions 
based on the appropriate information, such as flowrate in liters/minute 
multiplied by sampling time. If a pump using a rotameter for flowrate 
control was used for sample collection, a pressure and temperature 
correction must be made for the indicated flowrate when the pump was 
calibrated under substantially different conditions than those that exist 
during sampling. The expression for the correction is:
f = flowrate during sampling
t = sampling time
PI = pressure during calibration of samplimg (mmHg)
P2 = pressure of air sampled (mmHg)
T1 = temperature during calibration of sampling pump (K)
T2 = temperature of air sampled (K)
The concentration of the glycidyl ether in the air sampled can be 
expressed in mg/cu m.
Corrected mg/sample = Total weight
DE
Corrected volume = f x t
where:
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mg/cu m = Corrected mg x 1,000 (liter/cu m) 
Air volume sampled (liters)
Another method of expressing concentration is ppm:
ppm = mg/cu m x 24.45 x 760 x T + 273 
MW P 298
where:
P = pressure (mmHg) of air sampled
T = temperature (C) of air sampled
24.45 = molar volume (liters/mole) at 25 C and 760 mmHg
MW = molecular weight (g/mole) of the glycidyl ether
760 = standard pressure (mmHg)
298 = standard temperature (K)
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X. APPENDIX II
The following method for AGE is adapted from the draft report of the 
NIOSH validated method [78], If certain parameters are changed, such as 
the solvent and the gas-chromatographic operating conditions, it may be 
suitable for other glycidyl ethers.
Principle of the Method
A known volume of air is drawn through a Tenax-GC resin tube to trap 
the organic vapors present. The sampling tube consists of a front 
adsorbing section and a backup section. The resin in each tube is 
transferred to a vial and the AGE is desorbed with diethyl ether and 
analyzed by gas chromatography.
Range and Sensitivity
This method was validated over the range of 19-87 mg/cu m at an 
atmospheric temperature of 17 C and atmospheric pressure of 752 mmHg using 
a 3-liter sample volume. This sample volume is based on two-thirds of the 
5% breakthrough capacity determined at 90% relative humidity when sampling 
a test atmosphere at 2 times the OSHA standard (45 mg/cu m ) . This method 
is capable of measuring much smaller amounts if the desorption efficiency 
is adequate. Desorption efficiency must be determined over the range used.
SAMPLING AND ANALYTICAL METHOD FOR AGE
149
The upper limit of the range of the method is dependent on the 
adsorptive capacity of the Tenax-GC resin tube. This capacity can vary 
with the concentrations of AGE and other substances in the air.
Interferences
When two or more compounds are known or suspected to be present in 
the air, such information, including the suspected identities of the 
compounds, should be transmitted with the sample. It must be emphasized 
that any compound that has the same retention time as AGE at the operating 
conditions described in this method is an interference. Retention-time 
data on a single column cannot be considered as proof of chemical identity. 
If the possibility of interference exists, separation conditions (column 
packing, temperature, etc) must be changed to circumvent the problem.
Precision and Accuracy
The Coefficient of Variation (CVT) for the total analytical and 
sampling method in the range of 19-87 mg/cu m was 0.058. This value 
corresponds to a 2.6 mg/cu m standard deviation at the OSHA standard level 
(45 mg/cu m).
On the average, the concentrations obtained at the OSHA standard 
level (22 mg/cu m) using the overall sampling and analytical method were 
0.5% lower than the "true" concentrations in a limited number of laboratory 
experiments. Any difference between the "found" and "true" concentrations 
may not represent a bias in the sampling and analytical method but rather a 
random variation from the experimentally determined "true" concentration. 
Therefore, no recovery correction should be applied to the final result.
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The data are based on validation experiments using the internal
standard method.
Advantages and Disadvantages
The sampling device is small, portable, and involves no liquids. 
Interferences are minimal, and most of those which do occur can be 
eliminated by altering chromatographic conditions. The tubes are analyzed 
by means of a quick, instrumental method.
One disadvantage of the method is that the amount of sample that can 
be taken is limited by the number of mg that the tube will hold before 
overloading. When an atmosphere at 90% relative humidity containing 92 
mg/cu m of AGE was sampled at 0.8 liter/minute, 5% breakthrough was 
observed after 15 minutes (capacity = 12 liters or 1.1 mg). The sample 
size recommended is less than the 5% breakthrough capacity at 90% relative 
humidity for a test atmosphere at 2 times the OSHA standard (90 mg/cu m) to 
minimize the probability of overloading the sampling tube.
The precision of the method is affected by the reproducibility of the 
pressure drop across the tubes. This drop will affect the flowrate and 
cause the volume to be imprecise, because the pump is usually calibrated 
for one tube only.
Apparatus
(a) A calibrated personal sampling pump whose flow can be 
determined within ±5% at the recommended flowrate.
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(b) Resin tubes. Glass tube with both ends flame-sealed, 10-cm
long with 8-mm outer diameter and 6-mm inner diameter, containing two 
sections of 35/60 mesh Tenax-GC resin. The adsorbing section contains 100 
mg of resin, the backup section 50 mg. A small wad of silylated glass wool 
is placed between the front adsorbing section and the backup section; a 
plug of silylated glass wool is also placed in front of the adsorbing 
section and at the end of the backup section. Since the pressure drop 
across the tube must be less than 25 mmHg at a flowrate of 1 liter/minute,
it is necessary to avoid overpacking with glass wool.
(c) Gas chromatograph equipped with a flame ionization detector.
(d) Column (20-foot x 1/8-inch stainless steel) packed with 10% 
FFAP stationary phase on 100/120 mesh Supelcoport.
(e) An electronic integrator or some other suitable means of 
measuring peak areas.
(f) Sample containers with Teflon-lined caps, 5-ml.
(g) Microliter syringes, 10-jul and 500-jul, and other convenient 
sizes for making standards and for taking sample aliquots for dilution.
(h) Pipets, 2-ml, delivery type.
(i) Volumetric flasks, 1-ml and 10-ml or convenient sizes for 
making standard solutions and dilution of samples.
Reagents
(a) Diethyl ether, anhydrous.
(b) AGE, 99%.
(c) Isoamyl alcohol or other suitable internal standard. The
appropriate solution of the internal standard is prepared in ether.
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(d) Hexane. This is used to prepare solutions of AGE for 
preparing the analytical samples for desorption efficiency determination.
(e) Nitrogen, purified.
(f) Hydrogen, prepurified.
(g) Air, filtered compressed.
Sampling Procedure
(a) Calibration of Personal Pumps. Each personal pump must be
calibrated with a representative Tenax-GC resin tube in line, as shown in 
Figure XIV-1. This will minimize errors associated with uncertanties in
the sample volume collected.
(b) Collection and Shipping of Samples.
(1) Immediately before sampling, break the two ends of the 
resin tube to provide an opening at least one-half the internal diameter of 
the tube (3 mm).
(2) The section containing 50 mg of resin is used as a 
backup and should be positioned nearest the sampling pump.
(3) The resin tube series should be placed in a vertical 
position during sampling to minimize channeling through the resin.
(4) Air being sampled should not be passed through any hose 
or tubing before entering the resin tube.
(5) A sample size of 3 liters is recommended. Sample at a 
flowrate of 0.2 liter/minute for 15 minutes. The flowrate should be known 
with an accuracy of at least ±5%.
153
(6) The temperature and pressure of the atmosphere being
sampled should be recorded. If pressure reading is not available, record 
the elevation.
(7) The resin tube should be labeled appropriately and
capped with plastic caps. Under no circumstances should rubber caps be 
used.
(8) With each batch of 10 samples, one resin tube that has
been handled in the same manner as the sample tubes (break, seal, and
transport), except that no air is sampled through it, should be submitted.
This tube should be labeled as a blank.
(9) Capped resin tubes should be packed tightly and padded
before they are shipped to minimize breakage during shipping.
Analysis of Samples
All glassware used for the laboratory analysis should be washed with 
detergent and thoroughly rinsed with tap water and distilled water.
(a) Preparation of Samples. In preparation for analysis, remove
the plastic caps used to cover tube after sample collection, and remove and 
discard the glass wool. The resin in the front 100-mg section is
transferred to a 5-ml screw-capped sample container. The separating 
section of glass wool is removed and discarded. The second 50-mg section
is transferred to another container. These two sections are analyzed 
separately.
(b) Desorption of Sample. Prior to analysis, 2.0 ml of ether is
pipetted into each sample container. Samples should be desorbed for 30 
minutes. Tests indicate that this is adequate if the sample is agitated
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occasionally during this period. The sample vials should be capped as soon 
as the solvent is added to minimize volatilization. For the internal 
standard method, desorb using 2.0 ml of internal standard solution in 
ether.
(c) Gas-chromatographic Conditions. The typical operating 
conditions for the gas chromatograph are:
(1) Nitrogen carrier gas flow, 30 ml/minute (60 psig).
(2) Hydrogen gas flow to detector, 30 ml/minute (25 psig).
(3) Air flow to detector, 300 ml/minute (60 psig).
(4) Injector temperature, 200 C.
(5) Manifold temperature (detector), 280 C.
(6) Column temperature, 150 C.
A retention time of approximately 10.0 minutes is to be expected for 
the analyte using these conditions and the recommended column. The 
internal standard elutes between ether and the AGE.
(d) Injection of Samples. A 2-/il aliquot of the sample solution 
is injected into the gas chromatograph. The solvent-flush method or other 
suitable alternative, such as an automatic sample injector, can be used 
provided that duplicate injections of a solution agree well. No more than 
a 3% difference in area is to be expected.
(e) Measurement of Area. The area of the sample peak is measured 
by an electronic integrator or some other suitable form of area 
measurement, and preliminary results are read from a standard curve.
Determination of Desorption Efficiency
(a) Importance of Determination. The desorption efficiency of a
particular compound can vary from one laboratory to another and also from
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one batch of Tenax-GC to another. Thus, it is necessary to determine the 
percentage of the specific compound that is removed in the desorption 
process for the particular batch of resin used for sample collection and 
over the concentration range of interest. The desorption efficiency must
be at least 75% at the OSHA standard level.
(b) Preparation for Determination. Desorption efficiency must be 
determined over the sample concentration range of interest. To determine 
the sample concentration range that should be tested, the samples are 
analyzed first. Then the analytical samples are prepared based on the 
relative amount of AGE found in the samples. The desorption efficiency 
must be determined at least twice for each concentration of AGE found in 
the samples.
The analytical samples are prepared as follows: Tenax-GC, equivalent
to the amount in the front section (100 mg), is measured into a 5-ml screw- 
capped vial. This resin must be from the same batch as that used in 
obtaining the samples.
A known amount of a solution of AGE in hexane (spiking solution) is
injected directly into the resin by means of a microliter syringe. Adjust
the concentration of the spiking solution so that no more than a 10-^1
aliquot is used to prepare the analytical samples.
For the validation studies conducted to determine the precision and 
accuracy of this method, six analytical samples at each of the three 
concentration levels (0.5, 1, and 2 times the OSHA standard of 45 mg/cu m) 
were prepared by adding an amount of AGE equivalent to that present in a 3- 
liter sample at the selected level. A stock solution containing 67.34 mg 
of AGE/ml of hexane was prepared. One-, 2-, and 4-/ul aliquots of the
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solution were added to Tenax-GC resin tubes to produce solutions of 0.5, 1, 
and 2 times the OSHA standard level. The analytical samples were allowed 
to stand at least overnight to assure complete adsorption of the analyte 
onto the resin. A parallel blank tube was treated in the same manner 
except that no sample was added to it.
The procedure described can be used to prepare the analytical samples 
that are analyzed to determine desorption efficiency over the concentration 
range of interest.
(c) Procedure for Determination. The analytical samples and the 
blank are desorbed and analyzed as described in Analysis of Samples. 
Calibration standards are prepared by adding the appropriate volume of 
spiking solution to 2.0 ml of ether with the same syringe used in the 
preparation of the samples. Standards should be prepared at the same time 
that the sample analysis is done and should be analyzed with the samples.
If the internal standard method is used, prepare calibration
standards by using 2.0 ml of ether containing a known amount of the 
internal standard.
The desorption efficiency (DE) equals the average weight in ng 
recovered from the tube divided by the weight in n% added to the tube, or:
DE = Average weight png) recovered 
Weight (¿tg) added
The desorption efficiency may be dependent on the amount of AGE 
collected on the resin. Plot the desorption efficiency against the weight 
of AGE found. This curve is used to correct for adsorption losses.
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Calibration and Standards
(a) Add 2.0 ml of ether (or 2.0 ml of internal standard solution
in ether) to a 5-ml vial. The same solution of AGE in hexane may be used
to prepare calibration standards, or microliter aliquots of pure AGE could 
be diluted to the appropriate volume for the standard concentration range 
of interest. The concentration of standards can be expressed in terms of 
Hg of AGE/2.0 ml of ether.
(b) A series of standards, varying in concentration over the range
of interest, is prepared as described above and analyzed under the same
gas-chromatographic conditions and during the same time period as the 
unknown samples. Curves are established by plotting peak area (ordinate) 
against sample concentration in jug/2.0 ml.
For the internal standard method, use ether containing a 
predetermined amount of the internal standard. The internal standard 
concentration used was approximately 70% of the concentration at 44 mg/cu 
m. The area ratio of the AGE to that of the internal standard is plotted 
against the AGE concentration in jug/2.0 ml.
Note: Whether the external standard or internal standard method is
used, standard solutions should be analyzed at the same time the sample 
analysis is done. This will minimize the effect of variations in the gas- 
chromatographic detector response.
Calculations
Read the weight, in jug, corresponding to each peak area from the 
standard curve. No volume corrections are needed, because the standard 
curve is based on ¡ J t g / 2 . 0 ml of ether, and the volume of sample injected is
identical with the volume of the standards injected.
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Corrections for the blank must be made for each sample: 
fig = jug sample - jug blank
where:
¡ig sample = jug found in front (100-mg) sample section
fig blank = jug found in front (100-mg) blank section
A similar procedure is followed for the backup (50-mg) section.
Read the desorption efficiency from the curve for the amount found in
the front section of the tube. Divide the total weight by this desorption
efficiency to obtain the corrected ¿ig/sample.
Corrected jug/sample = Weight (jug) of front section
DE
Add the amounts present in the front and backup sections for the same
sample to determine the total weight in the sample.
(e) Determine the volume in liters of air sampled at ambient 
conditions based on the appropriate information, such as flowrate in 
liters/minute multiplied by sampling time. If a pump using a rotameter for 
flowrate control was used for sample collection, a pressure and temperature 
correction must be made for the indicated flowrate. The expression for 
this correction is:
Corrected volume = f x t/ /P1 x Tff\
\%P2 T1 j
where:
f = flowrate during sampling
t = sampling time
PI = pressure during calibration of sampling pump (mmHg)
P2 = pressure of air sampled (mmHg)
T1 = temperature during calibration of sampling pump (K)
T2 = temperature of air sampled (K)
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The concentration of the AGE in the air sampled can be expressed in
mg/cu m, which is numerically equal to ¿ig/liter:
mg/cu m =  Corrected g____________
Air volume sampled (liters)
Another method of expressing concentration is ppm (corrected to
standard conditions of 25 C and 760 mmHg):
ppm = mg/eu m x 24.45 x 760 x T + 273 
MW P 298
where:
P = pressure (mmHg) of air sampled 
T = temperature (C) of air sampled
24.45 = molar volume (liters/mole) at 25 C and 760 mmHg 
MW = molecular weight of AGE 
760 = standard pressure (mmHg)
298 = standard temperature (K)
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XI. APPENDIX III
This sampling and analytical method is adapted from a method tested 
by NIOSH [79]. It was found unsuitable for determining DGE at the current 
Federal standard of 2.8 mg/cu m because recovery of DGE from the sampling 
tubes was unacceptably low. However, it is believed that, with immediate 
desorption of samples as described below, this method can be used to 
measure DGE in air at the recommended concentration limit of 1.0 mg/cu m.
Principle of the Method
A known volume of air is drawn through a charcoal tube to collect 
organic vapors. The sample is immediately desorbed with methylene chloride 
and analyzed by gas chromatography. The area of the resulting peak is 
determined and compared with areas obtained from the injection of 
standards.
Range and Sensitivity
The range and sensitivity of this method is dependent on the 
decomposition of the DGE on the charcoal prior to analysis. If 
decomposition time is minimized, the recovery of DGE from the samples 
should be adequate to analyze for the compound at the recommended standard.
SAMPLING AND ANALYTICAL METHOD FOR DGE
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Interferences
When the amount of water in the air is so great that condensation 
actually occurs in the charcoal tube, organic vapors will not be trapped 
efficiently. When two or more compounds are known or suspected to be 
present in the air, such information, including the suspected identities of 
the compounds, should be transmitted with the sample. It must be 
emphasized that any compound that has the same retention time as DGE at the 
operating conditions described in this method is an interference. 
Retention-time data on a single column cannot be considered proof of 
chemical identity. If the possibility of interference exists, separation 
conditions (column packing, temperature, etc) must be changed to circumvent 
the problem.
Precision and Accuracy
The Coefficient of Variation (CVT) and standard deviation at half the 
current Federal standard (1.5 mg/cu m) for DGE using this method were 0.081 
and 0.090, respectively [79]. While the CVT and standard deviation for 
this method have not been determined at the recommended limit of 1.0 mg/cu 
m, it is likely that the method as modified will be able to detect DGE at 
this limit given a standard deviation of 0.1.
Advantages and Disadvantages of the Method
The sampling method uses a small, portable sampling device that 
involves no liquids. Interferences are minimal, and most of those that do 
occur can be eliminated by altering chromatographic conditions. The tubes
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are analyzed by means of a quick instrumental method. The method can also 
be used for the simultaneous analysis of two or more substances suspected 
to be present in the same sample simply by changing gas-chromatographic 
conditions from isothermal to a temperature-programmed mode of operation.
The major disadvantage of this method is the necessity for immediate 
desorption of samples and the attendant problems of breakage, spillage, and 
evaporation associated with transporting liquid samples to the analytical 
laboratory.
Another disadvantage is that the amount of sample that can be taken 
is limited by the number of milligrams that the tube will hold before 
overloading. When the sample value obtained from the backup section of the 
charcoal trap exceeds 25% of that found on the front section, the 
possibility of sample loss exists. The precision of the method is affected 
by the reproducibility of the pressure drop across the tubes. This drop 
will affect the flowrate and cause the volume to be imprecise, because the 
pump is usually calibrated for one tube only.
Apparatus
(a) An approved and calibrated personal sampling pump whose flow 
can be determined within ±5% at the recommended flowrate.
(b) Charcoal tubes: glass tube with both ends flame sealed, 7-cm- 
long with a 6-mm outer diameter and a 4-mm inner diameter, containing two 
sections of 20/40-mesh activated charcoal separated by a 2-mm portion of 
urethane foam. The activated charcoal is prepared from coconut shells and 
is fired at 600 C prior to packing. The adsorbing section contains 100 mg
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of charcoal, the backup section 50 mg. A 3-mm portion of urethane foam is 
placed between the outlet end of the tube and the backup section. A plug 
of silylated glass wool is placed in front of the adsorbing section. The 
pressure drop across the tube must be less than 1 inch of mercury at a 
flowrate of 1 liter/minute.
(c) Glass vials with Teflon-lined screw caps, for desorbing and 
shipping samples.
(d) Gas chromatograph equipped with a flame ionization detector.
(e) Column (10-foot x 1/8-inch stainless steel) packed with 5% 
Carbowax 20M on 80/100-mesh acid-washed DMCS Chromosorb W.
(f) An electronic integrator or some other suitable method for 
measuring.
(g) Microliter syringes: 10-/ul, and other convenient sizes for
making standards.
(h) Pipets: 0.5-ml delivery pipets or 1.0-ml type graduated in
0.1-ml increments.
(i) Volumetric flasks: 10-ml or convenient sizes for making
standard solutions.
Reagents
(a) DGE, reagent grade.
(b) Methylene chloride, chromatographic quality.
(c) Nitrogen, purified.
(d) Hydrogen, prepurified.
(e) Filtered compressed air.
Sampling Procedure
(a) Calibration of Personal Pumps. Each personal pump must be
calibrated with a representative charcoal tube in the line, as shown in 
Figure XIV-1. This will minimize errors associated with uncertainties in 
the sample volume collected.
(b) Collection and Shipping of Samples.
(1) Immediately before sampling, break the ends of the tube 
to provide an opening at least one-half the internal diameter of the tube 
(2 mm).
(2) The smaller section of charcoal is used as a backup and 
should be positioned nearest the sampling pump.
(3) The charcoal tube should be placed in a vertical 
position during sampling to minimize channeling through the charcoal.
(4) Air being sampled should not be passed through any hose 
or tubing before entering the charcoal tube.
(5) The temperature and pressure of the atmosphere being 
sampled should be recorded. If pressure reading is not available, record 
the elevation.
(6) The charcoal in the front and back section of the tube 
should be transferred to separate glass vials immediately after sampling. 
One milliliter of methylene chloride should be added to each vial, and they 
should be capped with Teflon-lined screw caps.
(7) One tube should be handled in the same manner as the 
sample tube (break, desorb, and transport), except that no air is drawn 
through this tube. An intact charcoal tube should also be shipped to the 
laboratory with the samples.
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(8) Capped vials should be packed tightly and padded before
they are shipped to minimize breakage during shipping.
Analysis of Samples
(a) Gas-chromatographic Conditions. The typical operating
conditions for the gas chromatograph are:
(1) Nitrogen carrier gas flow, 50 ml/minute (60 psig).
(2) Hydrogen gas flow to detector, 65 ml/minute (24 psig).
(3) Air flow to detector, 500 ml/minute (50 psig).
(4) Injector temperature, 220 C.
(5) Manifold temperature (detector), 275 C.
(6) Column temperature, 205 C
(b) Injection. The first step in the analysis is the injection of 
the sample into the gas chromatograph. To eliminate difficulties arising 
from blowback or distillation within the syringe needle, one should employ 
the solvent-flush injection technique. The 10-pl syringe is first flushed 
with solvent several times to wet the barrel and plunger. Draw 3 /il of 
solvent into the syringe to increase the accuracy and reproducibility of 
the injected sample volume. The needle is removed from the solvent, and 
the plunger is pulled back about 0.2 ¿ul to separate the solvent flush from 
the sample with a pocket of air to be used as a marker. The needle is then 
immersed in the sample, and a 5-;ul aliquot is withdrawn, taking into 
consideration the volume of the needle, since the sample in the needle will 
be completely injected. After the needle is removed from the sample and 
prior to injection, the plunger is pulled back 1.2 ptl to minimize 
evaporation of the sample from the tip of the needle. Observe that the
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sample occupies 4.9-5.0 jul in the barrel of the syringe. Duplicate 
injections of each sample and standard should be made. No more than a 3% 
difference in area is to be expected.
(c) Area Measurement. The area of the sample peak is measured by
an electronic integrator or some other suitable form of area measurement, 
and preliminary results are read from a standard curve prepared as 
discussed below.
Determination of Desorption Efficiency
(a) Importance of Determination. The desorption efficiency of a 
particular compound can vary from one laboratory to another and also from 
one batch of charcoal to another. Thus, it is necessary to determine at 
least once the percentage of the specific compound that is removed in the
desorption process, provided the same batch of charcoal is used.
(b) Procedure for Determination. Activated charcoal equivalent to
the amount in the first section of the sampling tube (100 mg) is measured 
into a 2.5-inch, 4-mm inner diameter glass tube, flame-sealed at one end.
This charcoal must be from the same batch as that used in obtaining the
samples and can be obtained from unused charcoal tubes. The open end is 
capped with Parafilm. A known amount of DGE is injected directly into the 
activated charcoal with a microliter syringe, and the tube is capped with 
more Parafilm. The amount injected is equivalent to that present in an air 
sample at the selected level. Six tubes at each of three levels (0.5, 1, 
and 2 times the standard) are prepared in this manner and allowed to stand 
at least overnight to assure complete adsorption of the DGE onto the
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charcoal. These tubes are referred to as the samples. A parallel blank 
tube is also prepared. The sample and blank tubes are desorbed and 
analyzed in exactly the same manner as the sampling tube. Two or three 
standards are prepared by injecting the same volume of compound into 1.0 ml 
of methylene chloride with the same syringe used in the preparation of the 
samples. These are analyzed with the samples. The desorption efficiency 
(DE) equals the average weight in mg recovered from the tube divided by the 
weight in mg added to the tube, or:
DE = Average weight (mg) recovered 
Weight (mg) added
The desorption efficiency is dependent on the amount of DGE collected 
on the charcoal. The desorption efficiency is plotted against the weight 
of DGE found.
Calibrations and Standards
It is convenient to express concentrations of standards in terms of 
mg/ml of methylene chloride, because samples are desorbed in this amount of 
methylene chloride. The density of DGE is used to convert mg into nl for 
easy measurement with a microliter syringe. A series of standards, varying 
in concentration over the range of interest, is prepared and analyzed under 
the same gas-chromatographic conditions and during the same time period as 
the unknown samples. Curves are established by plotting concentration in 
mg/ml versus peak area. Note: Since no internal standard is used in the
method, standard solutions must be analyzed at the same time that the 
analysis of samples is done. This will minimize the effect of known day- 




The weight in mg corresponding to each peak area is read from the
standard curve. No volume corrections are needed, because the standard
curve is based on mg/ml of methylene chloride and the volume of sample 
injected is identical to the volume of the standards injected.
Corrections for the blank must be made for each sample:
mg = mg sample - mg blank
where:
mg sample = mg found in front section of sample tube
mg blank = mg found in front section of blank tube
A similar procedure is followed for the backup sections.
Add the weights found in the front and backup sections to get the 
total weight in the sample.
Read the desorption efficiency from the curve for the amount found in 
the front section. Divide the total weight by this desorption efficiency 
to obtain the corrected mg/sample.
Corrected mg/sample = Total weight
DE
Determine the volume (in liters) of air sampled at ambient conditions 
based on the appropriate information, such as flowrate in liters/minute 
multiplied by sampling time. If a pump using a rotameter for flowrate 
control was used for sample collection, a pressure and temperature 
correction must be made for the indicated flowrate when the pump was
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calibrated under substantially different conditions than those that exist
during sampling. The expression for the correction is:
Corrected volume = f x t/ jPl x T2\
\flp2 TlJ
where:
f = flowrate during sampling
t = sampling time
PI = pressure during calibration of sampling (mmHg)
P2 = pressure of air sampled (mmHg)
T1 = temperature during calibration of sampling pump (K)
T2 = temperature of air sampled (K)
The concentration of DGE in the air sampled can be expressed in 
mg/cu m.
mg/cu m = Corrected mg x 1,000 (liters/cu m)
Air volume sampled (liters)
Another method of expressing concentration is ppm:
ppm = mg/cu m x 24.45 x 760 x T + 273 
130 P 298
where:
P = pressure (mmHg) of air sampled 
T = temperature (C) of air sampled
24.45 = molar volume (liters/mole) at 25 C and 760 mmHg 
130 = molecular weight (g/mole) of DGE 
760 = standard pressure (mmHg)
298 = standard temperature (K)
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XII. APPENDIX IV 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific
product or material shall be provided in the appropriate block of the
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially
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formal chemical nomenclature. Every known chemical designation or
competitor’s trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name
derived from a recognized system of nomenclature. Where possible, avoid
using common names and general class names such as "aromatic amine,"
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50- 
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the
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American National Standards Institute Inc. Flashpoint, shock sensitivity, 
or similar descriptive data may be used to indicate flammability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury 
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in 
parts/hundred parts of water by weight; specific gravity (water = 1); 
percent volatiles (indicated if by weight or volume) at 70 F (21.1 C);
evaporation rate for liquids or sublimable solids, relative to butyl 
acetate; and appearance and odor. These data are useful for the control of 
toxic substances. Boiling point, vapor density, percent volatiles, vapor 
pressure, and evaporation are useful for designing proper ventilation 
equipment. This information is also useful for design and deployment of 
adequate fire and spill containment equipment. The appearance and odor may 
facilitate identification of substances stored in improperly marked 
containers, or when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, including flashpoint and autoignition temperature in degrees 
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to
cleanup detail. Specific neutralizing chemicals or procedures should be
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill" or "incineration." Warnings such as "comply with
local, state, and Federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Mines 
approval class, ie, "Supplied air," "Organic vapor canister," etc. 
Protective equipment must be specified as to type and materials of
construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on
any aspect of safety or health not covered in other sections should be
inserted in Section IX. The lower block can contain references to
published guides or in-house procedures for handling and storage.
Department of Transportation markings and classifications and other
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous substance. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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REACTIVITY OF THE GLYCIDYL ETHERS
The epoxide group is very reactive and there are several types of
chemical reactions in which it will take part. Because glycidyl ethers
contain the epoxide group, they would be expected to undergo the types of
reactions that have been demonstrated for this moiety. Some reactions that 
have significance for biologic systems are summarized in Figure XIII-1 
[6,98]:
(a) In the presence of hydrogen ions, the epoxide behaves as an 
ionized, very reactive radical and is capable of multiple additive 
reactions on the electronegative radicals. The epoxide ring is cleaved, 
and an alcohol (hydroxyl group) is formed.
(b) With organic acids, the alcohol is formed and an
esterification takes place.
(c) Phenols react to form the alcohol and the aromatic ring
attaches through the ether linkage.
(d) Some nucleophilic compounds react directly on the epoxide,
cleaving the ring and making the oxygen electronegative. If the R group is 
nucleophilic, the effect is stronger.
(e) The epoxides are also described as alkylating agents or
electrophilic agents, which are postulated to form a carbonium ion in which 
the positive charge resides on one of the carbon atoms [6]. The carbonium 
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(e) Carbonium Ion Formation
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BIOLOGICALLY IMPORTANT REACTIONS OF EPOXIDES 
Adapted from references 6,98
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Experimental evidence also indicates that glycidyl ethers are very 
reactive biologically. They have been used for tumor inhibition because of 
their alkylating properties [52]. They have produced chromosomal 
aberrations in plants [6,53-55], and Hine et al [41,48] have demonstrated 
their radiomimetic effects on blood cells. BGE has been shown to be 
mutagenic in mammals [58], and all glycidyl ethers tested have shown some 
mutagenic activity in bacterial systems [49,57,58]. However, very high 
doses were generally required to produce these effects and attempts to find 
consistent structure-activity relationships among various glycidyl ethers 
have met with little success [48,56],
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XIV. TABLES AND FIGURE
TABLE XIV-1
SYNONYMS AND STRUCTURAL FORMULAS FOR SOME GLYCIDYL ETHERS
Alkyl glycidyl ether (C12)
*Oxirane, (methoxydodecyl)- 
Lauryl glycidyl ether 
Aliphatic glycidyl ether






CH3 (CH2) , ,  -  O -C H 2- C H - C H 2
0
/ \
H 2C -C H -C H 2- 0  - c h 2- c h - c h 2
1,4-Butanediol diglycidyl ether 
*Oxirane, 2,21[1,4-butanediol 
bis(oxymethylene]bis- 
Butane-1,4-diol diglycidyl ether 
1,4-Bis-(2,3-epoxypropoxy)butane
n-Butyl glycidyl ether (BGE)
*Oxirane, (butoxymethyl)- 
Glyceryl butyl ether 
l-Butoxy-2,3-epoxypropane 
Butyl 2,3-epoxypropyl ether
2.3-Epoxypropyl ether of butanol-1










Diethylene glycol diglycidyl ether
0 o
/\ / \ 
h 2c - c h - c h 2 -  o  - c h 2- c h 2- c h 2 - c h 2-  o  - c h 2- c h - c h 2
0
/ \




o - c h 2- c h - c h 2
1°, 0  
/  \  /  \  
h 2c - c h - c h 2-  o  - c h 2- c h - c h 2
/°\ 0  
! \ / \ 
H 2C -C H -C H 2 -  0  -  CH2-C H 2 -  O -  C H j - C H j -  O -  C H j-C H  - C H j
Dicyclopentadiene glycidyl ether
Diglycidyl ether of substituted glycerin
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Q D - 0 - C H , - C H - C H oV
A  o
/  \  /  \  
c h 2 - c h - c h 2-  o  -  r  - o - c h 2^ - c h - c h 2
R *  a liphatic radicals 
(average mw 100)
TABLE XIV-1 (CONTINUED)
SYNONYMS AND STRUCTURAL FORMULAS FOR SOME GLYCIDYL ETHERS
Diphenylol propane diglycidyl ether 
*Oxirane, 2,2'-[(1-methylethylidene) 
bis(4,1-phenylene oxymethylene)]bis-













/  \  
- o - c h 2- c h - c h 2










0 - C H , - C H - C H ,
0






Neopentyl glycol diglycidyl ether 
*Oxirane, 2,2 T[1,3-(2,2-dimethyl)
propane diyl bis(oxymethylene1] bis-







h 2c - c h - c h 2- o - c h 2- c - c h 3- o - c h 2- c h - c h 2
CH0
o 
/  \  
0 - C H 2- C H - C H 2
Resorcinol diglycidyl ether 




Triethylene glycol diglycidyl ether
Ethoglucid o
Etoglucid / ^ H
Epodyl
o/ \
o - c h 2- c h - c h 2
0 
/  \  
o - c h 2- c h - c h 2
o/ \













(water = 1.0 at 4 C)
Vapor pressure







(760 mmHg and 25 C)
Empirical formula 
Formula weight
Allyl Glycidyl Ether 
C6H1002 
114.14
Colorless liquid; characteristic but 
not unpleasant odor
153.9 C (760 mmHg )
Forms glass at -100 C
3.32 (25 C)
0.9698 (20 C)




Miscible with acetone, toluene, and 
octane
57.2 C
1 mg/cu m = 0.214 ppm 
1 ppm = 4.67 mg/cu m












(water = 1 at 4 C)
Vapor pressure
% in saturated air
Solubility
Conversion factors 





Viscosity C 25 C
Epoxide equivalent weight
Conversion factors 
(760 mm Hg and 25 C)
1 Ether (continued)
Colorless liquid; slight, irritant 
odor
164 C (760 mmHg)
3.78 (25 C)
0.9087 (25 C)
3.2 mmHg (25 C)
0.42 (25 C)
2% in water (20 C)
1 mg/cu m = 0.188 ppm 







1 mg/cu m = 0.149 ppm 
1 ppm = 6 . 7 2  mg/cu m
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TABLE XIV-2 (CONTINUED)








(water = 1.0 at 4 C)
Vapor pressure
% in saturated air
Flashpoint
Conversion factors 




Colorless liquid; pronounced, irri­
tant odor
260 C (760 mmHg)
3.78 (25 C)
1.262 (25 C)
0.09 mmHg (25 C)
0.0121 (25 C)
64 C
1 mg/cu m = 0.188 ppm 
1 ppm = 5 . 3 2  mg/cu m
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TABLE XIV-2 (CONTINUED)







(water = 1.0 at 4 C)
Vapor pressure



















137 C (760 mmHg)
4.15 (25 C)
0.9186 (20 C)
9.4 mmHg (25 C)
1.237 (25 C)
18.8%
Soluble in ketones and alcohols
1 mg/cu m = 0.210 ppm 






























(water = 1.0 at 4 C)
Refractive index
Conversion factors 
(760 mmHg and 4 C)
Ether (continued)




12.9% in octane; completely soluble 
in acetone and toluene
1 mg/cu m = 0.163 ppm 




Colorless solid; slight, phenolic 
odor
150-160 C (0.05 mmHg)





1 mg/cu m = 0.110 ppm 
1 ppm = 9.09 mg/cu m
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TABLE XIV-2 (CONTINUED)
PHYSICAL AND CHEMICAL PROPERTIES OF SELECTED GLYCIDYL ETHERS
















133-149 C (0.1 mmHg) 
195-197 C (2 mmHg)





1 mg/cu m = 0.093 ppm 
1 ppm = 10.73 mg/cu m
Adapted from references 1-5
TABLE XIV-3
OCCUPATIONS WITH POTENTIAL EXPOSURE TO GLYCIDYL ETHERS
Adhesive makers and users 
Automobile workers 
Cable makers
Casting and molding workers
Custom-blended epoxy resin system production workers
Dental laboratory technicians
Dentists
Electrical appliance production workers 
Electronic equipment production workers 
Flooring makers 
Laminators




Polyglycidyl ether production workers 
Soft drink canners 
Telephone production workers 
Telephone installers
Adapted from references 17,19-22
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TABLE XIV-4
ACUTE TOXICITY OF GLYCIDYL ETHERS
LD50 (g/kg) LC50 i(mg/cu m)
Oral SC Dermal 8-hr 4-hr
Compound Rat Mouse Rabbit Mouse Rat Rabbit Rat Mouse
Ref­
erence
AGE 1.60 0.39 - - 2.55 3,120 1,260 23
BGE 3.43 - - - 2.26 - - 32
I t 2.26 1.53 - - 4.93 5,480 >18,600 23
f t 2.05 - - - 2.52 - - 37
I f 2.5 - - - - - - 30
CGE - - 0.96 - - - - 36
DGE 0.45 0.17 - - 1.5 >1,060 160 23
IGE 4.20 1.30 - - 9.65 5,220 7,120 23
PGE 3.85 1.40 - - 2.99 >60 >60 23
r t 4.26 - - - 1.50* - - 34
t i 2.6-3.8 - - 2.16 - - - 35
t i
- - 0.76 - - - - 36
Alkyl glycidyl 
ether (C8-C10)
9.4 - - - - - - 30
Alkyl glycldyl 
ether (C12-C14)













2.57 0.98 1.24 — 33
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TABLE XIV-5
DEGREE OF IRRITATION* PRODUCED IN RABBITS 
BY TOPICAL APPLICATION OF UNDILUTED GLYCIDYL ETHERS
Skin Eyes
Single Repeated Single
Compound Application Application Application












































































DEGREE OF IRRITATION* PRODUCED IN RABBITS 


































♦Numerical scores are based on the method described by Draize [43] 
and by Smyth et al [34]. Maximum severity is indicated by a score 
of 8 for skin irritation and 110 for eye irritation in the Draize sys­
tem, and by a score of 10 for both skin and eyes in the method of Smyth 
et al.
**Severe hyperemia of the cornea, disappearing within 96 hr 
***Applied for 7 hr x 7 d
195
TABLE XIV-6





















AGE + (0)* n.d.** n. d . n.d. n.d. n.d. 57
BGE + (-) n.d. n.d. n.d. n.d. n.d. 57
If + (-) - - + - + 58
CGE + (-) + - + - - 58
DGE + (-) n.d. n.d. n.d. n.d. n.d. 57
PGE + (-) n.d. n.d. n.d. n.d. - 49
Alkyl glycidyl 
ether (C12-C14)
-(+) - ?*** - - - 58
Dicyclopentadiene 
glycidyl ether




+ (0) n.d. n.d. n.d. n.d. n.d. 57
Diphenylol propane 
diglycidyl ether
-(+) n.d. n.d. n.d. n.d. n.d. 57
M + (+) - - ? - - 58
Neopentyl glycol 
diglycidyl ether
+ (0) + ? + - ? 58
♦Character in paretheses indicates the effect of adding rat liver homogen- 
ate to the assay: (+) = increased mutagenic activity; (-) = decreased
activity; (0) = no effect.
**n.d. = Compound not tested in this system




CALIBRATION SETUP FOR PERSONAL SAMPLING PUMP 
WITH CHARCOAL OR TENAX-GC TUBE
197 *  U.S. GOVERNMENT PRINTING OFFICE: 1978—  7 5 7 - 1 4 1 / 1 8  1 6
D E P A R T M E N T  O F  
H E A L T H , E D U C A T IO N , A N D  W E L F A R E
P U B L I C  H E A L T H  S E R V I C E  
C E N T E R  F O R  D I S E A S E  C O N T R O L  
N A T I O N A L  I N S T I T U T E  F O R  O C C U P A T I O N A L  S A F E T Y  A N D  H E A L T H  
R O B E R T  A .  T A F T  L A B O R A T O R I E S  
4 6 7 6  C O L U M B I A  P A R K W A Y .  C I N C I N N A T I .  O H I O  4 3 2 2 6
O F F I C I A L  B U S I N E S S
P E N A L T Y  F O R  P R I V A T E  U S E ,  * 3 0 0
P O S T A G E  A N D  F E E S  P A I D  
U . S .  D E P A R T M E N T  O F  H E . *  
H E W  3 9 6
DHEW (NIOSH) Publication No. 78-166
